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ABSTRACT 
1.1  The Role of Growth-Associated Transcription Factors c-Jun and ATMIN in 
Neuronal Regeneration and Repair 
Subsequent  to  neuronal  injury,  increased  levels  of  protein  synthesis  accompany 
associated rises in transcription factor expression. Two transcription factors involved in the 
cellular stress response are c-Jun and ATMIN.  
Neuron-specific deletion of c-Jun resulted in defects in perineuronal sprouting, lymphocyte 
recruitment and microglial activation. Motoneurons also exhibited an atrophic phenotype, 
reduced target reinnervation and resistance to cell death. Additionally, mutants lacking Jun 
expression  in  peripheral  Schwann  Cells  exhibited  decreased  regeneration  and  target 
muscle reinnervation, with accompanying deficits in cell survival, which highlights the dual 
role of c-Jun in  response to stress.  Homozygous deletion of JNK1,  JNK2 or  JNK3,  or 
substitution  of  the  c-Jun  N-terminal  serine  phosphoacceptor  sites  (ser63&73),  with 
alanines  (JunAA),  did  not  produce  a  difference  in  response  to  injury.  This  evidence 
indicates that N-terminal phosphorylation of ser63&73 does not play an essential function 
for axonal regeneration in vivo, while the whole c-Jun is clearly needed to successfully 
mount a regenerative response. 
ATMIN
ΔN  mutants,  which  have  CNS-specific  Nestin::Cre-mediated  ATMIN  deletion, 
exhibited  higher  transcription  factor  expression  (c-Jun,  Activating  Transcription  Factor-
3/ATF3) in facial motoneurons – both baseline and following peripheral facial axotomy - 
and  increased  central  post-traumatic  sprouting  of  CGRP-and  galanin-immunoreactive 
motoneurites. Although there was no effect on gross functional recovery or neuronal cell 
death,  retrograde  transport  of  florescent  markers  (Fluoro-Gold,  MiniRuby)  revealed 
augmented branching under normal conditions and during the reinnervation of peripheral P a g e  | 4 
 
 
 
motor  targets.  In  the  spinal  cord  injury  model,  ATMIN
Δn  animals  showed  increased 
numbers  of  corticospinal  tract  (CST)  axons  projecting  to  both  dorsal  horns  and 
contralateral CST, as well as bilateral impairment in precise co-ordinated motor behaviour 
following  dorsolateral  hemisection.  This  highlights  the  role  of  ATMIN  as  an  important 
regulator of axonal guidance and pruning in neuronal development and regeneration. 
Altogether,  these  findings  demonstrate  the  essential  roles  of  c-Jun  and  ATMIN  in  the 
neuronal stress response following nerve transection. 
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L2/HNK-1    L2 Carbohydrate  
LIF       Leukaemia Inhibitory Factor  
MAC-1     aM integrin  
MAGs      Associated glycoproteins  
MAP       Mitogen Activated Protein  
MAPK      Mitogen-Activated Protein Kinase  
MAPKK, MEK     MAPK Kinase  
MAPKKK     MAPK Kinase Kinase  
MBP       Myelin Basic Protein  
MCSF      Monocyte Colony Stimulating Factor  
MHC       Major Histocompatibility Complex  
MN       Motor Neuron  
MPF       Maturation/M-phase promoting factor  
MR       Miniruby  
MU       Mutant  
N       Neurons  
NA       Uncorrected profile estimate per unit of area 
NBS -1      Nibrin  
Ncd      Neuronal Cell Death 
Nes::cre     Nestin promoter-driven Cre Recombinase  
NESC      Neuroepithelial Stem Cell  
NeuN      Neuronal Nuclei  P a g e  | 19 
 
 
 
NF kappa-b     Nuclear factor kappa-b  
NGF       Nerve Growth Factor  
NO       Nitric oxide  
NP      Neuropeptide 
NOD       Non-Obese Diabetic  
NRSF/REST     Neuron-restrictive silencer factor/RE-1 silencing transcription factor  
NT -3      Neurotropin 3  
NV      Corrected estimate of object number per unit of volume  
(numerical density) 
O       Oligodendrocytes  
O2-      Superoxide  
OLV       Optical luminosity value  
P0 x jun
f/f     Mice lacking c-Jun in Schwann cells  
P0      Myelin Protein 0  
P0::cre     P0 promoter-driven Cre Recombinase  
pAPCs     Professional antigen presenting cells  
PB       Phosphate Buffer  
PB/BSA     Bovine Serum Albumin in 0.1M PB  
PBS       Phosphate buffered saline  
PCR       Polymerase chain reaction  
PFA       Paraformaldehyde  
PI(4,5)P2    Phosphoinositol-4,5-diphosphate  
PI3K       Phosphatidyl-inositol-3 kinase  
PKA       Protein Kinase A  
PMP22    Peripheral myelin protein-22  
PNS       Peripheral Nervous system  
POSH      Plenty of SH3  
Rb       Rabbit  
ROS       Reactive Oxygen Species  
RST       Rubrospinal tract  
Rt       Rat  
SC       Schwann Cell  
SCID       Severe Combined Immunodeficiency  
SEM       Standard Error of the Mean  
Ser63&73    Serine 63 and 73  P a g e  | 20 
 
 
 
SHH       Sonic Hedgehog  
SI       Staining intensity  
SKRP-1    Stress –activated protein kinase pathway-regulating phosphatase 1  
SQ/TQ motifs    Serine or threonine residues followed by glutamine  
SRS      Systematic Randomly Sampled  
STAT-3    Signal transducer and activator of transcription-3  
Syn::cre     Synapsin promoter-driven Cre Recombinase  
T      Mean thickness of the section  
TF      Transcription Factor 
TFC       Transcription Factor Complex  
TGF       Transforming Growth Factor  
Thr91&93    Threonines 91 and 93  
TNFR      Tumour necrosis factor receptors  
TPA      12-O- Tetradecanoylphorbol-13 acetate  
TRAIL      TNF-related apoptosis-inducing ligand  
TRE      12-O- Tetradecanoylphorbol-13 acetate Response Element  
TUNEL     TDT UTP Nick End Labelling  
uSTT       Unpaired Student‘s t test  
VAChT     Vesicular Acetyl Choline Transporter  
WT       Wild type  
Zn2
+      Zinc  
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CHAPTER 2:  INTRODUCTION 
 
Nerve injury results in weakness, altered sensation, pain and loss of function below the 
level of the injury. Here, the extent of nerve injury (and also the resulting pain) can range 
from  mild  to  severe,  necessitating the  need for  better  understanding  of  the  underlying 
mechanisms in injury management.  
Axonal  injury  –  particularly  peripheral  nerve  injury  –  can  affect  several  different 
neurological systems. One of the most common peripheral nerves affected by injury is the 
facial motor nerve, of which the most prevalent type of injury is Bell‘s palsy. Each year, 
roughly one in 5000 individuals in the UK develops this condition (BUPA, 2009). Although 
Bell‘s palsy usually arises spontaneously from edema caused by viral infection or diabetes, 
eighty percent of facial motor nerve trauma also results in Bell‘s palsy.  
From a research point of view, the assembly of facial motoneurons into a tightly packed, 
easily  identifiable  nucleus  with  high  homogeneity,  the  separation  by  the  Blood  Brain 
Barrier  (BBB)  of  facial  motor  neurons  from  their  axons  and  the  well  characterized, 
successful  regenerative  response  of  the  facial  motor  nerve  also  makes  it  an  ideal 
paradigm in which to study the cellular response to injury.  P a g e  | 22 
 
 
 
2.1  Peripheral Regeneration 
In anatomical terms, the central nervous system (CNS) consists of the brain and spinal 
cord;  the  peripheral  nervous  system  (PNS)  consists  of  all  other  nerve  tissue  located 
peripherally to the CNS. After injury, the PNS regenerates spontaneously whereas the 
CNS does not. These mechanisms are poorly understood, but involve synchronization of 
several key factors and systems, including the expression of both neuronal growth signals 
and trophic cues from the local microenvironment. 
2.1.1  Wallerian Degeneration 
In the injured peripheral nerve, a series of events will take place. First, neurofilaments and 
microtubules  in  the  axoplasm  of  the  distal  nerve  segment  begin  to  deteriorate.  This 
process was first characterized by Augustus Waller (Waller, 1850) and is called Wallerian 
Degeneration. Wallerian Degeneration is powered by a Ca2+ proteolytic mechanism that 
involves Calpain (Nixon et al., 1994; Schlaepfer and Hasler, 1979). Severed neurite ends 
retract via a vesicle-mediated process (Krause et al., 1994) and as early as thirty minutes 
after injury, both proximal and distal axons degenerate several hundreds of micrometres, a 
process termed Acute Axonal Degeneration (AAD, Kerschensteiner et al. 2005). Schwann 
cells degrade myelin into smaller units called ovoids, which are marked for opsonisation by 
peripheral  macrophages  (Vargas  and  Barres,  2007).  Wallerian  Degeneration  proceeds 
down the distal nerve segment in a particular fashion, with the axotomized portion of the 
distal tip degrading within hours, neuromuscular denervation occurring within 12-24 hours 
and axonal shaft degradation around 3 days following injury (Chaudhry et al., 1992; Griffin 
and Thompson, 2008; Griffin et al., 1996; Gillingwater and Ribchester, 2003; Raivich et al., 
1991). It is essential that peripheral macrophages and Schwann Cells quickly phagocytose P a g e  | 23 
 
 
 
the extracellular debris created by this process, since extracellular myelin has been shown 
to be inhibitory to axonal sprouting (McGee and Strittmatter, 2003).  
2.1.2  Schwann Cell Activation 
Two to three days post-injury, Schwann cells become activated and begin to proliferate 
(Salonen  et  al.,  1988).  Schwann  cells  separate  from  their  myelin  sheath  at  Schmidt-
Lanterman incisures and create Bands of Büngner which guide axons to their appropriate 
targets (Williams and Hall, 1971b, 1971a; Ghabriel and Allt, 1979a, 1979b). They also 
release cytoplasmic Ciliary Neurotrophic Factor (CNTF) stores and express several growth 
and survival associated factors such as Brain-Derived Neurotrophic Factor (BDNF), Glial 
Cell-Derived Neurotrophic factor (GDNF) and Leukaemia Inhibitory Factor (LIF, Boyd and 
Gordon 2002, 2003; Meyer et al. 1992; Sendtner et al. 1994; Terenghi 1999). 
Although the Schwann cells separate from the myelin, the basal lamina remains intact. 
Studies show that as long as the basal lamina remains intact, elongation can proceed – 
even in the absence of Schwann cells (Fugleholm et al., 1994).  
2.1.3  Developmental Regulation of Schwann Cells 
Schwann cells originate from neuroepithelial stem cell precursors in the neural crest. Upon 
regulatory  signals  like  Sox-10  upregulation,  they  differentiate  into  Schwann  Cell 
precursors, which express Myelin Protein 0 (P0) and brain fatty acid binding protein, as 
well as Cadherin 19 (Takahashi and Osumi, 2005; Jessen, 2004). Morphologically, their 
processes begin to envelop bundles of axons – indicating differentiation into the immature 
SC phenotype, which express markers S100 protein, GFAP and O4 glycolipid.  P a g e  | 24 
 
 
 
At this point, a fate decision is made to either become myelinating or non-myelinating; this 
decision  is  influenced  by  neuregulin-1  expression,  which  inhibits  P0  and  subsequent 
myelination signals  (Cheng and Mudge,  1996).  In addition,  transcription  factor  Krox-20 
(also known as Early Growth Response Protein 2/Egr2) is indispensable for Schwann cell 
myelination, although it is not required for oligodendrocyte myelination (Parkinson et al., 
2004; Lee et al., 1997; Jessen, 2004). Other pro-myelin cues are provided by Nab1 and 2, 
Oct-6, Brn2 and NFκB (Yoon et al., 2008; Ghislain and Charnay, 2006; Le et al., 2005; 
Nickols et al., 2003; Jaegle et al., 2003; Topilko et al., 1994).  
Schwann Cells can revert back from myelinating or non-myelinating SCs to immature SCs 
in the presence of high levels of c-Jun and via cyclic adenosine monophosphate (cAMP) 
and the inhibition of the Krox-20 pathways (Parkinson et al., 2008; Mirsky et al., 2008). 
Here, c-jun and Krox-20 have antagonistic functions in Schwann Cell differentiation (Krox-
20) and de-differentiation (c-Jun).  
2.1.4  Chromatolytic Response 
Following nerve injury, lesioned neurons initiate a chromatolytic response. The neuronal 
cell body cytoplasm swells and displaces the nucleus to the periphery of the cell soma 
(Bishop,  1982).  Restructuring  of  the  rough  endoplasmic  reticulum  causes  basophilic 
material  in  the  cytoplasm  to  be  more  evenly  distributed.  Several  electrophysiological 
processes are affected: chromatolytic cells exhibit decreased resting potential, conduction 
velocity  and  duration  of  after-hyperpolarization  as  well  as  increases  in  action  potential 
overshoot  (Huizar  et  al.,  1977).  There  is  also  the  onset  of  proximal  sprouting.  This 
regenerative sprouting refers to the growth cones that project from the proximal tip of the 
injured axon and extend filopodia along bands of Büngner toward extracellular targets, 
expressing markers CGRP, Galanin and Vesicular Acetyl Choline Transporter (VAChT) P a g e  | 25 
 
 
 
(Makwana et al., 2009). Motor neuron axons extend processes preferentially toward their 
target distal segment along a chemotactic gradient – a process known as Neurotropism – 
and sometimes innervate several different Schwann cell tubes in the distal segment (Cajal, 
1928).  
Experiments using peripheral nerve grafts in the CNS show that some CNS neurons, in 
particular retinal ganglion cells, medullary and pontine reticular neurons, as well as striatal, 
cerebellar and thalamic neurons, can extend axonal processes through a peripheral nerve 
graft (Campbell et al., 2005; Hüll and Bähr, 1994; Schuetz et al., 2003; Tom and Houle, 
2008; Houle et al., 2006; Zhang et al., 1995; Woolhead et al., 1998; Vaudano et al., 1995, 
1998, 1996). Since these neuronal populations do not spontaneously regenerate in the 
CNS,  this  differential  growth  response  indicates  that  the  extracellular  Schwann  Cell 
environment might play a pivotal role in successful regeneration.  
2.1.5  Preferential Motor Reinnervation 
Not all Schwann Cells are created equal. Peripheral motor neurons exhibit a phenomenon 
known  as  preferential  motor  reinnervation  (Brushart,  1988,  1993;  Brushart  and  Seiler, 
1987).  Motor axons preferentially reinnervate  motor targets  and not sensory targets or 
cutaneous tissue. This is thought to be due primarily to the differential nature of Schwann 
cells that surround sensory and motor axons. Schwann cells surrounding sensory axons 
exhibit a pruning phenotype, whereas those surrounding motor neuron axons encourage 
growth.  L2  Carbohydrate  (L2/HNK-1)  is  expressed  primarily  on  Schwann  cells  that 
innervate  motor  pathways  rather  than  sensory  ones.  Through  association  with  cell 
adhesion  molecules,  L2  Carbohydrate  is  thought  to  play  a  role  in  preferential  motor 
reinnervation; it is present both during and after Wallerian Degeneration, which highlights 
its  omnipresent  role  in  this  phenomenon  (Nieke  and  Schachner,  1985a;  Martini  et  al., P a g e  | 26 
 
 
 
1994). However, preferential reinnervation is not unique to motor neurons; studies using 
the  transected  femoral  nerve  show  that,  after  sequential  labelling,  transected  femoral 
sensory neurons show preferential sensory reinnervation (Madison et al., 1996) and more 
recent studies suggest an alternative trophic hierarchy model, with muscle contact at the 
top, followed by terminal branch length and/or contact with skin (Robinson and Madison, 
2004). 
2.1.6  Rate of Regeneration 
Speed  of  regeneration  varies  depending  on  degree  of  nerve  injury.  Characterized  by 
Sunderland (Sunderland, 1951), a first degree injury, which affects only myelination, can 
take up to twelve weeks to heal fully. Second through sixth degree injuries, which involve 
much more damage and also Wallerian Degeneration, sometimes never regenerate fully, 
although, in rodents, reinnervation is generally believed to proceed at a rate of 2-6 mm per 
day (Hadlock et al., 2005).  
Due  primarily  to  the  extracellular  environment,  damaged  neurons  in  the  PNS  tend  to 
regenerate spontaneously whereas their CNS counterparts do not (Vaudano et al., 1995). 
As  such,  approaches  to  CNS  repair  commonly  consist  of  attempts  to  shape  the  CNS 
environment  in  a  way  that  would  closely  mimic  that  of  the growth-permissive  PNS.  In 
particular, if one modifies or deletes a particular type of gene, especially one involved in 
growth, death or repair, it could affect regrowth of damaged axons. 
2.2  Central Regeneration  
Shortly after injury, neuronal cells express immediate early genes – such as transcription 
factors  (TFs)  c-jun,  c-fos  and  ATF3.  In  the  PNS,  upregulation  remains  consistent P a g e  | 27 
 
 
 
throughout  the  course  of  regeneration;  in  the  CNS,  this  reaction  is  quickly  quenched. 
Nerve  Growth  Factor  (NGF),  Brain-Derived  Neurotrophic  Factor  (BDNF),as  well  as 
Laminin  and  several  cell  adhesion  molecules  also  show  lower  levels  of  expression  in 
response to CNS rather than PNS injury. Additionally, sprouting growth cones that are 
integral for PNS regeneration are quickly dampened by the CNS extracellular environment. 
Several key factors found in CNS glia and not PNS glia are commonly attributed to this 
differential growth. 
2.2.1  Oligodendrocytes 
First, the CNS contains three major types of glia – Oligodendrocytes (or Oligodendroglia), 
Astrocytes (or Astroglia) and Microglia. Microglia are a special population derived from a 
monocytic  lineage  which  behave  primarily  in  an  immune  surveillance  and  phagocytic 
function;  their  role  will  be  discussed  later.  Oligodendrocytes  are  bulbous  glia  primarily 
responsible for producing CNS myelin. However, oligodendrocytes function differentially to 
their  peripheral  counterparts  –  the  Schwann  cells.  Some  of  the  most  pronounced 
differences involve their role in myelination and phagocytosis. While peripheral Schwann 
cells myelinate axons in a strictly 1 to 1 fashion – that is, one Schwann Cell will myelinate 
only one axon – each oligodendrocyte can myelinate several axons simultaneously (Melli 
and Höke, 2007). After injury, Wallerian degeneration occurs in the distal nerve segment of 
CNS axons as well as PNS axons; however failure of these CNS axons to regenerate is 
partially attributable to differential glial activation. As mentioned previously, Schwann Cells 
are capable of phagocytosing extracellular debris when ‗activated‘ by neuronal damage, 
whereas oligodendrocytes are not – thus they are unable to make the myelin ovoid bodies 
present in regenerating peripheral nerves. After injury, oligodendroglia continue to produce 
myelin whereas Schwann cells decrease synthesis of both myelin lipids and proteins within 
48h following injury (Trapp et al., 1988; White et al., 1989; Morrison et al., 1991). Myelin P a g e  | 28 
 
 
 
contains several cell surface proteoglycans that inhibit neuronal growth, some of which are 
called  nogo  (Filbin,  2003;  Schwab,  2004),  myelin  associated  glycoprotein  (MAG)  and 
oligodendrocyte-myelin glycoprotein (OMGP,Spencer, 2004). It has been shown that all 
three of these molecules bind to the nogo receptor present in neuronal growth cones and 
cause the cones‘ subsequent collapse (Giger et al., 2008). Also, due to the tight regulation 
of  the  Blood  Brain  Barrier  (BBB),  less  monocytic  infiltration  (which  helps  clean  up 
extracellular myelin and debris) is present in the CNS compared to the PNS. 
2.2.2  Astrocytes 
Astrocytes  are  star-shaped  glia  that,  under  normal  circumstances,  provide  structural 
integrity within the brain.  They display a multitude of immune cell signalling receptors, 
including Toll-like receptors, nucleotide-binding oligomerization domains, double-stranded 
RNA-dependent protein kinase, scavenger receptors, mannose receptors and components 
of the complement system (Farina et al., 2007). They also have a role in promoting brain 
metabolic  processes  and  helping  to  maintain  the  BBB.  Astrocytes  express  two  main 
intermediate  filament  proteins  –  vimentin  and  Glial  Fibrilatory  Acidic  Protein  (GFAP). 
During development, vimentin immunoreactivity predominates, but is slowly replaced by 
GFAP in differentiated neurons. Once Astrocytes become activated, usually as a result of 
neural injury or trauma, they upregulate GFAP, and after severe trauma, also vimentin 
(Bramanti  et  al.,  2010).  They  then  extend  processes  to  injured  neurons  and  begin  to 
secrete reactive oxygen intermediates like interleukin (IL)-1β, inducible nitric oxide (NO) 
synthase, the NO metabolite nitrite and superoxide (O2-), in vitro studies link this with the 
ERK1/2, p38 MAPK and JNK signalling pathways  (Tichauer et al., 2007; Ranaivo and 
Wainwright, 2009). Astrocyte reaction also leads to the production of growth factors, like 
GM-CSF, that promote microglial growth and activation (Ovanesov et al., 2008; Lee et al., 
1994)  and  initiate  the  cell  response  to  damage  (Liu  et  al.,  1994).  Recent  data  shows P a g e  | 29 
 
 
 
Astrocyte activation can also induce oligodendrocyte proliferation in response to injury via 
the  sonic  Hedgehog  (SHH)  pathway  (Amankulor  et  al.,  2009)  and  that  astrocytes  and 
microglia function cooperatively in the neuronal response to injury (Pifarré et al., 2009; 
Butchi et al., 2009; Martin et al., 1994; Ranaivo et al., 2009).  
Astrocytes also exhibit unique properties that inhibit central regeneration. Notably, after 
injury, reactive astrocytes as well as oligodendroglial precursors, contribute to glial scar 
formation– which is largely inhibitory to growing axons due to the enhanced expression of 
Chondroitin  Sulfate Proteoglycans (CSPGs). Common CNS repair strategies consist of 
using  a  compound  called  chondroitinase  ABC  to  degrade  certain  disaccharide 
glycosamino glycan (GAG) chains in these CSPGs. This alleviates the inhibitory effects of 
CSPGs  and  promotes  axonal  passage  through  the  glial  scar  (Bradbury  et  al.,  2002; 
Curinga et al., 2007).  
2.2.3  Synaptic Stripping 
Along  with  brain  resident  microglia,  Astrocytes  participate  in  a  CNS  process  called 
synaptic stripping (Blinzinger and Kreutzberg, 1968) During this process, presynaptic clefts 
between dendrites of damaged neurons and terminal boutons of undamaged neurons are 
filled  and  separated  by  processes  of  activated  astrocytes  and  microglia.  It  is  unclear 
whether microglia and astrocytes invade these clefts to separate the presynaptic boutons 
from  the  postsynaptic  dendrites  or  whether  neurons  first  create  the  space;  however 
microglia are present  in stripped synapses from day 2-4 following injury and activated 
astrocytes invade soon after (Graeber et al., 1988; Streit and Kreutzberg, 1988; Graeber 
and  Kreutzberg,  1986;  Aldskogius  et  al.,  1999).  Recent  studies  using  focal  cortical 
inflammation  models  suggest  that  synaptic  stripping,  at  least  by  microglia,  is P a g e  | 30 
 
 
 
neuroprotective,  due  to  the  absence  of  pathology  following  both  acute  and  immune-
mediated lesion using injection of killed bacteria (Trapp et al., 2007). 
2.2.4  T Cells 
A T-cell is a type of immune effector cell that homes to the site of injury and there can 
exert its trophic effects as a mediator of either the pro-inflammatory or anti-inflammatory 
response. Pro-inflammatory responses in the central nervous system are thought to be 
neurodestructive, while anti-inflammatory responses are considered neuroprotective. Th1 
and Th17 subsets of T-cells are pro-inflammatory, whereas Th2, Tr1, and Foxp3(+) Treg 
cells are anti-inflammatory. Furthermore, CD4(+) T helper (Th) 2 cells, but not Th1 cells, 
have been shown to participate in the rescue of mouse facial motoneurons (FMN) from 
axotomy-induced  cell  death  (Xin  et  al.,  2008),  possibly  through  NTF-dependent 
mechanisms that support motoneuron survival before target reconnection occurs (Serpe et 
al., 2005). Furthermore, these CD4(+) T cells can initially be activated peripherally and 
subsequently reactivated centrally. (Sanders and Jones, 2006). 
T cells enter the injury site within the first 24 hours following insult. Although initial rate of 
infiltration is consistent, there is evidence that after 14 days, at  the peak  of the injury 
response, the number of invading T-cells in the facial motor nucleus is proportional to the 
severity of insult and resulting cell death – animals with crush injury showed fewer T-Cells 
in the facial motor nucleus than did animals with facial nerve resections (Ha et al., 2008). 
In addition, there is evidence of indirect microglial regulation of CD3 positive lymphocyte 
recruitment following injury through monocyte colony stimulating factor (MCSF) secretion, 
but T cells do not moderate microglial reactivity in the axotomized FMN (Ha et al., 2006). 
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peripheral nerve injury (Kalla et al., 2001), later interactions between T cells and microglia 
do seem to confer modest neuroprotection to injured motoneurons (Ha et al., 2006). 
2.3  Inflammation and Regeneration- Microglia and Macrophages in the Nervous 
System 
In the brain, resident microglia play a significant role in clearing debris within the CNS. In 
several  types  of  injury  models,  damage  to  the  BBB  allows  peripheral  macrophages to 
invade  the  brain  and  participate  in  the  injury  response;  this  can  affect  experimental 
outcome.  
However,  recent  studies  show  microglia  and  macrophages  have  different  roles  in  the 
regenerative  response  and  that  invading  peripheral  macrophages  can  regulate  local 
inflammation, as well as repress microglial activation (Shechter et al., 2009). Because of 
this, several researchers use injury models like the axotomized facial motor nucleus where 
the BBB remains intact and peripheral macrophages do not enter the nucleus itself.  
2.3.1  Microglia 
Microglia  are  perhaps  the  most  important  inflammatory  mediators  in  the  CNS;  they 
comprise almost twenty percent of the CNS glial population and are loosely deemed brain-
resident  macrophages.  Like  their  PNS  counterparts,  they  originate  from  myeloid 
precursors. However, as their name suggests, these cells are also glia and form structural 
support for neurons as well. Microglia constantly circulate and patrol the brain and are 
quick to detect neuronal injury. In their ramified (or inactivated) form, microglia have a 
small nucleus and long, extended processes that they use to scan the environment. These 
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(MHC),  which  is  characteristic  of  other  antigen  presenting  cells  (APCs,  Aloisi,  2001). 
However, when microglia are activated - due to cues from the neuronal cellular response - 
they develop large, bulbous nuclei and start to express cell surface αM integrin subunit, 
MHC  (either  type  I  or  II),  as  well  as  CD40,  CD11b,  Fc  receptors  I–III,  complement 
receptors (CR1, 2, and 4), β2 integrins, the co-stimulatory molecules CD80, CD86, and 
intercellular adhesion molecule-1 (ICAM-1, Matsumoto et al. 1986; P. L. McGeer et al. 
1993; Hickey & H. Kimura 1988; Minagar et al. 2002; Woodroofe et al. 1991). They are 
then able to secrete reactive intermediates like TNF-α, NO, IL-6 or TGF-β1, IL-1β and IL-
10 and participate in the injury response as chemical signalling cells (Dopp et al., 1997; 
Woo et al., 2003; Kraft et al., 2009; Jana et al., 2002). Interestingly, depending on the 
stimulus, microglia play different roles in the injury response; for example, microglia show 
a  neurotoxic  phenotype  following  treatment  with  lipopolysaccharides  (LPS)  but  show 
neuroprotection when primed with interleukin-4 (IL-4, Butovsky et al. 2006). In response to 
cellular debris, microglia upregulate cell-surface TNF receptors (TNFRs) 1 and 2 (Dopp et 
al., 1997), as well as transcription factors AP1 and STAT3 (Qin et al., 2007; Suh et al., 
2005). Phagocytic microglia express αXβ2 integrin subunit on their cell surface and are 
known  effector  cells that  can  engulf  debris  and  participate  in the  clearing response  to 
neuronal  insult  (Bohatschek  et  al.,  2004,  2001).  Inside  the  cell,  chemically  destructive 
lysozomes form and chemotoxic intermediates are secreted. Phagocytic microglia found in 
periventricular zones preferentially cannibalise other phagocytic microglia during normal 
development (Hristova et al., 2009). Although some authors claimed that, after axotomy, a 
significant proportion of activated microglia are derived from peripheral hematopoietic cells 
that enter the CNS and differentiate into microglia in situ (Priller et al., 2001), this has been 
disproved in many experiments (Fluegel 2001, Bohatschek 2001).  P a g e  | 33 
 
 
 
2.3.2  Macrophages 
Peripheral macrophages play a similar role to microglia; however they are generally more 
efficient due to their activation. They express MHC on their cell surfaces and are able to 
ingest debris, degrade axons and present antigen to T-Cells (which are identifiable by CD3 
immunoreactivity). Activated macrophages can act as pro- or anti-inflammatory mediators, 
dependent on the means by which they are activated (DiPietro et al., 1998; Gallin and 
Goldstein, 1992) Interferon-(IFN-)γ is the classical macrophage activating factor leading to 
synthesis  and  release  of  inflammatory  mediators,  enhanced  phagocytosis  and 
upregulation of MHC class II and co-stimulatory molecules (North, 1978; Murray, 1988). 
However,  other  stimuli  such  as  interleukin-(IL-)  4  can  initiate  a  state  of  ‗alternative 
activation‘ with the development of anti-inflammatory characteristics (Goerdt and Orfanos, 
1999).  In  addition,  invading  macrophages,  through  ILβ  upregulation,  enhance  NGF 
expression;  NGF  is  an  important  intermediate  in  axonal  regeneration,  which  will  be 
discussed  later  (Lindholm  et  al.  1987;  Nathan  and  Sieff  1987).  Furthermore,  there  is 
evidence that axonal outgrowth is increased by macrophage application (Stolz et al., 1991; 
Miyauchi  et  al.,  1997)  and  that  inflammation  near  the  nerve  cell  body  enhances 
regeneration of DRGs (Lu and Richardson, 1991). 
2.4  Injury Associated Molecules 
Nerve  transection  rapidly  induces  several  different  molecular  pathways  in  the  injured 
neuron. These include cell death signals, neurotrophic factors, cell adhesion molecules, 
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2.4.1  Cell Death Signals 
There  are  several  cell  surface  molecules  associated  with  signalling  cell  death.  For 
example, CD95 (fas, APO-1), TNF-related apoptosis-inducing ligand (TRAIL) R1/R2 (DR4 
and DR5, respectively) and tumour necrosis factor receptors (TNFR) 1 and 2 have been 
linked to neuronal cell death following injury; all but TNFR2 carry identified cytoplasmic 
death domains (Terrado et al., 2000; Raivich et al., 2002; Ugolini et al., 2003; Schutze et 
al., 2008) However, not every time that these signals are induced does it lead to cell death. 
Thus, Fas and TNFR1 are capable of transducing anti-apoptotic signals through activation 
of  a  MAPK  cascade  or  nuclear  factor  kappa-b  (NF  kappa-b)  downstream  activation 
(Schutze et al., 2008) .  
Other factors found further downstream include the caspase and bax systems. Genetic 
deletion of both of these systems has been shown to prevent cell death (Chan et al., 2003; 
Yick et al., 2003; Sun and Chang, 2003; Sun and Oppenheim, 2003). Caspase systems 
consist of cysteine proteases that cleave after an aspartate residue (Alnemri et al., 1996) 
in their substrates and are a conserved family of enzymes that irreversibly commit a cell to 
die. The first caspase identified in humans was interleukin-1 -converting enzyme (ICE), 
also known as caspase-1, (Cerretti et al., 1992; Thornberry et al., 1992) . However, the 
role of caspase-1 in apoptosis was not properly characterized until its nematode worm 
Caenorhabditis elegans correlate - cell-death abnormality-3 (ced-3) was found and its role 
was elucidated (Yuan et al., 1993; Xue et al., 1996). Since then, at least 14 separate 
caspases have been identified in mammalian systems, of which 11 exist in humans (Shi, 
2002). Furthermore, caspase action seems to be regulated at a post-translational level, 
due to the need for rapid activation after injury. Caspases are first synthesized as pro-
caspases and once they are activated by death receptors like FAS, TRAIL 1 /2 and TNFR 
and  the  like,  active  caspases  aggregate  in  a  cluster  formation  where  they  proceed  to P a g e  | 35 
 
 
 
establish an effector phenotype (Yuan and Horvitz, 2004). Both Bax and caspases act 
downstream of c-Jun phosphorylation by JNKs (Chan et al., 2003; Sun et al., 2003; Sun et 
al.,  2003);  this  suggests  that  cellular  atrophy,  as  a  result  of  c-Jun  n-terminal 
phosphorylation, could induce Bax and subsequent caspase cascades.  
2.4.2  Neurotrophic Factors 
Not  only  is  the  cellular  response  to  damage mediated  by  death  signals,  but  it  is  also 
controlled by neurotrophins released into and by the local microenvironment. Leukaemia 
Inhibitory  Factor  (LIF),  Ciliary  Neurotrophic  Factor  (CNTF),  Fibroblast  Growth  Factor 
(FGF), Nerve Growth Factor (NGF) and neurotropin 3 (NT-3) are factors secreted near the 
site of injury that help mediate the axonal response by acting on regenerating proximal 
axonal tips (Eckenstein et al., 1991; Funakoshi et al., 1993; Sendtner et al., 1994a).  
CNTF  binds  to  and  activates  the  CNTF  receptor  (CNTFR),  subsequently  inducing 
downstream  activation  of  signal  transducer  and  activator  of  transcription-3  (STAT-3). 
STAT-3 is phosphorylated in the proximal neuronal tip and is later found in the cell body, 
presumably via retrograde transport (Lee et al., 2004), which suggests that it could carry 
the injury signal from the site of injury to the cell soma. Furthermore, neuronal deletion of 
STAT-3 has been linked to increased levels of post-traumatic cell death (Schweizer et al., 
2002). Experiments ablating CNTF function show a significant delay in the appearance of 
phosphorylated STAT-3 and also a delay in its nuclear translocation following neuronal 
stress (Dobrea et al., 1992; Rende et al., 1992). The fact that this function of STAT-3 is 
delayed  and  not  ablated  in  CNTF-deficient  animals  suggests  that  there  are  other 
compensatory,  albeit  less  efficient,  mechanisms  at  work  upstream  of  STAT-3.  Another 
moderator of CNTF action is Reg2 (rat) or RegIIIβ in mice. This 16 kDa secretory protein 
helps to preserve the integrity of motor neurons during development and is a powerful P a g e  | 36 
 
 
 
Schwann cell mitogen. Normally, following facial nerve section, CNTF applied locally will 
enhance  regeneration  and  help  rescue  the  injured  neonatal  facial  motor  nerve.  This 
response was absent in globally deleted RegIIIβ mutants, although motoneurons do show 
delayed myelination (Tebar et al., 2008). This illustrates the role of CNTF as an integral 
intermediate in chemical neuromodulation of the regenerative response after injury. 
Another important neurotrophic mediator is NGF. As discussed earlier in the introduction, it 
can  be  induced  by  ILβ  upregulation  by  macrophages.  NGF  has  been  described  as  a 
regulator  of  the  negative,  denervation  response  following  nerve  injury  (Raivich  and 
Makwana, 2007). Normally, similar to STAT-3, NGF is retrogradely transported to the cell 
body after injury. However, after axonal damage, particularly to the sciatic nerve, levels of 
endogenous  NGF  retrogradely  transported  to  the  soma  decrease  by  almost  tenfold 
(Raivich et al., 1991). This decrease lasts for roughly 48 hours, after which NGF levels 
reach threefold reduction from baseline, and this threefold reduction continues until the 
onset of regeneration. Interestingly, NGF neutralization using specific antibodies results in 
a  conditioning  lesion-like  effect  in  sympathetic  neurons  (Shoemaker  et  al.,  2006)  and 
axotomy-like changes even to intact cells, especially in levels of transcription factors like c-
jun, and neuropeptides (NPs) like galanin, CGRP and Neuropeptide Y (Gold et al., 1993; 
Shadiack et al., 2001a). However, if this antibody neutralization is coupled with axotomy, 
there is no effect on speed of regeneration (Diamond et al., 1987). This may be due to a 
reduction  in  the  amount  of  high-affinity  NGF  receptors  at  this  time  (Raivich  and 
Kreutzberg,  1987a,  1987b;  Verge  et  al.,  1989).  If  NGF  is  applied  externally,  it  shows 
variable results. In vitro studies link exogenous NGF application with increased neuronal 
sprouting  (Angeletti  et  al.,  1968).  In  vivo  studies,  however,  show  that  exogenous 
application  of  NGF  to  axotomized  neurons  results  in  altered  expression  of  axotomy-
induced transcription factors and growth associated molecules (Verge et al., 1995; Gold, 
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Hirata  et  al.,  2002).  This  highlights  the  role  of  negative  retrograde  signalling  and  lack 
thereof in successful peripheral mechanisms of repair.  
Lastly, studies characterizing speed of axonal regeneration have thus far focused on three 
groups of factors: Trophic Factors (like Insulin-like Growth Factor [IGF]-1, IGF-2 and Brain-
Derived Neurotrophic Factor [BDNF]), transforming growth factor (TGF) Beta Superfamily 
members (including glial-cell derived neurotrophic factor [GDNF]) and neurokines (like LIF 
and IL6). In the pinch test, a universal indicator of regenerative speed, application of IGF-1 
and  2,  as  well  as  overexpression  of  IL6  and  its  receptor,  both  resulted  in  improved 
regeneration  (Kanje  et  al.,  1989;  Glazner  et  al.,  1993;  Hirota  et  al.,  1996),  whereas 
blocking IGF-1 and 2 with antibody, as well as genetic deletion of IL6, has been shown to 
reduce  speed  of  axonal  regeneration  in  peripheral  systems  (Galiano  et  al.,  2001). 
Conversely, ablation of IL6 has led to reduced glial scar formation, increased sprouting in 
the  facial  motor  nerve  model  (Galiano  et  al.,  2001);  it  also  enhances  recovery  when 
applied after spinal cord injury (Okada et al., 2004). BDNF and GDNF application post-
injury did not improve regeneration post-injury, presumably due to the fact that expression 
levels  of  their  respective  receptors  on  axotomized  neurons  slowly  decreases  during 
chronic disconnection (Hammarberg et al., 2000). However, BDNF and GDNF application 
did promote axonal regeneration of motor neurons that had suffered chronic axotomy 3 
months prior to nerve resuture (Boyd et al., 2002, 2003a). This indicates that insufficient 
BDNF  and  GDNF  support  might  be  contributing  to  the  lack  of  response  post-injury. 
Furthermore, inhibition of BDNF (Streppel et al., 2002b) and GDNF (Sun et al., 2003) also 
decreased  collateral  sprouting  post-peripheral  nerve  transection,  which  highlights  their 
integral, albeit complicated role in sprouting after neuronal injury. Taken together, these 
data illustrate the complex and  intricate  role of neurotrophic factors  in engineering the 
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2.4.3  Cell Adhesion Molecules 
In  addition  to  soluble  molecules  molecules  that  play  a  part  in  the  orchestration  of  a 
complete  cellular  response,  regenerating  neurons  also  extend  filopodia  into  the 
neighbouring microenvironment whose interactions within the immediate vicinity dictate the 
extent and direction of axonal progression. Axotomized neurons upregulate a plethora of 
adhesion molecules that interact with extracellular matrix and cell surface molecules in the 
local  environment  (Werner  et  al.,  2000;  Vogelezang  et  al.,  2001;  Raivich  et  al.,  2002; 
Ekstrom et al., 2003; Gschwendtner et al., 2003; Wallquist et al., 2004). In response to 
axotomy,  neurons  upregulate  receptors  for  CD44  hyaluronic  acid,  (Jones  et  al.,  1997, 
2000; Kloss et al., 1999) and galectin-1 (Horie and Kadoya, 2000; Akazawa et al., 2004; 
McGraw  et  al.,  2004a,  2004b),  as  well  as  cell  surface markers  involved  in  homophilic 
binding, such as ninjurin (Araki and Milbrandt, 2000) and gicerin/CD146 (Hiroi et al., 2003). 
Further to this, FLRT3 – which has previously been characterised to complex with FGF 
receptors on cell membranes and subsequently upregulate FGF signalling (Bottcher et al., 
2004) and was characterized by Robinson, (Robinson et al., 2004) also shows enhanced 
expression  following  nerve  injury.  As  mentioned  previously,  Galanin  immunoreactivity 
increases in injured neuronal cell bodies, and is transported into extending growth cones. 
c-Jun has been suggested as a putative mediator of the cellular response to stress and 
studies show that CD44 and Galanin both have AP1 sites on their gene promoters (Anouar 
et al., 1999; Corness and Hökfelt, 1998; Lee et al., 1993; Raivich et al., 2004b) 
Eventually, modifications of neuronal cell surface markers lead to changes in expression 
levels of cell adhesion molecules on neighbouring non-neuronal cells. As such, adhesion 
molecules such as L1, NCAM and N-cadherin (Nieke and Schachner, 1985b; Bixby et al., 
1988; Martini et  al., 1994; Archer et al., 1999), and extracellular  matrix molecules like 
laminin, fibronectin, tenascin and NG2 are upregulated by non-neuronal cells in the local P a g e  | 39 
 
 
 
microenvironment after peripheral nerve injury (Manthorpe et al., 1983; Kuecherer-Ehret et 
al., 1990; Martini et al., 1990; Taira et al., 1994; Vogelezang et al., 2001; Rezajooi et al., 
2004;  Nolin  et  al.,  2008;  Buss  et  al.,  2009).  In  particular,  L1  has  recently  been 
characterized as a negative regulator of Schwann Cell proliferation in the PNS (Guseva et 
al., 2009). 
Lastly, proteases and matrix inhibitors also show upregulation after neuronal injury in both 
neurons and their non-neuronal counterparts (Sesaki and Jensen, 2001; Demestre et al., 
2004;  Davies  et  al.,  2006;  Rolls  et  al.,  2008).  Chondroitin  Sulphate  Proteoglycans, 
particularly  the  glycos  –aminoglycan  (GAG)  side  chains  thereof,  have  previously  been 
characterized as major inhibitors of axonal regeneration (Asher et al., 2000; Bradbury et 
al., 2002; Properzi et al., 2003; Sandvig et al., 2004; Beggah et al., 2005; Buss et al., 
2009) 
Upregulated  in  the  glial  scar  by  reactive  astroglia,  these GAG  chains  are  inhibitory  to 
axonal growth. Current studies are underway mapping regeneration using Chondroitinase 
ABC to specifically degrade these GAG chains (Yick et al., 2003; Ikegami et al., 2005; 
Curinga  et  al.,  2007;  Tom  et  al.,  2008;  Nakamae  et  al.,  2009).  Currently,  moderate 
functional improvements have been observed after topical Chondroitinase ABC application 
after spinal cord injury  (Bradbury et al., 2002; Galtrey et al.,  2007; Garcia-Alias et  al., 
2009; Tom et al., 2008; Ikegami et al., 2005). Similarly to GAG proteins, myelin-associated 
glycoproteins (MAGs) are synthesized by Schwann cells in response to injury. Ablation of 
MAG through specific antibody targeting has been shown to facilitate motor innervation 
(Mears et al., 2003) and duplication of peripheral myelin protein-22 (PMP22) gene has 
been shown to delay axonal maturation and remyelination in nerve xenografts (Sahenk et 
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Functional studies on cell adhesion have so far focused on the role of laminin, its alpha7 
beta1  integrin  receptor,  galectin  and  beta2-microglobulin  (β2-MG)  in  cellular  adhesion 
during  regeneration.  Genetic  global  deletion  of  β2-MG—an  important  component  of 
surface  MHC  1  interactions—results  in  a  20  percent  reduction  of  regenerating  motor 
neuron axons to cross the proximal to distal gap in the cut peripheral nerve, as well as 
increased levels synaptic stripping (Oliveira et al., 2004). Furthermore, deletion of alpha7 
integrin  subunit  causes  an  almost  40  percent  reduction  in  speed  of  motor  axon 
regeneration in similar peripheral systems, as well as delayed target reinnervation after 
facial  axotomy  (Werner  et  al.,  2000).  Similar  responses  were  observed  in  vitro,  which 
caused the disappearance of a conditioning-lesion response in sensory neurons cultured 
in matrigel or in collagen covered surfaces complemented with laminin – the substrate for 
alpha7 beta1 integrin receptors (Ekstrom et al., 2003).  
Animals lacking c-Jun in the CNS show reduced alpha7 integrin subunit upregulation post 
facial nerve transection, which could account partially for the poor regenerative response 
exhibited by these animals (Raivich et al., 2004a). Ablation of all gamma 1-dependent 
laminin isoforms, including those that are the primary ligands for alpha7 beta1 integrin, 
laminins  1  (α1β1γ1),  2  (α2β1γ1)  and  4  (α2β2γ1),  led  to  similar,  albeit  more  severe 
regenerative effects. Animals with cell-specific laminin 1 gamma chain deletion, renders 
the alpha beta gamma trimer inactive in peripheral Schwann cells. They thus exhibited 
lower levels of axon reinnervation into the distal segment of the crushed sciatic nerve 30 
days  post-injury  (Chen  et  al.,  2003;  Chen  and  Strickland,  2003).  On  the  other  hand, 
deletion of alpha4 chain in laminin 8 (α4β1γ1) did not affect axonal regeneration, although 
it  reduced  the  remyelination  of  the  regenerating  axons  (Wallquist  et  al.,  2005).  As 
mentioned previously, alpha-7 deficient mutants exhibit reduced rate of motor regeneration 
and  delayed  target  reinnervation.  It  has  also  been  observed  that  these  animals  show 
massive upregulation of beta1 integrin after facial nerve  injury,  which  coincides  with a P a g e  | 41 
 
 
 
strong increase in central axonal sprouting (Makwana et al., 2009). This might suggest that 
some compensatory mechanism, involving other alpha subunits, might be involved in this 
system.  
Laminin activity is not limited to a unimolecular or bimolecular signalling system. Due to 
their trimeric and combinatorial structure, laminins have been known to act as ligands for 
several different receptors, including the integrins, gicerin/CD146, alpha-dystroglycan, and 
beta 1,4-galactosyltransferase (Taira et al., 1994; Powell and Kleinman, 1997; Ekblom et 
al., 2003). Overexpression of the latter, beta 1,4-galactosyltransferase I, in Schwann cell 
and sensory neuron co-cultures has led to increased axonal outgrowth (Shen et al., 2003), 
and  may  reflect  the  interaction  of  laminin/galactosyltransferase  complexes  with 
downstream  axonal  receptors.  Either  way,  mounting  evidence  suggests  that  cellular 
adhesion molecules play a significant and essential role in the neuronal response to injury; 
without these molecules, neurons would not be able to extend processes into the local 
microenvironment which ultimately result in functional connections. 
2.4.4  Cell Surface Interactions 
Once  cells  form  channels  of  recognition  and  communication,  cell  surface-cytoskeletal 
interactions  permit  continued  ‗discourse‘  between  these  channels.  Codistribution  with 
phosphoinositol-4,5-diphosphate, PI(4,5)P2, of GAP43, MARCKS and CAP23 cytoplasmic 
proteins  summarised  by  the  acronym  GMC  (Willard  et  al.,  1980;  Hoffman,  1989; 
Wiederkehr et al., 1997; Bomze et al., 2001; McNamara et al., 2003), at raft regions of the 
cell  membrane  (Laux  et  al.,  2000)  accompany  cellular  changes  that  lead  to  actin 
cytoskeleton polymerization, organization and disassembly (Caroni, 1997, 2001; Frey et 
al.,  2000;  Laux  et  al.,  2000;  Golub  and  Caroni,  2005)  appearance  of  filopodia  and 
microspikes and also initiation of neurite outgrowth (Bomze et al., 2001).  P a g e  | 42 
 
 
 
Studies show that GMC molecules, while being functionally interchangeable, bind solely to 
acidic phospholipids like the aforementioned PI-(4, 5)-P2, along with calcium/calmodulin, 
protein kinase C and actin filaments. Furthermore, calcium-containing or calcium-absent 
calmodulin interactions with GMC proteins (Gerendasy et al., 1995; Dunican and Doherty, 
2000) provide a mechanism whereby growth cone signals can be inferred from changes in 
intracellular calcium levels (Hong et al., 2000; Nishiyama et al., 2003; Henley and Poo, 
2004; Henley et al., 2004; Ooashi et al., 2005). For example, inhibition of calcium influx by 
nimodipine  has  been  shown  to  enhance  axonal  regeneration  after  several  types  of 
peripheral injury – including that of the facial nerve (Andersen et al., 1990; Bar et al., 1990; 
Angelov et al., 1996; Bishop and Milton, 1998; Mattsson et al., 2001, 2005; Hydman et al., 
2007).  
Lastly,  Rho  GTPases,  such  as  RhoA,  Rac,  Cdc42  and  TC10,  are  known  to  act  as 
regulatory  switches  that  affect  cytoskeletal  structure,  dynamics,  and  cell  adhesion 
(Aepfelbacher et al., 1997; Murphy et al., 1999; Bass and Humphries, 2002; Aspenstrom 
et al., 2004; Begum et al., 2004; Coisy-Quivy et al., 2006; Bement et al., 2007; Benarroch, 
2007). Rho GTPase activation is effected by receptor-linked adaptor molecules such as 
slit-robo GTPase-activating protein 2 (Madura et al., 2004; Lin et al., 2005). After nerve 
injury, rhoA, rac, cdc42 and TC10 are upregulated, however the most striking increase in 
expression is that exhibited by TC10 (Tanabe et al., 2000; Aspenstrom et al., 2004). As 
mentioned previously, CNS neurons do not tend to regenerate spontaneously like their 
PNS  counterparts,  however,  inhibition  of  rhoA,  as  well  as  overexpression  of  cyclin-
dependent-kinase inhibitor p21 (Cip1/WAF1), which inhibits rho-kinase function by binding, 
have both been shown to enhance regeneration in CNS models (Dergham et al., 2002; 
Ellezam  et  al.,  2002;  Tanaka  et  al.,  2002).  Moreover,  studies  show  that  enhanced 
expression of p21, which is accomplished by upregulating nuclear localized protein p311, 
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motor neuron injury (Fujitani et 
al.,  2004).  Taken  together, 
these  data  suggest  that 
complex  cytoskeletal 
interactions  contribute  to  and 
maintain  the  neuronal 
regenerative  response  to 
injury. 
2.4.5  Intracellular  Signalling 
Molecules 
There  are  several  important 
intracellular  signalling 
molecules  involved  in  the 
regenerative  response.  As 
mentioned  previously,  many  are  kinases  or  activated  by  kinase  activity  –  other 
mechanisms  of  action  include  acetylation,  amino  acid  substitution  and  allosteric 
modification.  
 
The Mitogen-Activated Protein Kinase (MAPK) system  is one of the major intracellular 
signalling systems involved in proliferation, differentiation survival and death (Figure 2-1). 
In brief, this system generally consists of a G-Coupled ligand receptor that interacts with 
three kinases- a MAPK Kinase Kinase (MAPKKK), a MAPK Kinase (MAPKK, MEK) and a 
MAPK  -  of  which  each  of  the  former  phosphorylates  and/or  activates  the  latter  in  a 
sequential mechanism. The Ras/Raf system of activation, resulting in extracellular signal-
 
Figure 2-1: MAPK Cascade 
RAS  GTPase  interacts  with  RAF,  which  then  activates  MEK,  which 
phosphorylates ERK1/2 to induce its transcriptional activity. P a g e  | 44 
 
 
 
related kinase (ERK) one and two activation, is a classic example of a MAPK system. 
Upon transcription factor binding to the growth receptor, GTPase Ras activates the protein 
kinase  Raf  (a  MAPKKK)  via  an  allosteric  mechanism  (Kolch,  2000).  Raf  goes  on  to 
phosphorylate and activate MEK (a MAPKK), and this, in turn, activates ERK (a MAPK). 
Studies  show  ERK  is  upregulated  in  response  to  axonal  injury  (Kiryu  et  al.,  1995). 
Inhibition of Ras, Raf, MEK and ERK1/2 has been linked to decreased survival and neurite 
outgrowth in embryonic neurons; this case seems to be reversed in adult neurons (Liu and 
Snider, 2001; Makwana et al., 2009a; Chang et al., 2003; Desbarats et al., 2003; Wiklund 
et al., 2002) . This illustrates that there exists a pro and anti-apoptotic dichotomy between 
naïve and adult Erk pathways. Erk 1 and 2 are also involved in C-terminal acetylation of c-
Jun and subsequent c-Jun activation (Raivich, 2008). There is an observed increase in 
phosphatidyl-inositol-3 kinase (PI3K) in response to upregulation of the ERK cascade (Ito 
et al., 1998). PI3K is an upstream kinase of Protein Kinase B, or AKT (Owada et al., 1997; 
Murashov  et  al.,  2001),  which  has  been  linked  to  axonal  regeneration  and  enhanced 
postnatal, but not adult motor neuron survival (Namikawa et al., 2000). Another important 
PI3K  family  member,  which  mediates  cellular  response  to  stress,  is  the  PI3K-related 
protein Ataxia Telangiectasia Mutated (ATM). Studies show that mice deficient in upstream 
ATM  show  increased  AP-1  activation  (Weizman  et  al.,  2003)  and  that  ATF3  over-
expression in particular can negatively regulate cell cycle progression from G1 to S phase 
(Fan et al., 2002). This data highlights the importance of intracellular activation signals in 
propagating the neuronal response to stress and damage. 
Several transcription factors have been linked to regeneration and the cellular response to 
stress,  including  c-Jun,  ATMIN,  JunD,  ATF3,  Sox  11  and  STAT3  (Herdegen  and 
Zimmermann, 1994; Pennypacker,  1997; Buschmann et al., 1998; Kenney and Kocsis, 
1998; Lindwall et al., 2004; Campbell et al., 2005; Seijffers et al., 2006; Kanu, 2010). For 
example,  STAT3  neuronal-specific  deletion  increases  neuronal  cell  death  after  injury P a g e  | 45 
 
 
 
(Schweizer  et  al.,  2002)  and  ATF3  expression  or  upregulation  has  been  linked  to 
increased sprouting in vitro and in vivo (Nakagomi et al., 2003; Pearson et al., 2003a; 
Campbell et al., 2005; Seijffers et al., 2007; Kiryu-Seo et al., 2008), as well as changes in 
cell-cycle regulation. ATF3, when complexed with c-Jun is part of a larger transcriptional 
complex called AP1; because of its importance in the neuronal response to damage and 
this research, it will be discussed separately, as will the stress response protein ATMIN. 
2.5  AP1 Transcription Factors 
One  of  the  most  interesting  regeneration-associated  transcription  factors  is  AP1, 
consisting primarily of c-Jun dimers. c-Jun is an immediate early transcription factor shown 
to  be  upregulated  in  cell  repair  and  also  damage.  It  forms  both  homodimers  and 
heterodimers with other transcription factors, including members of the Jun dimerization 
Protein (JDP), C-Fos and ATF/CREB families. Homodimers or heterodimers containing c-
Jun are collectively referred to as the Activator Protein 1 (AP1) Transcription complex. The 
AP1 transcription complex binds to DNA at 12-O-Tetradecanoylphorbol-13-acetate (TPA) 
Response Element (TRE) sequences and activates genes downstream of its binding site 
(Angel and Karin, 1991). Although TRE has basal activity prior to stimulation (Angel et al., 
1991), it is highly activated following AP1 binding. 
Depending on its dimerization partner and the system in which it functions, c-Jun has been 
shown to function in both pro-apoptotic and pro-regenerative roles (Raivich and Behrens, 
2006; Broude et al., 1999; Vaudano et al., 1998; Hüll et al., 1994; Canettieri et al., 2009; 
Han  et  al.,  1992;  Smeal  et  al.,  1989;  Chiu  et  al.,  1988;  Kobayashi  et  al.,  2009).  For 
example,  JNK  phosphorylation  increases  stability  of  c-Jun  against  ubiquitin-mediated 
cellular degradation (Musti et al., 1997) but can also increase degradation dependent on 
its partner, for example with c-Myc (Alarcon-Vargas and Ronai, 2004). Likewise, cyclic P a g e  | 46 
 
 
 
AMP response element (CRE)BII will heterodimerize with c-Jun when Jun is complexed 
with CRE but not c-Fos or JunB to mediate downstream effects (Benbrook and Jones, 
1990; Macgregor et al., 1990), showing differential preference and activation based on 
binding partner. 
Importantly, c-Jun shows prolonged upregulation in PNS, but not CNS regeneration and is 
expressed at high levels during the entire regenerative process in the periphery (Broude et 
al., 1997). c-Jun is upregulated in regenerating nerves (Utikal et al., 2009; Lindwall and 
Kanje, 2005a; Campbell et al., 2005; Zhou et al., 2004; Mason et al., 2003; Chaisuksunt et 
al.,  2003)  and  is  also  involved  in  Heat  Shock  Protein  (HSP)  27  upregulation  when 
complexed with ATF3 (Nakagomi et al., 2003). Heat Shock proteins have previously been 
shown  to  play  a  pro-regenerative  role  in  the  injury  response.  In  vivo,  forced  neuronal 
expression of ATF3, first characterized by Tsujino (2000), strongly improved DRG neurite 
outgrowth in the injured spinal cord (Seijffers et al., 2007). In concert, c-Jun and ATF3 
have been shown to mediate in vitro neurite outgrowth (Pearson et al., 2003a; Nakagomi 
et al., 2003; Campbell et al., 2005; Kiryu-Seo et al., 2008) and cellular response to stress 
(Chaum  et  al.,  2009).  Since  global  deletion  of  c-jun  is  lethal  in  early  embryogenesis, 
neuron-specific  deletion  of  c-Jun  using  Nestin::Cre  and  a  floxed  c-Jun  cassette  was 
generated (Behrens et al., 2003), which abolished post-axotomy neuronal cell death, and 
strongly  reduced  peripheral  regeneration  and  central  axonal  sprouting  following  injury 
(Raivich et al., 2004a; Makwana, Werner, et al., 2009).  
c-Jun  has  diverse  and overlapping  roles  in  both  normal  biological  processes  and  also 
following injury; it shows multi-faceted regulation at both the protein and transcriptional 
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2.5.1  c-Jun Protein interactions 
c-Jun protein function can be influenced by physical interaction with other AP1 factors in 
its immediate environment. For example, c-Jun:c-Fos heterodimers are more efficient DNA 
binding proteins than c-Jun homodimers due to increased thermostability (Smeal et al., 
1989) and, due to differences in both protein and mRNA half-life, (Angel and Karin, 1992), 
can  affect  the  injury  response  differentially;  c-Jun:c-Fos  heterodimers  are  thought  to 
initiate  the  induction  response  while  c-Jun:c-Jun  homodimers  maintain  it  (Angel  et  al., 
1988; Schonthal et al., 1988). Dimerization of c-Jun occurs via hydrophobic interactions in 
the leucine zipper region of AP1 transcription factor subunits (Kouzarides and Ziff, 1988; 
Ransone et al., 1989; Gentz et al., 1989; Turner and Tjian, 1989; Smeal et al., 1989), they 
align  to  form  ‗coiled  coil  arrangements.‘  There  is  also  evidence  of  Fos:Jun 
Heterodimerization affecting transcriptional motility; as a monomer, Fos can translocate 
between nucleus and cytoplasm, however, once bound to c-Jun in the nucleus, it remains 
nuclearly  localized  (Malnou  et  al.,  2007;  Angel  et  al.,  1991).  In  addition,  certain  AP1 
subunits cannot bind to DNA or induce transcription on their own, and thus must rely on c-
Jun  for  regulational  activity  (Chiu  et  al.,  1988;  Sassone-Corsi,  Sisson,  et  al.,  1988; 
Sassone-Corsi,  Lamph, et  al.,  1988;  Kouzarides  et  al.,  1988;  Nakabeppu  et  al.,  1988; 
Halazonetis et al., 1988). 
2.5.2  c-Jun transcriptional regulation 
c-Jun has a very long 5‘ untranslated region, which extends for roughly 1 kb (Hattori et al., 
1988) and, in contrast to c-Fos (Sassone-Corsi et al., 1988; Schonthal et al., 1989), c-jun 
transcription seems to be positively autoregulated (Angel et al., 1988). This is most likely 
due to the high-affinity AP-1 binding site in the jun promoter region; although induction of 
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in mRNA, it only corresponds with a 3-4 fold increase in c-Jun protein synthesis (Angel et 
al.,  1988)  highlighting  the  role  of  both  transcription  and  post-translational  events  in 
regulating  c-Jun  function.  Furthermore,  depending  on  the  stimulus,  maximal  c-jun 
transcription levels are reached at different timepoints (Kim et al., 1990; Boyle et al., 1991) 
and if the SP1 or CTF sites in the c-jun promoter are deleted, both basal and induced 
transcription increase substantially after TPA treatment  (Han et al., 1992; Unlap et al., 
1992). Sp1 has been shown to recruit ATF3, c-Jun, and STAT3 to the TRE (Kiryu-Seo et 
al.,  2008).  Furthermore,  other  Jun  isoforms  like  JunB  and  JunD  have  been  shown  to 
competitively inhibit c-jun transcription (Chiu et al., 1989; Schutte et al., 1989; Angel et al., 
1992). While c-Jun is induced only by TPA, junB can also be induced by cAMP, and cAMP 
upregulation is known to inhibit c-jun transcription (Angel et al., 1987; Buscher et al., 1988; 
Chiu et al., 1988; Bravo et al., 1987; Angel et al., 1992). Recently, cyclic AMP response 
element-binding protein (CREB)-regulated transcription coactivator 1 (CRTC1) was found 
to modulate c-Jun and c-Fos transcriptional activity via AP-1 target gene promoter binding 
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2.5.3  JNK 
Close  proximity  of 
Phosphorylation sites to ‗basic 
region‘  DNA  binding  site  and 
subsequent  activity  assays 
indicate  that  c-Jun 
phosphorylation alters binding 
activity  (Boyle  et  al.,  1991) 
and can do so in the absence 
of  de  novo  protein  synthesis 
(Angel  et  al.,  1987).  This 
suggests  the  potential  of  N-
terminal  c-Jun 
phosphorylation  to  play  an 
integral  role  in  the  c-Jun 
reaction  to  stress  and  cell 
damage (Figure 2-2). 
Mitogen Activated Protein Kinases (MAPKs) are serine/threonine kinases, which can be 
classified into three main subtypes: extra cellular signal-regulated kinases (ERKs), p38 
MAPKs and c-Jun N-terminal kinases (JNKs, Brust et al., 2007). Jun N-Terminal Kinase 
(JNK)  is  a  type  of  MAPK  that  binds  specifically  to  and  phosphorylates  the  c-jun  N-
Terminus. This has been tracked specifically to serine 63 and 73 (Ser63&73) n-terminal 
phosphoacceptor sites (Smeal et al., 1994) and partially threonines 91 and 93 (Thr91&93), 
although earlier  studies proposed  5 to 7 putative targets with a pSer:pThr ratio of 5:1 
(Boyle  et  al.,  1991).  JNKs  are  expressed  in  neurons,  microglia,  astrocytes  and 
 
Figure 2-2: Jun Interactions 
c-Jun  participates  in  several  transcriptional  cascades  –  both 
phosphorylation-dependent  and  phosphorylation-independent.  C-Jun 
can also function without N-Terminal activation. Activation dependent 
MKK4/7  activates  JNKs  which  then  phosphorylate  c-Jun  at  serine 
residues  63&73.  Jun  function  can  also  be  affected  by 
dephosphorylation  at  Threonine  239  and  c-terminal  acetylation 
involving ERK and P300. P a g e  | 50 
 
 
 
oligodendrocytes in the brain (Fan et al., 2002) and are thought to initiate and participate in 
the chromatolytic cellular response seen after nerve injury. This hypothesis is supported by 
the fact that JNKs, like c-Jun, are immediately activated following peripheral nerve injury 
and remain so throughout the entire regenerative response – increasing the amount of 
phospho-c-Jun in the process (Eminel et al., 2008; Waetzig et al., 2006; Whitmarsh, 2006). 
JNKs can also travel anterogradely along axon microtubules via kinesin motor proteins 
(Verhey and Rapoport, 2001; Verhey, 2007).  
There are 10 different JNK splice variants, of which functional specificity is derived from 
different functional domains (Gupta et al., 1996). Of the three main isoforms, JNK1, JNK2 
and JNK3, JNK1 and JNK2 are ubiquitously expressed in mammals and JNK3 expression 
is targeted mainly to the heart, brain and testis. (Waetzig and Herdegen, 2005; Brecht et 
al.,  2005b).  Isoforms  vary  in  their  α  and  β  docking  regions,  which  regulate  substrate 
specificity and subsequent biological function in vivo (Waetzig et al., 2005; Kuan et al., 
1999b). Crystal structure analysis shows that protein structure and conformation state of 
JNKs can also affect their ability to be phosphorylated by upstream kinases (Heo et al., 
2004; Xie et al., 1998; Takatori et al., 2008; Shaw et al., 2008) and thus their effector 
potential. Experiments using TNF-α induced apoptosis also showed that JNK can perform 
in an isoform-specific manner depending on upstream signalling cues (Liu et al., 2004). 
MEK1 has also been shown to preferentially activate JNK1 over JNK2 in epithelial systems 
via small conformational differences in JNK1 (Takatori et al., 2008). Furthermore, cellular 
localization  of  upstream  signalling  molecules  can  also  affect  JNK  activity.  Cerebellar 
granule  neurons  have  MEK  kinase  Kinase  exclusively  (MKK)4  in  nuclei  and  MKK7 
expressed throughout the cell. Ablation of Nuclear MKK4 led to lower JNK, c-Jun and 
ATF2 activity during development, without changes in MKK7 or JNK expression (Wang et 
al.,  2007).  Therefore,  isoform  specific  regulation  of  upstream  kinases  also  affects 
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Furthermore, JNKs are primarily located in the cytoplasm and must translocate into the 
nucleus to affect most of their downstream signalling targets, such as c-Jun, JunD, ATF-2, 
Elk-1,  p53,  NFAT4  (Waetzig  et  al.,  2005;  Brecht  et  al.,  2005b;  Hess  et  al.,  2004). 
Therefore, JNKs generally form scaffolding complexes with JNK interacting proteins (JIPs), 
plenty of SH3 (POSH), filamin B, β-arrestin-2, GRIP1 associated protein 1 (GRASP-1), 
stress-activated protein kinase pathway-regulating phosphatise 1 (SKRP-1) or IκB kinase 
complex-associated  protein  (IκAP)  that  give  them  increased  mobility,  stability  and 
downstream  interaction  potential  (Yang  et  al.,  2007;  Waetzig  et  al.,  2006;  Whitmarsh, 
2006) This interaction can be generalized – as is the case with JIPs – or it can be isoform 
specific  –  as  is  the  case  with  β-arrestin-2  which  only  binds  a  specific  JNK3  isoform 
(Dickens  et  al.,  1997;  Guo  and  Whitmarsh,  2008).  There  is  also  evidence  of  JNK 
interactions with other AP1 transcription factors, c-Jun-E3 ligases (such as FBW7 and 
itch), cytoplasmic proteins and mitochondria (Widmann et al., 1999; Tararuk et al., 2006; 
Huang et al., 2008; Eminel et al., 2008; Zhou et al., 2008; Anzi et al., 2008).  
Substitution of JNK phosphorylation motifs with those for PKA abolishes c-Jun-mediated 
JNK effects (Smeal et al., 1994). Similarly, substitution of ser63&73 with alanine residues 
(junAA)  prevents  JNK-mediated  (Yang  et  al.,  1997)  excitotoxic  cell  death  following 
exposure to kainite, as does global JNK3 deletion (Behrens et al., 1999; Brecht et al., 
2005a). Although JNKs have no effect on retinal photoreceptor apoptosis (Grimm et al., 
2001), JunAA and JNK3 mutants show transient improvement in outcome after targeted 
dopaminergic cell death (Brecht et al., 2005b). JNK1 has been linked to diabetes – global 
JNK1-deleted mutants are protected against type II diabetes mellitus and JNK1 expression 
accelerates β-cell death in the pancreas. In addition JNK2 global mutants are resistant to 
hypercholesterolemia-induced  endothelial  dysfunction  (Varona-Santos  et  al.,  2008). 
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dependent  neuronal  cell  death  in  both  neuronal  and  non-neuronal  cells  (Weston  and 
Davis, 2007).  
Conversely,  if  JNK  upregulation  is  induced  in  vitro,  either  endogenously  or  through 
transfection, all isoforms can induce neurite sprouting in PC12 cells or primary neuronal 
cell cultures (Waetzig and Herdegen, 2003; Riese et al., 2004; Eminel et al., 2008). JNKs 
– particularly JNK1 - are thought to do this through increasing microtubule stability (Chang, 
Jones, et al., 2003; Björkblom et al., 2005; Rosso et al., 2005; Ciani and Salinas, 2007). 
JNK enhancement can also increase growth rates of fibroblasts (Castellazzi et al., 1991) 
and transcriptional activation of AP-1 promoters (Radler-Pohl et al., 1993). Alternatively, 
after JNK upregulation via exposure to p75 neurotrophin receptor ligands, inflammatory 
stimuli  or  reactive  oxygen  species  (Vollgraf  et  al.,  1999;  Casaccia-Bonnefil,  2000; 
Miskimins  et  al.,  2002;  Casaccia-Bonnefil  et  al.,  2008)  increased  glial  cell  death  is 
observable, especially in oligodendroglial precursors, via the p53 pathway (Ladiwala et al., 
1999). This cell death can be prevented by incubation with JNK antagonists (Eilers et al., 
2001; Senger et al., 2002; Jurewicz et al., 2003; Zhuang et al., 2006; Fernandes et al., 
2007). Phospho-c-Jun has also been shown to enhance downstream expression of Bcl2-
interacting mediator of cell death (BIM) and ATF3 (Mei et al., 2008b).  
Extensive research points to the fact that JNK inhibition can be a useful treatment for 
neurodegenerative conditions (Behrens et al., 1999; Brecht et al., 2005a; Waetzig et al., 
2005; Waetzig et al., 2006; Borsello and Forloni, 2007) Several clinical trials using JNK 
inhibition  to  treat  neurodegeneration  are  currently  underway  (Haeusgen  et  al.,  2009; 
Suckfuell et al., 2007; Behrens et al., 1999; Brecht et al., 2005a; Waetzig et al., 2005; 
Waetzig et al., 2006; Borsello et al., 2007). and presently, there are about 12 different JNK 
inhibitors (Bogoyevitch and Arthur, 2008). Derivatives of Celgene‘s (summit, New Jersey, 
USA) SP600125, CC-359 and CC-930, are JNK ATP-binding site inhibitors in trials for P a g e  | 53 
 
 
 
neurodegenerative conditions, leukaemia and fibrotic disease (Haeusgen et al., 2009) and 
XG-102, from Xigen Pharm (Lausanne, Switzerland) blocks JNK binding to substrates and 
is in phase I trials for stroke and traumatic hearing loss (Haeusgen et al., 2009; Suckfuell 
et al., 2007). However, only the latter is effective after the onset of injury and is thus most 
clinically  relevant.  Pharmacologically,  chemical  inhibition  of  mixed  lineage  kinases  - 
upstream regulators of JNK - with CEP-1347 enhanced survival of embryonic sensory, 
sympathetic and motor neurons, as well as auditory hair cells and PC12 cells following 
withdrawal of trophic support (Lindwall and Kanje, 2005b; Borasio et al., 1998; Maroney et 
al.,  1998,  1999;  Pirvola  et  al.,  2000)  Although  there  is  evidence  it  can  help  prevent 
dopaminergic cell death in vitro (Saporito et al., 2002; Mathiasen et al., 2004) and in vivo 
(Saporito et al., 1999, 2000), CEP-1347 does not improve outcome for patients with early 
Parkinson‘s Disease (Wang and Johnson, 2008). Also, competitive inhibition of JNK using 
the DJNKI1 fragment of Jun Interacting Protein (JIP) blocked c-jun phosphorylation and 
also led to decreased levels of NMDA-induced cortical neuron cell death in vitro (Borsello 
et al., 2003).  
2.6  ATMIN 
Ataxia Telangiectasia Mutated (ATM) Interacting protein or ATMIN is an 88 kDa substrate 
of the phosphatidylinositol kinase-related, ATM enzyme. This enzyme will normally bind 
and phosphorylate the transcription factor NBS-1 (Nibrin) to promote the repair of double 
stranded DNA breaks. However, in the absence of double stranded breaks, for example 
after hypotonic stress, UV light exposure or treatment with hydroxyurea, ATM will also bind 
to  and  phosphorylate  ATMIN  to  halt  cell  cycle  progression,  activate  checkpoints  and 
promote  repair  (Kanu  and  Behrens,  2007,  2008).  First  characterized  in  its  truncated 
version, based on N-terminal interactions with Chk2 checkpoint kinase, as 66 kDa ATM/ 
Ataxia  telangiectasia  and  Rad3  related  (ATR)-substrate  Chk2-interacting  Zn
2+-finger P a g e  | 54 
 
 
 
protein (ASCIZ, McNees et al. 2005) deletion of ATMIN also results in increased sensitivity 
to DNA base-damaging agents and altered immunoglobulin gene diversification following 
histone deacetylase inhibition in DT40 cell lines (Oka et al., 2008). DNA damage response 
proteins generally have SQTQ cluster domains (Traven and Heierhorst, 2005; Lee et al., 
2008), which are present in the ATMIN gene, however the shorter ASCIZ version of the 
gene contains two N-terminal C2H2 zinc (Zn
2+) fingers, whereas the longer ATMIN version 
contains four (McNees et al., 2005; Kanu et al., 2007). Alternative splicing between exons 
indicates that both the 66 kDa ASCIZ and 88 kDa ATMIN forms of the gene  exist but 
functional analysis reveals that the longer ATMIN transcript is the more prevalent in nature 
(McNees et al., 2005). Although its in vitro role during cell stress has been characterized, 
little is known about its involvement in vivo.  
2.7  Cell Type-Specific Promoters of Cre Recombinase 
2.7.1  Nestin 
First  discovered  in  1985  as  an  antigen  recognized  by  monoclonal  antibody  Rat-401 
(Hisanaga  and  Hirokawa,  1988),  Nestin  was  finally  characterized  as  an  intermediate 
filament protein in 1990 and is a 198 kDa protein spanning more than 1600 amino acids 
(Cooper  and  Hausman,  2006;  Lendahl  et  al.,  1990).  Its  highly  conserved  exon-intron 
structure is identical in mice, rats, and humans (Michalczyk and Ziman, 2005a). Present 
from E7, nestin expression is slowly downregulated as other, more cell-specific, filament 
proteins take over  during post-natal cellular  differentiation  (Lothian and Lendahl, 1997; 
Zimmerman et al., 1994; Dahlstrand et al., 1995; Hockfield and McKay, 1985). Nestin is 
thought  to  participate  in  developmental  regulation  by  stabilizing  cell  structure  and  co-
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2005a); this takes place via threonine phosphorylation at  residue 316  (Eriksson et  al., 
1992; Sahlgren et al., 2001; Skalli et al., 1992). The principal activator of nestin is cyclin-
dependent protein kinase (cdc) 2. Along with cyclin B, cdc2 forms the maturation/M-phase 
promoting factor (MPF), which orchestrates mitotic progression of the cell cycle from G2 
phase to M phase (Dahlstrand et al., 1992). Another putative phosphorylation target is 
Nestin‘s  serine-rich  c-terminus  –  which  could  facilitate  Nestin‘s  interaction  with  other 
cytoskeleton components via side branch modification  (Michalczyk and Ziman, 2005b). 
Intermediate filaments are divided into 6 classes; Nestin codes for a class 6 intermediate 
filament  gene  (Dahlstrand  et  al.,  1995;  Lendahl  et  al.,  1990).  Because  of  its  short  N-
terminus, Nestin can only form heterodimers – not homodimers – and prefers to do so with 
class  3  intermediate filament  proteins  vimentin and  α-internexin  (Eliasson  et  al.,  1999; 
Marvin et al., 1998; Michalczyk et al., 2005a). Although it is primarily characterized as an 
early  developmental  marker,  nestin  expression  is  upregulated  in  the  adult  during 
pathogenesis – for example in the glial scar and during regeneration (Michalczyk et al., 
2005a,  2005b)  Nestin is a well-characterized neuronal stem cell marker  (Okuno et al., 
2010;  Hernández-Benítez  et  al.,  2009;  Vukojevic  et  al.,  2009;  Bramanti  et  al.,  2010; 
Kozubenko  et  al.,  2009;  Pilkington,  2005),  although  it  is  also  present  in  various  other 
tissue, including the testes (Fröjdman et al., 1997), pancreas (Rovira et al., 2009; Ueno et 
al., 2005), olfactory epithelium (Minovi et al., 2010), retina (Kohno et al., 2006; Wislet-
Gendebien et al., 2005), muscle (Lendahl et al., 1990), skin (Medina et al., 2006), teeth 
(About et al., 2000; Graham et al., 2006), liver (Forte et al., 2006; Li and Chopp, 1999), 
kidneys (Zou et al., 2006), adrenals (Toti et al., 2005) and mammary epithelial stem cells 
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2.7.1.1  CNS-Specific Conditional Deletion 
Nestin mediated cre excision is a well characterized mechanism for gene deletion in the 
CNS  Successful  recombination  targets  gene  deletion  to  Neurons,  Astrocytes, 
Oligodendrocytes and Schwann Cells (Hanada et al., 2009; Heffron et al., 2009; Read et 
al., 2009; Raivich et al., 2004a; Kanu et al., 2008; Rao, 1999). Previous studies using 
Nestin promoter-driven c-jun showed decreased cellular response, increased motoneuron 
survival and decreased regeneration in c-Jun deficient mice. However, since nestin is not 
neuron specific, it remains unclear whether the effects observed in neuronal regeneration 
were due to the specific action of Jun deletion in neurons or other Nestin+ progenitor-
derived cells. 
2.7.2  Synapsin 
Synapsins  are  a  type  of  phosphoprotein  specifically  associated  with  the  cytoplasmic 
surface of pre-synaptic neurons (Huttner et al., 1983; Pieribone et al., 1995). Synapsins 
are encoded by three separate genes – Synapsin I, II and III (Rosahl et al., 1995; Kao et 
al.,  1998;  Esser  et  al.,  1998;  Hosaka  and  Südhof,  1998b,  1998a).  Post-transcriptional 
modification  creates  three  distinct  Synapsin  isoforms  –  a,  b  and  b-like  –  that  are 
distinguishable  primarily  by  structural  differences  in  the  C-Terminus  of  the  molecule 
(Hilfiker et al., 1999). The Synapsin N-terminal is mostly conserved, and contains a protein 
kinase  A  (PKA)  and  Ca
2+/calmodulin-dependent  protein  kinase  I  (CaM  kinase  I) 
phosphorylation site, which suggests that N-Terminal activation plays an important role in 
Synapsin function (Hilfiker et al., 1999). This activation is regulated, at least in part, by 
opiate ligands (Nah et al., 1993). The Synapsin protein consists of 3-6 primary regions, 
which  differ  based  on  organism;  these  regions  are  labelled  A-J,  and  are  arranged 
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is highly conserved between species – both vertebrate and invertebrate (Hilfiker et al., 
1999). Despite the somewhat dissimilar sequence structure in other regions, Synapsins 
share  high  levels  of  amino  acid  congruence  –  with  high  levels  of  proline,  glutamine, 
alanine and serine, as well as MAP kinase and CaM kinase II activation sites. Synapsins 
are found in all neurons except those containing ribbon synapses (Usukura and Yamada, 
1987), although there is conflicting morphological evidence that they are present in DRGs 
(Sims et al., 2008; Zhu et al., 2001).  
Genetic deletion studies show that Synapsins I and II are important for presynaptic vesicle 
formation and repeated action potential firing (Li et al., 1995; Lonart and Simsek-Duran, 
2006; Rosahl et al., 1995). Global mutants exhibit deregulation of basal neurotransmission 
(Lonart  et  al.,  2006),  with  impairments  in  neurotransmitter  reserve  pool  after  high-
frequency  stimulation  (Rosahl  et  al.,  1993,  1995).  Synapsin  global  mutants  show 
increased  propensity  toward  seizure  behaviour  both  baseline  (Synapsin  II)  and  after 
electrical stimulation (Synapsin I, Li et al., 1995; Rosahl et al., 1995). Also, they show 
more age-related neuronal loss and gliosis in the cerebral cortex and hippocampus, with 
accompanying  age-dependent  increases  in  cognitive  impairment  (Corradi  et  al.,  2008). 
Furthermore, Synapsin deletion also affects other synaptic vesicle proteins; for example, 
mutants show decreased abundance but increased activation of rabphilin (Lonart et al., 
2006) in synaptic terminals.  
2.7.2.1  Neuron-Specific Conditional Deletion 
The neuronal specificity of the Synapsin gene makes its promoter an ideal candidate for 
conditional  gene  deletion  strategies.  Synapsin  I  protein  is  present  in  the  presynaptic 
bouton at a concentration of roughly 10-20 M, with roughly 10-30 Synapsin I molecules 
per vesicle (Schiebler et al., 1986; Ho et al., 1991; De Camilli et al., 1990). Synapsin I has P a g e  | 58 
 
 
 
previously been characterized as a neuron-specific promoter (Usukura et al., 1987; Zhu et 
al., 2001; Hasue et al., 2005; He et al., 2004; Xia et al., 2003; May et al., 2004; Tamai et 
al., 2008; Ferguson et al., 2007; Sims et al., 2008; Kügler  et al., 2001). The proximal 
region of the Synapsin I promoter is sufficient to direct neuron-specific gene expression, 
due to negative regulation by the zinc finger protein, neuron-restrictive silencer factor/RE-1 
silencing  transcription  factor  (NRSF/REST,  Schoch  et  al.,  1996). In  contrast  to  Nestin, 
which targets floxed gene deletion to all neurons in the CNS, Synapsin I is a more specific 
promoter, excising the gene of interest solely in neurons. It creates the ideal system in 
which to investigate neuron-specific effects. 
2.7.3  P0 
P0 is the most abundant myelin protein in the PNS, composing roughly 50% of total myelin 
protein in peripheral nerves (Sommer and Suter, 1998). The P0 gene was first isolated in 
1985, is found on Chromosome 1 and is activated prior to myelination in all immature SCs 
and also in SC precursors (Cheng et al., 1996; Lee et al., 1997, 2001; Lemke and Axel, 
1985; Kuhn et al., 1990). P0 protein, an IgG family member, is stabilized by homophilic 
interactions and its expression is regulated by neuronal signalling cues (Sommer et al., 
1998; Xu et al., 2000), although SCs in culture can express low levels of P0 even in the 
absence of neurites (Sommer et al., 1998; Burroni et al., 1988). Its enhanced expression 
provides  a  regulatory  signal  for  Schwann  Cells  to  differentiate  toward  a  myelinating 
phenotype. As such, it is an ideal molecular candidate for gene deletion studies targeting 
Schwann  Cells.  Indeed,  several  studies  have  examined  the  effects  of  global  and 
conditional mutation and deletion of this gene. P0-globally deficient mice exhibited deficits 
in motor coordination, tremors and occasional convulsions. Immunologically, they showed 
severe hypomyelination of peripheral axons, vast axonal degeneration and poor neurite 
integrity.  Furthermore,  some,  but  not  all,  molecules  involved  in  myelination  were P a g e  | 59 
 
 
 
dysregulated  in  P0  deficient  mice  (Giese  et  al.,  1992;  Xu  et  al.,  2000).  Minimal  P0 
expression  has  also  been found  in  other  areas  and  subpopulations  of  cells,  where  its 
significance is largely unknown (Bhattacharyya et al., 1991; Lee et al., 1997; Sato et al., 
1999; Sato and Endo, 2000; Yamauchi et al., 1999). 
2.7.3.1  Schwann Cell Conditional Deletion 
The P0 promoter can also be used for conditional mutation systems, such as Cre::LoxP, to 
excise certain genes specifically from all Schwann Cells; to excise a gene specifically from 
myelinating SCs, Myelin Basic Protein (MBP) targeted deletion has been employed (Niwa-
Kawakita et al., 2000). One such gene that has been explored using P0::Cre-mediated 
deletion is c-Jun. To date, its role has been explored in vitro, where c-Jun was essential for 
Schwann  cell  proliferation  and  death,  as  well  as  in  vivo  following  sciatic  nerve  injury. 
P0::Jun  mutants  showed  inability  to  de-differentiate  from  a  myelinating  to  immature 
phenotype and delayed demyelination in sciatic nerves after cut. This demyelination is 
necessary  for  a  successful  regenerative  response  due  to  the  axonal  inhibitory  cues 
present in myelin. As a result of the impaired demyelination response, more debris and 
nerve sheaths were present in distal nerve segments 3 and 5 days post-injury (Parkinson 
et al., 2008; Mirsky et al., 2008). Biochemically, this system showed that c-Jun was a 
negatively regulated by Krox-20 and, along with NOTCH, acted as an inhibitory pathway 
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2.8  Stereology – Optical Fractionator and the Abercrombie Correction 
2.8.1  Background 
The tenets of stereology rely upon extrapolating 3-D volumetric analyses from a series of 
2-D  sampling  sets.  3-D  Stereology  utilizes  random,  systematic  sampling  to  provide 
―unbiased‖  quantitative  data,  whereas  2-D  stereological  methods  derive  similar 
conclusions from ―assumption based‖ reasoning.  
The Abercrombie Correction is a type of 2-D stereological assessment first described in 
histological sections (Abercrombie, 1946) that is commonly used in the context of facial 
motoneuron  injury  models  (Serpe  et  al.,  2003a,  2005;  Huppenbauer  et  al.,  2005; 
Wainwright et al., 2009; Makwana et al., 2009, 2007; Mills et al., 2008). The Abercrombie 
correction is based upon the observation that cell sections inevitably contain both whole 
and  fragmented  cells  (which  have  been  cut  during  sectioning),  which  result  in  a 
phenomenon called the split cell error. Split cell error results from cell fragments at the 
upper and lower surfaces of the section being counted as if they were entire cells and thus 
results in over-estimation of the actual cell number. Abercrombie reasoned that the true 
number of cells equals the number of cells/fragments counted times a correction factor 
equal to the ratio of the section's thickness divided by the sum of the section's thickness 
plus the mean diameter of the cells or nucleoli: From this, the Abercrombie Correction was 
born – the formula is described below: 
 
Where: 
NV= corrected estimate of object number per unit of volume (numerical density) 
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NA= uncorrected profile estimate per unit of area 
T= mean thickness of the section (20 M) 
D= mean diameter of nucleolus perpendicular to sectioning direction (20M, Raivich et al., 
2004a; Coggeshall, 1992) 
The most common 3-D Stereological assessment is called the Optical Fractionator. It uses 
thick  sections  to  estimate  total  cell  counts  from  the  number  of  cells  sampled  with  a 
Systematic  Randomly  Sampled  (SRS)  set  of  unbiased  virtual  counting  spaces  (Micro 
Bright  Field  Bioscience,  2010).  This  samples  the  entire  region  of  interest  and  places 
uniform distance between unbiased virtual counting spaces in X, Y and Z planes. ―Guard‖ 
or ―buffer‖ zones in the Z-plane are utilized in the optical fractionator workflow to reduce 
split cell error. Mean cell density is calculated within the region of interest by dividing total 
number of counted cells by the number of counting spaces and their uniform volume. By 
multiplying average cell density with the volume of the investigated region of interest, one 
can obtain an ―unbiased‖ estimate of the total number of cells in the region of interest.  
2.8.2  Cell Size and Split Cell Error 
Both methodologies have systems in place to reduce split cell error. The Abercrombie 
Correction  utilizes  mathematical  principles  to  account  for  this,  whereas  Optical 
Fractionator has a ―guard‖ zone in place of one cell length at the top and bottom of the Z-
plane. One of the main arguements against the Abercrombie correction is that bias issues 
become apparent and less predictable when size distribution of cells is skewed or bimodal, 
for example, when D varies (Hendry, 1976). Also, for non-spherical objects, the mean D 
will change according to the sampling direction. Thus, objects must be spheroid like the 
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potential  drawback  and  individual  cell  diameters  can  be  measured  and  accounted  for; 
although  the  necessity  to  set  the  buffer  zone  based  on  the  largest  cell  diameter  as 
opposed to the smallest one means that large cells could be over-estimated or that smaller 
cells could be under-represented in final measurements. As a result, Optical Fractionator 
uses very thick sections to reduce the proportion of buffer/measured zone. 
2.8.3  Tissue Shrinkage and Section Size 
Tissue shrinkage is also an issue when using histological preparations. The Abercrombie 
method assumes a consistent T value, but individual section thickness can vary between 
and  even  within  sections.  Most  histological  sections  that  are  mounted  on  glass  slides 
collapse non-uniformly along the z-axis when the tissue dries. Traditional 3-D counting 
methods fail to take this into account, resulting in the possibility that such counts would be 
confounded by indeterminate degrees of distortion, depending upon where along the z-
axis the optical disector is placed (Benes and Lange, 2001). The only alternative is to use 
thin  sections,  which  pose  the  same  limitations  as  the  Abercrombie  method,  and  also 
increase  the  buffer/measured  zone  ratio.  For  such  sections,  counting  is  done  at  low 
magnification (ex. 20x) with a large depth of field. Under these conditions, all cells along 
the  entire  z-axis  can  be  included  in  the  analysis.  Although  distortion  is  minimized  by 
individual Z measurement beforehand in optical fractionator, it can never be completely 
controlled for in either stereological method. 
2.8.4  Non-Uniform Sampling Areas 
One of the central assumptions when using the Optical Fractionator and one of its main 
pitfalls  when  used  in  the  context  of  the  facial  motor  nucleus,  is  the  necessity  for  a 
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facial motor nucleus  are roughly 15-20um  size  (Raivich et  al., 2004a), show a  distinct 
lateral  concentration,  as  well  as  densely  packed  brainstem  nuclei.  Following  injury, 
motoneuron distribution is more evenly spaced, but the necessity for comparison between 
the two might present problems with Optical Fractionator analysis, at least in determining 
control  densities.  Since  3-D  techniques  rely  on  the  combination  of  several  random 
sampling  zones,  and  not  quantification  of  all  cells  in  all  areas,  cell  numbers  could  be 
augmented. Theoretically, the optical fractionator counting frame could be increased to 
accommodate for this, but this would still provide a less precise measurement. All things 
considered, manual counting of all motoneurons (as performed for 2-D analysis) in the 
nuclei seems the best approach for this type of cell distribution. 
2.8.5  Stereology Conclusions 
Both 2-D and 3-D stereological techniques present with unique benefits and drawbacks. 
The  fact  remains  that  most  facial  nerve  survival  data  has  been  collected  using  the 
Abercrombie system, but the ease, flexibility and novelty of the Optical Fractionator merit 
further investigation. Perhaps characterizing and comparing these two approaches could 
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AIMS 
2.9  Characterizing the Regenerative Response 
2.9.1  c-Jun 
In 2004, Raivich et al. reported that mice with a Neuroepithelial Stem Cell Marker (Nestin)-
specific c-Jun deletion, induced by the Cre::Lox P recombination system, exhibit several 
defects in the neuronal regenerative response. In brief, animals with this deletion showed 
reduced levels of neuronal cell death, target-muscle reinnervation, perineuronal sprouting, 
lymphocyte recruitment and microglial activation after facial nerve axotomy (Raivich et al., 
2004a). Surviving motor neurons in the facial motor nucleus also exhibited an atrophic 
phenotype.  
Since neuroepithelial stem cells differentiate into several distinct CNS populations such as 
neurons, oligodendrocytes, astrocytes and peripheral Schwann cells (Hanada et al., 2009; 
Heffron et al., 2009; Read et al., 2009; Raivich et al., 2004a; Kanu et al., 2008; Rao, 
1999), it remained unknown which of these cell types is the key regulator of the phenotype 
exhibited  by  Nestin::Jun  mice.  In  addition  to  different  potential  regulatory  cell  types, 
multiple activation sites for c-Jun have also been characterized  which  might affect the 
regenerative response. Activation of the c-Jun mediated transcriptional apparatus appears 
to be affected by interactions at 3 major sites: N-Terminal phosphorylation at Ser 63&73 
and Thr 91&93 by JNKs (Figure 0-1, Smeal et al. 1994; Morton et al. 2003), which can 
also  exert  indirect  effects  by  activating  the  transcription  factor  complex  (TFC)  which 
controls jun mRNA synthesis; dephosphorylation of Thr239 (Morton et al., 2003), which 
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ubiquitination and subsequent degradation; and finally, C-terminal lysine acetylation near 
aa257-276 (Vries et al., 2001), which results in activated c-Jun via the ERK pathway.  
Here,  the  regulatory  role  of  c-Jun  was  explored  using  cell-specific  deletions  of  P0  in 
Schwann  Cells  and  Synapsin  in  Neurons.  Also  examined  was  the  role  of  N-Terminal 
Phosphorylation  in  c-Jun‘s  regenerative  function  in  response  to  facial  motor  nerve 
transection. Using transgenic systems, we characterize the role of c-Jun in: 
  The Cellular Response to Injury – both Neuronal and Non-Neuronal 
  Motor Neuron Survival 
  Reinnervation – both Functional and Anatomical 
 
Figure  0-1:  Neuroepithelial  Stem  Cells  (NESCs)  express  Nestin  and  can  differentiate  into  Schwann 
Cells (SC, marker P0), Oligodendrocytes (O), Astrocytes (A) and Neurons (N, marker Synapsin I).  
All  of  these  cell  types  express  nuclear  transcription  factor  c-Jun.  c-Jun  activation  pathways  are  known  to 
involve N-Terminal phosphorylation at Ser 63&73 and Thr 91&93 by JNK, dephosphorylation of Thr239 and C-
terminal lysine acetylation near aa257-276 by p300.  P a g e  | 66 
 
 
 
As  one  further  characterizes  the  cellular  interactions  surrounding  c-Jun  function  in 
neuronal regeneration, one is better equipped to use available technology to exploit its role 
in cell survival after injury. 
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2.10  ATMIN 
Ataxia Telangiectasia is an autosomal recessive, multisystem condition, characterized by 
progressive cerebellar ataxia, oculocutaneous telangiectasia (dilation of small vessels in 
capillary  beds),  radiosensitivity,  predisposition  to  lymphoid  malignancies  and 
immunodeficiency, with defects in both cellular and humoral immunity (Lavin and Shiloh, 
1997).  Almost  a  decade  ago,  a  mutation  in  Ataxia  Telangiectasia  Mutated  (ATM),  a 
member  of  the  phosphatidylinositol  kinase-related  protein  cell  signalling  family,  was 
identified as the causative factor of this disease (Savitsky et al., 1995). ATM has since 
been well characterized and is a known mediator of cell signalling in response to DNA 
damage (Pandita, 2003). Active ATM phosphorylates numerous substrates including Smc1 
and  p53,  and  usually  targets  specifically  serine  or  threonine  residues  followed  by 
glutamine, termed ‗SQ/TQ' motifs (Kim et al., 1999; Shiloh, 2003). In particular, ATM has 
been shown to bind to and phosphorylate the transcription factor Nibrin (NBS-1), via c-
terminal interactions, to promote DNA repair resulting from double stranded breaks (Falck 
 
Figure 0-2:  ATM activates both Nibrin and ATMIN  via c-terminal phosphorylation to initiate cellular 
repair responses in the presence and absence (respectively) of double stranded breaks. P a g e  | 68 
 
 
 
et al., 2005; Kanu et al., 2007). Recently, a novel ATM substrate protein called ASCIZ was 
described  that  contained  multiple  SQ/TQ  sites  and  two  N-terminal  C2H2  zinc  (Zn2+) 
fingers  (McNees  et  al.,  2005).  However,  expressed  sequence  tag  (EST)  analysis 
suggested that its amino acid sequence was incomplete, and subsequently, two additional 
exons (encoding Zn2+ finger domains) were characterized; the complete 88.3 kDa gene 
was  then  termed  Ataxia  Telangiectasia  Mutated  Interacting  Protein  (ATMIN,  Kanu  & 
Behrens 2007). Both ATMIN and Nibrin interact with ATM using similar motifs and in a 
stimulus-dependent manner; however, whilst ATM activates the Nibrin pathway for cellular 
repair in response to double stranded DNA breaks, it activates the ATMIN pathway for 
cellular repair in the absence of double stranded breaks - for example, after hypotonic 
stress,  UV  light  exposure  or  treatment  with  hydroxyurea  (Figure  0-2,  Kanu  &  Behrens 
2007). Since ATMIN is involved in cellular repair after damage, it follows naturally that it 
might play a role in the response to injury. CNS specific ATMIN-null mutants were created 
using  the  Cre::Lox  P  system  of  conditional  mutation  (Nestin::ATMIN)  and  neuronal 
response to injury will be studied. Three factors will be investigated: 
  The Cellular Response to Injury – both Neuronal and Non-Neuronal 
  Motor Neuron Survival 
  Reinnervation – both Functional and Anatomical  
These factors will be explored in both PNS and CNS paradigms to further describe the role 
of ATMIN in response to traumatic injury. 
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CHAPTER 3:  MATERIALS AND METHODS 
All  procedures  complied  with  the  United  Kingdom  Animals  (Scientific  Procedures)  Act 
1986. 
3.1  Generation of Mutants 
3.1.1  Synapsin and P0 Jun: 
Mice  carrying  a  floxed  c-jun  allele,  c-jun
f/f  (Behrens  et  al.,  2002),  were  crossed  with 
animals expressing cre recombinase under the control of Synapsin I promoter (Zhu et al., 
2001)  and  then  crossed  again  to  generate  the  c-jun
f/f;  Synapsin::cre+  mutant  mice,  in 
which both c-jun alleles are inactivated in Neurons (c-Jun
S). Sibling animals lacking the 
cre  transgene,  with  functional,  unrecombined  homozygous  c-jun  (jun 
f/f),  and  also 
littermates  who  were  heterozygous  for  the  Synapsin::cre  mutation  (Syn::Cre  jun 
f/WT), 
served as controls. To avoid possible germline inactivation of Synapsin by cre (Rempe et 
al., 2006) only female Synapsin I::cre+ animals were mated to male c-junf/f mice. 
Mice  carrying  a  floxed  c-jun  allele,  c-jun
f/f  (Behrens  et  al.,  2002),  were  crossed  with 
animals expressing cre recombinase under the control of Myelin Protein 0 (P0) promoter 
(Feltri et al., 1999) and then crossed again to generate the c-jun
f/f; P0::cre+ mutant mice, in 
which both c-jun alleles are inactivated in Schwann cells (P0 x jun 
f/f). Sibling animals 
lacking the cre transgene, with functional, unrecombined homozygous c-jun (jun 
f/f), and 
also littermates who were heterozygous for the P0::cre mutation (P0 x jun 
f/WT), served as 
controls. P a g e  | 70 
 
 
 
3.1.2  JNK: 
Genetic inactivation of JNK1, JNK2 and ⁄ or JNK3 in mice has been described in detail 
elsewhere  (Yang  et  al.,  1997,  1997;  Dong  et  al.,  1998;  Kuan  et  al.,  1999a)  JNK  null 
mutants  were  backcrossed  once  with  C57  ⁄  BL6  mice.  Thereafter,  heterozygous  F1 
offspring were crossed to obtain F2 homozygous JNK knockout mice and homozygous 
wild type (WT) littermate controls. The F2 generation were set up in breeding pairs to 
produce  KO  and  WT  mice  used  in  these  experiments  (F3).  This  breeding  approach 
minimizes  genetic  strain  variability  between  KO  and  WT  animals  and  also  facilitates 
production  of  large  numbers  of  offspring  necessary  under  guidelines  of  the  Banburry 
Conference.  
3.1.3  JunAA 
JunAA animals carry a substitution mutation on the Jun allele where serines 63 and 73 are 
replaced with alanines; this prevents JNKs from binding to the N-terminal phosphorylation 
site and renders the gene product constitutively functionally inactive. Generation of these 
mutants  is  detailed  elsewhere  (Behrens  et  al.,  1999).  Briefly,  NotI-linearized  knock-in 
construct (20 mg) was electroporated into R1 embryonic stem (ES) cells. Reverse and 
Forward  primers  were  used  to  select  transfected  cells,  and  targeting  specificity  was 
confirmed  by  Southern-blot  analysis.  Individual  ES  cell  clones  (PGKbgeo:JunWT  or 
PGKbgeo:JunAA) were microinjected into C57BL/6 blastocysts. The floxed PGKbgeo gene 
was  later  removed  from  the  animals‘  germline  using  Cre  recombinase  by  pronuclear 
injection of a cre-expressing plasmid (Behrens et al., 1999). P a g e  | 71 
 
 
 
3.1.4  ATMIN: 
Mice  carrying  a  floxed  ATMIN  allele,  ATMIN
f/f  (Kanu  et  al.,  2007),  were  crossed  with 
animals  expressing  cre  recombinase  under  the  control  of  Nestin  promoter  and  then 
crossed again to generate the ATMIN
N mutant mice, in which both ATMIN alleles are 
inactivated  in  cells  derived  from  neuroepithelial  stem  cells  (Neurons,  Astrocytes, 
Oligodendrocytes  and  Schwann  Cells,  Rao  1999).  Sibling  animals  lacking  the  cre 
transgene,  with  functional,  unrecombined  homozygous  ATMIN  (ATMIN
f/f),  served  as 
controls. 
3.2  Surgery 
3.2.1  Facial Nerve Axotomy (FNA) 
Pups were anaesthetized using cooling anaesthesia on wet ice (4°C), and the extent of 
anaesthesia was determined by assessing reflex responses to tail pinch. Adult mice were 
anesthetized  with  tri-bromo-ethanol  (Avertin,  Sigma  Aldrich;  0.05mL  of  2.5%  solution 
injected  intraperitoneally)  or  Isoflurane  (5%  to  induce,  2%  to  maintain)  and  extent  of 
anaesthesia  was  determined  by  assessing  reflex  response  to  ear  pinch.  Oxygen  was 
administered at 1L/min. The animal was shaved beneath the right ear and the area was 
sterilized  using  70%  ethanol  in  ddH2O.  The  right  facial  nerve  was  transected  at  the 
stylomastoid foramen and both the retroauricular and main branches were severed. For 
crush  experiments,  only  retroauricular  branch  was  crushed  and  main  branch  was 
untouched. Nerve was crushed with fine forceps 3 times for 5 seconds. Successful facial 
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whisker  hair.  Animals  were  then  allowed  to  survive  for  1  (axotomy),  4  (crush),  14 
(axotomy) or 30 (axotomy) days.  
3.2.2  Dorsal Hemisection 
Dorsal  spinal  cord  hemisection  was  performed  at  level  C5.  Both  central  and  lateral 
ipsilateral corticospinal tracts were severed. Animals were anaesthetized using Isoflurane 
(5%  to  induce,  1-2.5%  to  maintain,  depending  on  animal)  and  the  spinal  cord  was 
exposed. Sterile paper tissue rolls were inserted and used to visualize the area and to hold 
the skin and muscle apart. C5 laminectomy was performed using forceps and the spinal 
cord was exposed. Dura mater was punctured roughly 0.5 mm lateral of the midline on the 
contralateral  (right)  side  using  an  insulin  syringe.  Fine  scissors  (Fine  Science  Tools, 
Heidelberg) were inserted into the hole roughly 2mm deep and a cut was made across the 
midline  to  the  ipsilateral  side  that  severed  the  ipsilateral  and  medial  CST.  An  insulin 
syringe was run between distal and proximal segments to confirm complete transection. 
3.2.3  Dorsolateral Hemisection 
Dorsolateral spinal cord hemisection was performed at level C5. Both central and lateral 
ipsilateral corticospinal tracts were severed, as well as the more ventrolateral ipsilateral 
rubrospinal tract. Animals were anaesthetized using Isoflurane (5% to induce, 1-2.5% to 
maintain, depending on animal) and the spinal cord was exposed. Sterile paper tissue rolls 
were inserted and used to visualize the area and to hold the skin and muscle apart. C5 
laminectomy was performed using forceps and the spinal cord was exposed. Dura mater 
was punctured roughly 0.5 mm lateral of the midline on the contralateral (right) side using 
an insulin syringe. Fine scissors (Fine Science Tools, Heidelberg) were inserted into the 
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that severed the ipsilateral and medial CST, as well as the RST. This lesion is roughly 
0.5mm deeper than a dorsal spinal cord axotomy. An insulin syringe was run between 
distal and proximal segments to confirm complete transection on the ipsilateral side. 
3.2.4  Retrograde Tracing  
Whisker  pad  reinnervation  was  assessed  by  applying  20-30  µL  of  4%  Fluorogold 
(Fluorochrome, Denver, CO) in ddH2O to a 2mm x 2mm piece of gelfoam (Pfizer, New 
York, NY) placed under both whisker pads 28 days after unilateral nerve cut. Pads were 
left  for  30  minutes  and  then  removed  and  the  wound  was  closed.  Subsequently,  the 
number of fluorescently labelled motoneurons in the injured and contralateral facial motor 
nuclei was quantified 48 hr after Fluorogold implantation (Werner et al., 2000). In addition, 
some  experiments  used  a  double  labelling  system  where  2-3µL  of  a  10%  solution  of 
MiniRuby (Invitrogen, Paisley, UK) in ddH2O was injected using a 10 µL Hamilton Syringe 
(Hamilton  Company,  Switzerland)  sub-cutaneously  into  the  contralateral  and  ipsilateral 
upper and lower eyelids on the same day as Fluorogold implantation.  
3.2.5  Stereotactic Anterograde Tracer Injection 
In  animals  that  received  dorsal  and  dorsolateral  spinal  cord  transection,  anterograde 
tracers were injected stereotactically at 30 days post-axotomy to visualise the lesion site 
and  track  anatomical  recovery.  In  both  cases  (dorsal  and  dorsolateral  transection), 
corticospinal axons were labelled with MiniRuby or FluoroRuby (Invitrogen, Paisley, UK) 
red  fluorescent  tracer  injected  into  the  contralateral  (right)  motor  cortex.  Since  the 
corticospinal pathways cross the midline at the pyramidal decussation, tracer was injected 
into the right side to ultimately label the left-injured section of spinal cord. 0.5 L of tracer 
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were  performed  stereotactically,  using  a  10  L  Hamilton  syringe  attached  to  a  Micro4 
MicroSyringe  Pump  Controller  (World  Precision  Instruments,  Sarasota,  USA) 
micropipettor. Animals were anaesthetized using Isoflurane anaesthetic (5% to induce, 1-
2.5% to maintain, depending on animal), an incision was made along the top of the skull 
with a size 15 or 20 scalpel and connective tissue was scraped away with the scalpel until 
the bregma was exposed. Measurements were taken twice before holes were drilled at the 
appropriate  sites  using  a  dental  drill.  All  injections  were  made  using  a  5L  or  10L 
Hamilton Syringe (Hamilton Company, Switzerland) with a pulled glass tip attached with 
superglue. Animals survived for 10-14 days post – injection to allow for anterograde tracer 
transport before undergoing transcardial perfusion. 
Table 1 Stereotactic Co-Ordinates for Motor Cortex 
Motor  Cortex 
Coordinates 
From Bregma 
Lateral (X)  Caudal/Rostral (Y)  Depth (Z)  Angle (˚) 
Site 1  1.0mm  -1.0mm  1.0mm  0˚ 
Site 2  1.0mm  -0.5mm  1.0mm  0˚ 
Site 3  1.0mm  +0.2mm  1.0mm  0˚ 
Site 4  1.0mm  +0.5mm  1.0mm  0˚ 
3.3  Analgesia, Antibiotic and Hydration 
All animals were given 0.05 – 0.1 mg/kg buprenorphine (vetergesic, Alstoe Animal Health, 
Hull,  UK)  sub-cutaneously  as  a  pre-operative  analgesic,  as  well  as  0.05  –  0.1  mg/kg 
buprenorphine sub-cutaneously every 8 hours additionally for at least 16 hours post-injury. 
Clamoxyl LA (Pfizer, Kent, UK) was given prophylactically as a pre-operative antibiotic via 
sub-cutaneous injection at 0.1mL/animal. 
In addition, all animals were given 0.5mL saline (Braun, Melsungen, Germany) or sterile 
water  via  a  sub-cutaneous  bolus  pre-operatively  to  prevent  dehydration.  Animals  were P a g e  | 75 
 
 
 
given  an  additional  0.5mL  bolus  (1mL  total)  if  haemorrhage  occurred  during  or  after 
surgery. 
3.4  Perfusion 
3.4.1  Facial Nerve Cut 
One, 14 or 30 days later, mice were deeply anesthetized with Intraperitoneal 2.5% Avertin 
(0.5mL)  or  Euthatal  (0.5  mL)  and  transcardially  perfused  with  200mL/animal  4% 
paraformaldehyde (PFA) in 0.1M phosphate buffered saline (PBS) (pH 7.4) preceded by a 
brief  wash  (150mL/animal)  with  0.1M  PBS  (pH  7.4,  Moller  et  al.  1996).  Brains  were 
extracted and after a 2h postfix in 1% PFA or 1h in 4%, tissue was moved to 30% sucrose 
(Fluka) overnight in PB solution in preparation for freeze sectioning.  
3.4.2  Facial Nerve Crush 
Four days after facial nerve crush, animals were anesthetized with Intraperitoneal 2.5% 
Avertin (0.5mL) or Euthatal (0.5 mL) and transcardially perfused for 10 minutes with 4% 
paraformaldehyde (PFA) in 0.1M phosphate buffered saline (PBS) (pH 7.4) preceded by a 
brief wash (5 minutes) with 0.1M PBS (pH 7.4, Moller et al. 1996). After 5 minutes in PBS 
and 10 minutes in 4% PFA, animals were perfused continuously for 45 minutes with 1% 
PFA. Brains were extracted placed in 30% sucrose (Fluka) overnight in PB solution in 
preparation  for  freeze  sectioning  and  facial  nerves  were  extracted  and  flash  frozen  in 
boats containing OCT (BDH biochemical) put on glass slides over dry ice (-80˚C). P a g e  | 76 
 
 
 
3.4.3  SCI 
Ten to fourteen days after stereotactic tracer injection, animals were deeply anesthetized 
with Intraperitoneal 2.5% Avertin (0.5mL) or Euthatal (0.5 mL) and transcardially perfused 
with 200mL/animal 4% paraformaldehyde (PFA) in 0.1M phosphate buffered saline (PBS) 
(pH 7.4) preceded by a brief wash (150mL/animal) with 0.1M PBS (pH 7.4, Moller et al. 
1996). Brains were extracted and spinal cords were left encased in bone/tissue. After a 2h 
postfix in 1% PFA or 1h in 4%, tissue was moved to 30% sucrose (Fluka) overnight in PB 
solution in preparation for freeze sectioning. Before freeze sectioning, spinal cords were 
removed from within the vertebral column and were flash frozen in boats containing OCT 
(BDH biochemical) using glass slides over dry ice (-80˚C). 
3.5  Freeze sectioning  
3.5.1  Hindbrain 
Tissue was cut at the level of the facial motor nucleus (the facial nucleus is ≈700 μm in 
length in the anterior–posterior direction) using a freezing cryostat (Leica CM 1900), with 
internal temperature of -20˚C and chuck temperature -15˚C, into 20 µM sections, taken up 
onto 0.5% gelatine (BDH Biochemical) coated glass slides or Superfrost Plus slides (BDH 
Biochemical) and stored immediately on dry ice. After roughly 1 minute on dry ice, slides 
were placed in a chilled box and stored at -80˚C for further use. 
Facial Nucleus was found by cutting the brain in half coronally post-sucrose cryoprotection 
to separate the hindbrain from the forebrain and then mounting the hindbrain, rostral side 
down, on a piece of wet filter paper on dry ice. The paper and hindbrain was allowed to 
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for cutting. Hindbrains for cutting were embedded in OCT (BDH biochemical) on a chuck in 
the  -20˚C  cryostat  until  the  OCT  solidified.  Dry  ice  was  placed  around  the  OCT  to 
accelerate  freezing.  Coronal  hindbrain  sections  were  taken  and  discarded  until  cutting 
reached the cerebellum, at which point a section was taken and the level was examined. If 
sections were in the Lateral Reticular nucleus, 30-35 sections were taken until the level of 
the  Nucleus  Ambiguus  was  reached.  This  was  verified  visually.  Once  in  the  Nucleus 
Ambiguus, landmarking was done via the Hypoglossal Nucleus, 4
th Ventricle and Dorsal 
Motor Nucleus of the Vagus Nerve. 3-5 sections were cut and then one was examined to 
determine level. Once the Hypoglossal Nucleus disappeared, the Dorsal Motor Nucleus of 
the Vagus Nerve was laterally displaced and the 4
th ventricle enlarged, single sections 
were taken and confirmed visually until the facial motor nucleus was reached. Abducens 
nuclei
 and the internal genu of the facial nerves were used to precisely
 match the location 
of the left (contralateral) and right (ipsilateral)
 sides. 
3.5.2  Facial Motor Nerve 
Facial Motor Nerve was cut longitudinally in 10μm sections using a freezing cryostat (Leica 
CM 1900), with internal temperature of -20˚C and chuck temperature -15˚C. Sections were 
taken up onto 0.5% gelatine (BDH Biochemical) coated glass slides or Superfrost Plus 
slides (BDH Biochemical) and sections were immediately frozen on dry ice. After roughly 1 
minute on dry ice, slides were placed in a chilled box and stored at -80˚C for further use. 
3.5.3  Spinal Cord  
Spinal cord was cut longitudinally in 40μm sections using a freezing cryostat (Leica CM 
1900), with internal temperature of -20˚C and chuck temperature -15˚C. Sections were 
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slides  (BDH  Biochemical)  and  every  fifth  section  was  either  spread  with  ddH20  and 
allowed to dry overnight or stored immediately on dry ice for later spreading and drying 
overnight. After roughly 1 minute on dry ice, slides were placed in a chilled box and stored 
at -80˚C for further use. 
3.6  Immunohistochemistry  
Tissue sections (20 µm) were rehydrated in ddH2O and spread. After drying on an angle in 
an  indirect  breeze  for  15  minutes,  they  were  circled  with  a  DAKO  pen  (DAKO, 
Cambridgeshire). After being fixed in 4% formaldehyde (BDH biochemical) for 5 minutes, 
sections were then washed with 0.1M Phosphate Buffer (PB) for a minimum of 5 minutes. 
After defatting for 2 minutes each in 50%, 100% and 50% Acetone (VWR), then washing 
for 2 minutes each in 0.1M PB, 0.1M PB and 0.1% Bovine Serum Albumin in 0.1M PB 
(PB/BSA, BDH biochemical), sections were blocked using 5% goat (Gt) serum (Sigma) in 
PB  for  30  minutes.  They  were  then  stained  overnight  at  4˚C  with  primary  antibodies, 
optimized previously and diluted in PB/BSA, as described in previous studies (Galiano et 
al., 2001; Werner et al., 2000); dilutions are described in  
Table 3 of the Appendix. Sections were then visualized using biotinylated immunoglobulin 
secondary antibody (1:100 in PB/BSA for one hour, Vector) after 30 minute incubation with 
mouse serum (ABD Serotec). They were then washed with PB ABC peroxidase complex 
(10% each A and B in PB for 1 hour, Vector), and stained with diaminobenzidine (25 mg in 
50mL of 10mM PB, Sigma), with hydrogen peroxide (17.6 µL in 50 mL DAB solution BDH 
biochemical) added immediately before initiating the reaction. Reaction was stopped using 
10mM  PB  and  ddH2O.  Sections  were  subsequently  dehydrated  in  increasing 
concentrations  of  ethanol  (70%,  70%,  90%  95%,  95%,  100%,  100%,  VWR)  and 
isopropanol  (BDH  biochemical),  then  immersed  thrice  in  Xylene  (VWR)  before  being P a g e  | 79 
 
 
 
covered with glass slide covers (VWR) using depex (BDH biochemical). A Sony 3 CCD 
video camera was used to obtain 8 bit digital images (based on a 0–255 scale of optical 
luminosity  values)  of the  antibody  stained  sections.  Immunohistochemical  staining  was 
quantified using the OPTIMAS 6.2 imaging system (Media Cybernetics Inc, Silver Spring, 
MD)  and  the  Mean-SD  algorithm.  The  overall  mean  optical  luminosity  value  for  the 
antibody staining intensity (SI) was determined for each facial motor nucleus, on both the 
ipsilateral  and  contralateral  side,  and  subsequently  the  SI  of  the  adjacent  glass  was 
subtracted.  
3.7  Reinnervation Distance 
Animals that survived for 4 days following a facial motor nerve crush were transcardially 
perfused  and  brains  were  extracted.  Tissue  was  processed  in  accordance  with  the 
protocol  described  above  and  sections  were  stained  for  CGRP  and  Galanin 
immunopositive growth cones according to  
Table 3 of the Appendix (Galiano et al., 2001; Werner et al., 2000). Galanin and CGRP+ 
growth cone lengths were measured using a Leica microscope with an attached vernier 
device (Figure 3-1). Measurements began at the injury site and were taken to the end of 
 
Figure 3-1: Measuring Regeneration Distance 
The Pythagorean Theorem states that Z
2 = X
2+Y
2. By determining X and Y lengths between the injury site (X1, 
Y1) and the last regenerating growth cone front (X2, Y2), reinnervation distance was quantified for WT and KO 
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the  furthest  regenerating  immunoreactive  growth  cone  front.  Distance  was  calculated 
using the Pythagorean Theorem:  
 
Where X and Y line length were calculated by subtracting X and Y co-ordinates in space 
between the injury site (X1, Y1) and the furthest regenerating nerve front (X2, Y2). In cases 
where  the  growth  cones  were  interrupted  or  crooked,  individual  line  lengths  were 
determined using the formula above and added or subtracted as appropriate to determine 
total length.  
3.8  Neuronal Cell Counts  
Tissue sections (20 µm) were rehydrated in ddH2O and spread. They were allowed to dry 
at an angle in indirect breeze for 15 minutes and then dried flat for at least 8 hours.  
3.8.1  Nissl 
4/5  sections  were  placed  in  4%  formaldehyde  (BDH  biochemical)  overnight  and  then 
solution was changed to 70% ethanol (VWR) overnight. These sections were then stained 
with Toluidine blue (Nissl). This is made by mixing 4g cressyl violet (Merck) in 40mL 100% 
Ethanol (VWR), shaking and inverting for 15 minutes, then adding this mixture to 360mL 
ddH2O and filtering using size 4 filter paper. Neuronal cell counts were made of ipsilateral 
and contralateral facial motor nucleus and percentage change between the left and right 
sides  was  calculated
  and  compared  between  groups.  The  Abercrombie  Correction 
(Equation 1) was used to determine relative percentage change between contralateral and 
ipsilateral side per histological
 section.  
Equation 2: Pythagorean Theorem - Z
2 = (X1-X2)
2+(Y1-Y2)
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3.8.2  Fluorogold and Miniruby 
1/5  sections were taken and  examined under a fluorescent microscope (Nikon Eclipse 
E600). Fluorogold positive cells were counted in the facial motor nucleus using both 64x 
and 16x filters at 450-490 nm wavelength. FMN neurons that were labelled with MiniRuby 
were also counted on these slides at 510-560 nm wavelength. 
3.9  Spinal Cord Axonal Counts 
Tissue sections (40 µm) were rehydrated in ddH2O and spread. They were allowed to dry 
at an angle in indirect breeze for 15 minutes and then dried flat for at least 8 hours. 1/5 
sections were taken and examined under a fluorescent microscope (Nikon Eclipse E600). 
The left scope was fitted with a lens conveying a vertical line to the field of vision and 
MiniRuby  and  MiniEmerald  positive  axons  that  transected  that  line  were  counted  0, 
±0.5mm,  ±1.0mm  and  ±1.5mm  past  the  lesion  site  at  450-490  nm  wavelength  for 
MiniEmerald and at 560 nm wavelength for FluoroRuby and MiniRuby. 
3.10  Whisker Function Assessment 
Animals received facial motor nerve transections and subsequent whisker function was 
recorded on both ipsilateral and contralateral sides. Measurements were taken at 2-3 day 
intervals until day 28, when Fluorogold implantation was carried out. Animals were rated 
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3.11   Rearing Test 
The  rearing  test  explores  gross  motor  co-ordination  and  is  sensitive  to  limb  use 
asymmetries  (Starkey et al., 2005). Briefly, animals were placed in a  Perspex cylinder 
(300mm height, 80mm diameter, Habitat) and spontaneous rearing was recorded using a 
Sony digital video camera recorder, DCR-TRV60E camera for five minutes. White paper 
was used as a backdrop and a mirror was placed at an angle behind the cylinder so that 
forepaws were visible at all times. Taped footage was later reviewed and weight bearing 
during each rear was quantified as right, left or both. If animals supported in one rear with 
alternating left and right, it was counted as both. Animals were placed in cylinders prior to 
surgery for habituation and also for baseline measurements. Animals were subsequently 
tested on days 2, 7, 14, 21 and 28 post-surgery. 
3.12   Grid Test 
The grid test assesses fine motor co-ordination and the animal‘s ability to accurately place 
the forepaws during spontaneous exploration (Starkey et al., 2005). Animals were placed 
on an elevated wire grid with 1cm x 1cm spacing. Edges were upward-facing and filed 
sharp to deter animals from going over the edges. A Sony digital video camera recorder, 
DCR-TRV60E  camera  was  placed  under  the  grid  facing  upward  and  spontaneous 
exploration was recorded for 3 minutes. Taped footage was later reviewed and foot slips 
were quantified for each foot during the first 100 steps. A foot slip was scored either when 
the paw completely missed the rung and fell through the rung or when the paw was placed 
correctly but subsequently fell through the rung upon weight bearing (Starkey et al., 2005; 
Selak  and  Fritzler,  2004;  Lee  et  al.,  2009;  Goldshmit  et  al.,  2008;  Hsu  et  al.,  2006). 
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measurements.  Animals  were  subsequently  tested  on  days  2,  7,  14,  21  and  28  post-
surgery.  
3.13  Statistical Analysis 
All  data  were  expressed  as  mean  ±  standard  error  of  the  mean  and  analysed  using 
unpaired student t test for 2 groups and ANOVA, followed by post-hoc Tukey for 3 groups, 
as appropriate. In the spinal cord, MiniRuby-labelled axons in all 6 compartments were 
corrected as a fraction of the average number of ipsilateral CST axons 1.5-0.5mm above 
the injury site,  and further normalised using the log (x+0.01) algorithm, as in previous 
studies (Galiano et al., 2001). For all statistical analysis, statistical significance was set at 
P < 0.05. 
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CHAPTER 4:  JUNS RESULTS: NEURONAL JUN IS AN 
ESSENTIAL FACTOR IN THE CELL RESPONSE TO INJURY 
Previous investigations link c-Jun deletion in the nervous system with increased neuronal 
survival  post  injury,  as  well  as  decreased  reinnervation  and  perineuronal  sprouting, 
increased expression of growth associated molecules and decreased non-neuronal cell 
activity (Raivich et al., 2004a; Makwana et al., 2009). However, since this particular gene 
deletion  was  mediated  by  a  nestin  promoter, this  could  have  resulted  in  cre-mediated 
excision  in  all  cells  of  a  neuroepithelial  lineage  –  including  Schwann  Cells,  Neurons, 
Oligodendrocytes and Astrocytes.  
These findings have interesting clinical implications – many neurodegenerative diseases 
such  as  MS,  ALS,  Huntington‘s  disease  and  Parkinson‘s  disease  would  benefit  from 
treatments designed to reduce levels of neuronal apoptosis. However, the broadness of 
the nestin-mediated deletion means that the potential therapeutic anti-apoptotic properties 
of c-Jun targeted gene-deletion could be attributed to any one of several cellular systems 
that are affected by a deletion in neuroepithelial stem cells. Any one of (or combination 
thereof) the aforementioned daughter cell types could be contributing to the phenotype 
seen in nestin-jun mutants. Furthermore, these systems could be contributing separately 
to increased survival and decreased reinnervation; if that is the case, specific targeting of 
c-Jun deletion to one differentiated cell type and not another could selectively increase 
neuronal  survival  whilst  leaving  reinnervation  unaffected.  Therefore,  it  is  necessary  to 
explore  c-jun  gene  deletion  in  terminally  differentiated  daughter  cells  (for  example, 
neurons and Schwann cells) to determine the role it plays in each. First, the role of c-Jun 
was  explored  using  the  Synapsin  promoter  to  target  cre  mediated  c-Jun  excision 
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4.1  Generation of Mice Lacking c-Jun in Neurons 
To characterize the role of neuronally expressed c-Jun in peripheral regeneration, animals 
were created with a neuron-specific deletion of c-Jun. This was done by crossing mice with 
a floxed c-jun allele (c-JunF/F) with animals expressing cre recombinase under the control 
of the Synapsin promoter, which targets recombination specifically to neurons (Zhu et al., 
2001; Hasue et al., 2005; He et al., 2004; Xia et al., 2003; May et al., 2004; Tamai et al., 
2008; Ferguson et al., 2007; Usukura et al., 1987; Sims et al., 2008; Kügler et al., 2001). 
The resulting F1 generation was crossed again with c-JunF/F mice to result in generation 
of  homozygous  mutant  c-JunS  and  homozygous  wild  type  animals.  Since  previous 
research shows that there is a possibility of germline recombination of Synapsin::Cre in the 
testes, which can affect offspring numbers in males, but not females (K. A. Street et al., 
2005; Hoesche et al., 1993; Rempe et al., 2006), female cre+ animals were bred with cre- 
(c-JunF/WT and c-JunF/F) males. c-JunS animals were born with Mendelian frequency 
and showed normal brain structure and histology, as indicated by Haematoxylin and Eosin 
(H&E) staining and Neuronal Nuclei (NeuN) immunoreactivity. However, as seen in Figure 
4-1, c-jun inactivation was present in several brain regions, including the cerebellum (Cb), 
cortex (Cx), brain stem (Bs), and hippocampus (Hc). In general, while brain organization 
and  histology  was  relatively  normal  in  c-Jun
S  mutants,  facial  motor  nucleus  counts 
revealed  a  14%  increase  in facial  motoneurons  in  c-Jun
S  animals,  with  2369  ±  92  in 
control c-Jun
F/F mice compared to 2699±123 in c-Jun
S mice (p < 0.05 in uSTT). 
To  account  for  differences  in  recombination  frequencies  established  by  Cre/LoxP-
mediated recombination (due to chromosomal location of recombination substrates, Vooijs 
et  al.  2001),  effects  of  Synapsin-mediated  c-jun  deletion  were  first  investigated  in 
heterozygous  c-Jun
F/WT Synapsin-I cre+ mouse.  There were no differences between  c-
Jun
F/WT Synapsin-cre+ and c-Jun
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copy of c-jun was sufficient to mediate its trophic effects. As a result, c-Jun
F/WT Synapsin-
cre+ heterozygotes and c-Jun
F/F wild type mice were included in the same control groups 
for the purpose of this study. 
4.2  c-jun is Induced Following Facial Nerve Transection 
Previous studies point to the presence of a strong c-jun induction following facial nerve 
injury (Raivich et al., 2004a; Crocker et al., 2001). To determine whether this was the case 
with c-Jun
S, regeneration was explored at 4 and 14 days following cut injury. Basal c-Jun 
protein levels were present in uninjured wild type facial motor neuron nuclei (Figure 4-1) 
and facial nerve transection led to a strong and robust increase in c-Jun immunoreactivity 
14 days following injury. Neither basal nor induced levels of c-Jun protein were present in 
facial motoneurons of c-Jun
S mutants. 
 
Figure 4-1: Normal FMN and Hippocampal Morphology in Jun
S Mice 
(A and C) Histological analysis (haematoxylin and eosin staining, [H&E]) of hippocampal sections of control 
animals (A, Jun
F/F) and Jun
S Mice (C). (B and D) c-Jun immunostaining on hippocampal sections of Jun
F/F (B) 
and Jun
S mice (D). (E-H) shows c-Jun immunopositive motor neurons in the facial motor nucleus of c-Jun
F/F 
and c-Jun
S mice on the control (co, E, G) and operated side (ax, F, H).  P a g e  | 87 
 
 
 
4.3  Neural c-Jun is Essential for Peripheral Axonal Regeneration  
Following  injury,  neurons  participate  in  a  complex  cellular  response  that  results  in 
sprouting  and  elongation  of  growth  cones  from  the  proximal  axonal  tip.  These  growth 
cones travel along the basal lamina to eventually reinnervate target muscle. Post facial 
nerve  injury,  this  reinnervation  is  examined  using  three  different  tests.  Anatomical 
reinnervation  was  determined  30  days  following  facial  nerve  cut,  and  extent  of 
regeneration is gauged via retrograde tracer transport from the site of injury to the facial 
motor nucleus. Functional recovery, also analyzed for 30 days following injury, determined 
functionality of those connections and was assessed by scoring whisker hair movement. 
Finally the reinnervation distance of CGRP and galanin immunopositive growth cones is 
measured 4 days after crush injury (Makwana et al., 2009). 
4.3.1  Whisker Hair Movement 
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Figure 4-2: Neuronal c-Jun is Necessary for Successful Functional Reinnervation after facial nerve 
axotomy 
Posttraumatic whisker hair motor performance was measured for 28 days after facial nerve axotomy, on a 
scale of 0 (no movement) to 3 (normal, strong movement similar to the contralateral side). c-Jun
S mutants 
showed impaired functional recovery compared to c-Jun
F/F counterparts; N=8 for c-Jun
F/F and N=8 for c-Jun
S 
mutants. *p<0.05 and ***p < 0.001 between c-Jun
F/F and c-Jun
S animals in unpaired Student‘s T-Test (uSTT).  P a g e  | 88 
 
 
 
Movement  of  whisker 
vibrissae  was  scored  at  2-3 
day intervals post-facial nerve 
axotomy  by  three  observers 
unaware  of  genotype  on  a 
scale of 0 (no movement) to 3 
(normal  movement,  similar  to 
that  of  contralateral  side). 
During the course of recovery, 
control  animals  showed 
steady  improvement  of 
whisker  function,  whereas  c-
Jun
S  animals  showed  only 
moderate  recovery  (Figure 
4-2).  Twenty-eight  days  after 
injury,  all  animals  showed 
normal  movement  on  the 
contralateral side (3.0). On the 
ipsilateral  side,  c-Jun
F/F 
animals  showed  2.78±0.11 
units of recovery (N=8) and c-Jun
S animals averaged an almost threefold lower score – 
1.13±0.07 (N=8).  
 
 
Figure 4-3 Characterizing Post-Operative Regenerative Response 
– Neuronally expressed c-Jun is essential for successful target 
reinnervation 
(A-D) Fluorogold expression in c-Jun
F/F (A, B) and  c-Jun
S (C, D) on 
the contralateral (A, C) and ipsilateral (B, D) sides 30 days following 
facial  nerve  tr ansection.  (E)  Quantification  of  retrogradely  labelled 
motoneurons in the facial motor nucleus of c-Jun
F/F (N=8) and c-Jun
S 
(N=9) animals, using FluoroGold, performed 28 days post -operatively. 
c-Jun
S  animals show virtually no anatomical reinnervation fol lowing 
peripiheral nerve injury. Contralateral side, white bars; ipsilateral side, 
black bars. *p<0.05 and ***p < 0.001 in uSTT between c-Jun
S and c-
Jun
F/F. (B) Ax/Co ratio of FluoroGold positive neurons is shown for c -
Jun
F/F, black bars and c -Jun
S, white bars. c-Jun
S animals show an 
almost 80% reduction in specific reinnervation. P a g e  | 89 
 
 
 
4.3.2  Anatomical Recovery 
To establish whether this deficit was due to lack 
of  axonal  reinnervation  or  just  function  of 
successfully  reinnervated  axons,  a  fluorescent 
tracer,  Fluorogold  (Fluorochrome,  Denver,  CO), 
was  implanted  via  a  gelfoam  insert  under  the 
whisker pad 28 days following facial nerve lesion. 
In  addition  to  Fluorogold,  MiniRuby  tracer 
(Invitrogen, Paisley, UK) was also injected in the 
area  surrounding  the  eyelid,  according  to  Ruff 
(2010) and (Popratiloff et al., 2001). Following 48 
hours  of  retrograde  transport,  animals  were 
perfused  and  facial  motor  nuclei  were  examined.  Contralateral  nuclei  served  as  intra-
animal controls.  c-Jun
F/F  animals averaged 22.1  ±2.9  (N=5) Fluorogold immunopositive 
neurons on the contralateral side and mutants showed 18.7±0.9 (N=6, p<0.001 in unpaired 
Student‘s  T-test).  On  the  axotomized  side,  c-Jun
F/F  controls  showed  6.7±1.3  and  KOs 
showed  0.7±0.2  according  to  Figure  4-3.  The  ratio  of  labelled  motoneurons  on  the 
axotomized compared to control side (ax/co ratio) was 30±4.5% for control animals and 
3.8±1.1%  for  c-Jun
S  mutants  –  a  more  than  7-fold  decrease  (p<0.001  in  unpaired 
Student‘s T-test) – indicating that neuronal c-Jun signalling is very important for successful 
axonal outgrowth. Without this anatomical connection, animals do not recover function to 
the  same  extent  after  peripheral  nerve  injury.  Previous  studies  in  animals  with 
neuroepithelial specific deletion of c-Jun (who share this phenotype) show that functional 
reinnervation also did not return to normal; corresponding anatomical reinnervation still 
remained about 3-4 times lower (Raivich et al., 2004a). 
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Figure 4-4: Neuronal c-Jun is Necessary for 
Facial  Motor  Nerve  Regeneration  and 
Sprouting after facial nerve axotomy 
Regeneration Distance was measured 4 days 
after  facial  nerve  crush  in  mm.  Axons  of  c-
Jun
S  mutants  reinnervate  less  than  half  the 
distance of their c-Jun
F/F littermates; N=6 for c-
Jun
F/F and N=4 for c-Jun
S animals. ***p<0.001 
between c-Jun
F/F animals and c-Jun
S mutants 
in uSTT.  P a g e  | 90 
 
 
 
4.3.3  Facial Nerve Regeneration  
To  determine  whether  neuronal  c-Jun  deletion  in  Jun
S  animals  directly  influenced  the 
regenerative process, we measured the distance of facial motor nerve axon outgrowth 96h 
after nerve crush at the stylomastoid foramen. The growth front of the regenerating CGRP-
and galanin-immunopositive motor neurites was quantified in longitudinally cut, fixed 10um 
thick  facial  nerve  sections  using  DAB  immunoreactivity  for  the  axonally  transported 
neuropeptides CGRP and galanin (Werner et al., 2000). As revealed in Figure 4-4, control 
c-Jun
F/F  wild-type  animals  averaged  a  regeneration  distance  of  5.8±0.1mm  for  CGRP 
immunopositive axon length. Mutants showed a 60% reduction in CGRP immunopositive 
axon length compared to wild type littermates, averaging 1.8±0.1mm for CGRP positive 
outgrowth.  Upon  comparing  Galanin  immunoreactive  protrusions,  the  same  threefold 
difference  was  observable:  wild  type  axon  length  was  5.4±0.2mm  and  mutants‘  axons 
grew an average distance of 1.9±0.1mm. N=6 for c-Jun
F/F wild type animals and N=4 for c-
Jun
S mutants; p<0.0001 in unpaired Student‘s T-test. 
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Figure 4-5 Increased Post-Facial Nerve Axotomy Cell Survival in Neuronal c-Jun-Deficient Mice. 
(A-E) Neuron-Specific c-Jun deletion increases levels of motoneuron survival 30 days post-facial nerve axotomy on the contralateral side (A, C) and axotomized side (B, 
D). Most jun-deficient surviving motoneurons are atrophic, as shown using higher magnification (E, arrows, right). Control side (co) and Axotomized side (ax); c-Jun
F/F and 
c-Jun
S. (F) Quantification of motoneuron number in facial nucleus of adult c-Jun
F/F and c-Jun
S mice on the contralateral (white bars) and ipsilateral side (black bars), 30 
days after facial nerve transection. *p < 0.05 and *p < 0.001 in uSTT between c-Jun
F/F and c-Jun
S groups (F and G), N = 8 for both c-Jun
F/F and c-Jun
S groups in (F) and 
(G). (G) Quantification of specific cell death Ax/Co in the facial motor nucleus of adult c-Jun
F/F (black bars) and c-Jun
S (white bars) mice, 30 days after facial nerve 
axotomy. P a g e  | 92 
 
 
 
4.4  Neural c-Jun Deletion Abolishes Neuronal Cell Death but Cells Display an 
Atrophic Phenotype 
Normally, 20-40% of adult axotomized mouse facial motoneurons die within 4 weeks of 
nerve cut (Ferri et al., 1998b; Serpe et al., 2003a; Makwana, Serchov, et al., 2009); this is 
largely attributable to inadequate trophic support during the regenerative process. This 
experiment investigated the role of neuronally expressed c-Jun in facial nerve survival by 
quantifying the number of surviving motoneurons 30 days after transection. 20m sections 
were taken at the level of the facial motor nucleus and 4/5 sections were stained with 
cresyl violet to expose surviving facial motoneurons. As seen in Figure 4-5, wild type c-
Jun
F/F animals showed 41% loss of facial motoneurons on the axotomized side – on the 
contralateral side, 2369±92 were present and on the injured side 1406±101 motoneurons 
survived.  Contrastingly,  c-Jun
S  mediated  deletion  reduced  cell  death  by  21%.  On  the 
contralateral side, c-Jun
S mutants showed 2699±123 surviving motoneurons and on the 
ipsilateral side, 2140±107. N=8 for c-Jun
F/F littermates and N=8 for Jun
S mutants; p<0.05 
in  unpaired  Student‘s  T-test.  Many  surviving  motoneurons  also  exhibited  an  atrophic 
phenotype  described  in  other  studies  targeting  c-Jun  deletion  to  CNS  neuroepithelial 
precursor-derived cells, which include neurons (Raivich et al., 2004a). Atrophic neurons 
showed  a  roughly  20%  reduction  in  diameter.  These results  indicate  that  c-Jun  in the 
neuron – and not other neuroepithelium-derived cells – is responsible for the increased cell 
survival  seen  in  the  aforementioned  study,  as  well  as  the  current  study  and  it  further 
elucidates the role of neuronal c-Jun signalling in the cell fate decision to die; in Jun‘s 
absence,  facial  motor  neurons  are  unable  to  die,  which  normally  results  from  axonal 
transection, and instead become atrophic.  P a g e  | 93 
 
 
 
4.5  Neuronal c-Jun is Essential for Non-Neuronal Cell Activation 
Facial nerve transection not only results in changes in the neuron itself, but it also affects 
neighbouring  non-neuronal  cells.  Brain-resident  Microglia  and  Astrocytes  become 
activated and begin to secrete chemical signalling molecules (Pifarré et al., 2009; Butchi et 
al.,  2009;  Martin  et  al.,  1994;  Ranaivo  et  al.,  2009). Within  the first  24  hours,  T-Cells 
invade from the vasculature (Kalla et al., 2001). While the cellular response peaks 4 days 
after injury, the inflammatory response does not reach a maximum  until 14 days after 
injury (Makwana, Werner, et al., 2009; Bohatschek et al., 2004; Moller et al., 1996; Ha et 
al., 2008), so responses at both timepoints were measured. Normally, activated microglia 
upregulate αM (MAC-1) integrin expression and home to the site of injury. There, they 
surround dying neurons and can help participate in the injury response. As seen in Figure 
4-6, 4 days after injury, wild type animals showed 12.6±1.0 αM units of optical luminosity 
value (OLV) on the contralateral side and 47.8±2.7 on the ipsilateral side (N=5). As seen in 
Figure 4-6 and Figure 4-7, by the 14
th day after injury, wild type animals exhibited 13.7±2.0 
on the contralateral side and 53.5±2.3 on the injured side (N=10). Jun
S animals showed 
diminished microglial activation at both time-points post-injury. At 4 days, the contralateral 
average was 12.1±1.0 and on the injured side, only 25.7±2.3 showed αM immunoreactivity 
(N=5,  p<0.001  in  unpaired  Student‘s  T-test).  At  14  days,  mutants  exhibited  12.5±3.3 
baseline  immunopositive  cells  and  21.2±3.0  on the  ipsilateral  side  (N=5,  p<0.00001  in 
unpaired Student‘s T-test).  
They also failed to exhibit αX immunopositive nodule formation characteristic of the wild 
type  injury  response  (Figure  4-6  and  Figure  4-7).  Upon  exposure  to  neuronal  debris 
following cell death, microglia adopt a phagocytic phenotype and upregulate expression of 
cell  surface  marker  αXβ2  integrin  and  assist  in  the  injury  response  by  disposing  of 
neuronal debris (Bohatschek et al., 2004, 2001; Kloss et al., 2001; Streit et al., 1988).  P a g e  | 94 
 
 
 
Generally,  levels  of  phagocytic  microglia  closely  reflect  levels  of  neuronal  cell  death 
(Raivich  et  al.,  2004a;  Makwana  et  al.,  2009;  Moller  et  al.,  1996).  While  no  αX 
immunopositive microglial nodules were present in uninjured facial motor nuclei (Figure 
4-6  and  Figure  4-7),  wild  type  animals  showed  23.7±4.1  phagocytic  microglia  on  the 
injured  side  (N=10).  In  stark  contrast,  Jun  deficient  animals  showed  no  phagocytic 
microglia in either the contralateral or the ipsilateral facial motor nucleus (N=7, p<0.001 in 
unpaired Student‘s T-test). Taken together, low-level microglial action reflects the much 
lower levels of cell death found in c-Jun
S mice.  
 
Figure 4-6 Neuronal c-Jun is Necessary for the Non-Neuronal Response to facial nerve axotomy. 
Diminished  non-neuronal  cell  response  to  facial  nerve  axotomy  in  c-Jun
S  mutants  at  day  14  (d14)  after 
axotomy compared to c-Jun
F/F controls. The facial motor nuclei from c-Jun
F/F littermate controls are shown in 
the  1
st  &  2
nd  columns  (A,B,E,F,I,J,M,N),  those  from  the  c-Jun
S  mutants  are  in  the  3
rd  &  4
th  column 
(C,D,G,H,K,L,O,P).  Second  and  4
th  columns  are  axotomized,  1
st  & 
3rd  columns,  contralateral  sides, 
respectively.  (A-D)  Neuronal  Jun  deletion  reduced  axotomy-induced  GFAP  activation  in  the  facial  motor 
nucleus. (E-H) Axotomy-induced αM upregulation following injury is greatly ablated in c-Jun
S facial motor 
nuclei. Phagocytic microglial infiltration (I-L), as well as CD3 immunopositive T-Cell migration (M-P) is absent 
in c-Jun
S mutants following facial nerve axotomy. Scale bar 0.2mm.  P a g e  | 95 
 
 
 
 
Another non-neuronal cell that 
is  an  important  player  in  the 
injury  response  is  the 
astrocyte.  Once  astrocytes 
become  activated,  they 
upregulate expression of Glial 
Fibrilatory  Acidic  Protein 
(GFAP) and participate in the 
injury  response,  displaying 
immune  cell  signalling 
receptors  such  as  Toll-like 
receptors,  nucleotide-binding 
oligomerization  domains, 
double-stranded  RNA-
dependent  protein  kinase, 
scavenger  receptors, 
mannose  receptors  and 
components  of  the 
complement system (Farina et 
al.,  2007)  and  secreting 
reactive intermediates like interleukin (IL)-1β, inducible nitric oxide (NO) synthase, the NO 
metabolite nitrite, superoxide (O2-) (Tichauer et al., 2007; Ranaivo et al., 2009). Wild type 
animals expressed 8.9±1.3 OLV units of GFAP luminosity (N=4) 4 days after facial nerve 
transection and 8.9±1.5 OLV units (N=10) 14 days after injury. This was greatly ablated, 
but not absent, in c-Jun
S KOs, which expressed roughly half as much immunoreactivity at 
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Figure  4-7  Neuronal  c-Jun  deletion  produces  severe  deficits  in 
non-neuronal cell activation after Facial Nerve Axotomy 
 (A, B) Quantification of microglial αM immunoreactivity at day 4 (d04, 
A) and day 14 (d14, B) in c-Jun
F/F and c-Jun
S animals after axotomy. 
(C-D)  Quantification  of  GFAP  immunoreactivity  –  an  indicator  of 
Activated Astroglia - at day 4 (d04, C) and day 14 (d14, D) in c-Jun
F/F 
and c-Jun
S animals after facial nerve transection. (E) Quantification of 
microglial  αX  immunoreactivity  at  day  14  in  c-Jun
F/F  and  c-Jun
S 
animals. (F) Quantification of CD3+ T-Cell immunoreactivity at day 14 
in c-Jun
F/F and c-Jun
S animals. Data was calculated using the MEAN-
SD  algorithm  (Moller  et  al.,  1996).  White  bars,  contralateral;  black 
bars, axotomized. *p< 0.05 and ***p< 0.001 in uSTT between c-Jun
F/F 
and c-Jun
S.  P a g e  | 96 
 
 
 
both  timepoints  (5.6±0.6  at  d4  [N=5]  and  5.4±1.1  at  d14  [N=5],  p<0.05  in  unpaired 
Student‘s T-test, see Figure 4-6 and Figure 4-7). 
T-cell recruitment was abolished by neural deletion of c-Jun. c-Jun
S animals had no CD3+ 
lymphocyte recruitment to the injured facial motor nucleus (N=7) whereas their wild type 
counterparts averaged 39.1±3.52 (N=10) CD3+ T-Cells per nucleus (Figure 4-6 and Figure 
4-7).  
Taken together, this data shows that the non-neuronal cell response relies heavily on the 
presence of neuronal c-Jun; this response is virtually non-existent without it. Microglia and 
Astrocytes fail to activate, CD3+ T-Cells are not recruited to the site of injury and microglia 
do not differentiate into a phagocytic phenotype. Lack of phagocyte activation could also 
be attributed to decreased levels of cell death. To determine whether lack of cell death 
andnon-neuronal response was due to inadequate neural cues or to Jun actions further 
downstream, the neuronal response to injury in Jun
N mutants was explored.  
4.6  Neuronal c-Jun is Necessary for Neuronal Cellular Response to Injury 
Nerve injury not only elicits changes in the local microenvironment but it also, perhaps 
more importantly, induces changes in the neuron itself that promote growth and sprouting. 
Immediate early transcription factors like c-Jun and ATF3 are upregulated within hours. 
Jun heterodimerizes with ATF3 to produce a type of AP-1 transcription complex which has 
been  implicated  with  downstream  actions  including  growth,  survival  and  sprouting 
(Pearson et al., 2003a; Nakagomi et al., 2003; Campbell et al., 2005; Kiryu-Seo et al., 
2008). CGRP and Galanin are expressed in the neuronal cell body and are transported 
anterogradely into axonal growth cones (Makwana et al., 2009). Adhesion molecules like 
CD44  hyaluronic  acid  receptor  and  α7β1  integrin  are  also  translated  and  used  for P a g e  | 97 
 
 
 
guidance and cell-cell communication  (Lin and  Chan,  2003; D. Wynick and  McMahon, 
2001).  Previous  studies  link  c-Jun  deletion  to  absence  of  CD44  expression  in  several 
neuronal  cell  types  following  injury  (Raivich  et  al.,  2004a).  All  of  these  regeneration 
associated molecules showed strong upregulation in wild type animals after injury.  
 
Figure 4-8 Neuronal c-Jun is Necessary for the Cellular Response to facial nerve axotomy. 
Abolished neuronal cell response to facial nerve axotomy in c-Jun
S mutants at day 14 (d14) after axotomy 
compared to c-Jun
F/F controls. The facial motor nuclei from c-Jun
F/F littermate controls are shown in the 1
st & 
2
nd columns (A,B,E,F)(Moller et al., 1996). White bars,I,J,M,N,Q,R), those from the c-Jun
S mutants are in the 
3
rd  &  4
th  column  (C,D,G,H,K,L,O,P,S,T).  Second  and  4
th  columns  are  axotomized,  1
st  & 
3rd  columns, 
contralateral sides, respectively. (A-D) Neuronal Jun deletion reduced axotomy-induced CD44 Hyaluronic acid 
expression in injured facial motor neurons. (E-H) Axotomy-induced galanin upregulation, as well as (I-L) CGRP 
and  (M-P)  β1  integrin  expression  following  injury  is  absent  in  c-Jun
S  facial  motor  nuclei.  (Q-T)  ATF3 
immunoreactivity is also is absent in c-Jun
S mutants following facial nerve axotomy. Scale bar 0.2mm.  P a g e  | 98 
 
 
 
Contrastingly,  they  showed  diminished  or  abolished  action  following  facial  nerve 
transection in activation in c-Jun
S animals (Table 4 of the Appendix, Figure 4-8 and Figure 
4-9). Galanin, CGRP, CD44 and α7β1 integrin fail to be upregulated either 4 or 14 days 
following  facial  nerve  transection  (Figure  4-8  and  Figure  4-9)  and  ATF3  shows  failed 
nuclear early upregulation 4 but not 14 days post-facial nerve axotomy (Figure 4-8 and 
Figure 4-9). This illustrates the importance of c-Jun for the neuronal injury response and 
suggests  an  alternate  but  slower  mechanism  of  ATF3  upregulation  following  injury. 
Without  upstream  signalling  from  c-Jun,  neurons  are  unable  to  initiate  the  cellular 
response  that  leads  to  non-neuronal  cell  recruitment  and  eventual  death  of  damaged 
neurons. 
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Figure 4-9: Abolished Neuronal Cell Response Following Facial Nerve Transection in c-Jun
S mutants. 
(A-B) Quantification of CGRP immunoreactivity at day 4 (d04, A) and day 14 (d14, B) after axotomy. (C-D) 
Quantification  of  Galanin  immunoreactivity  at  day  4  (d04,  C)  and  day  14  (d14,  D)  after  axotomy.  (E-F) 
Quantification of CD44 Hyaluronic acid immunoreactivity at day 4 (d04, E) and day 14 (d14, F) after axotomy. 
(G-H) Quantification of β1 integrin immunoreactivity at day 4 (d04, G) and day 14 (d14, H) after axotomy. (I-J) 
Quantification of ATF3 immunoreactivity at day 4 (d04, I) and day 14 (d14, J) after axotomy using the MEAN-
SD algorithm (Moller et al., 1996). White bars, contralateral side; black bars, axotomized side. *p< 0.05 and 
***p< 0.001 in uSTT between c-Jun
F/F and c-Jun
S mice. N=5 for 4D c-Jun
F/F and c-Jun
S. N=10 for 14D c-
Jun
F/F and N=6 for 14D c-Jun
S. P a g e  | 99 
 
 
 
JUN
S DISCUSSION: NEURONAL C-JUN ORCHESTRATES THE 
CELLULAR RESPONSE TO INJURY AND CELL DEATH 
Upon facial nerve transection, many growth and survival-associated transcription factors 
are immediately upregulated. One of the most important and well-characterized of these is 
the AP1 transcription complex, consisting of either c-Jun homodimers or heterodimers with 
other Jun, or ATF/CREB family members (Angel et al., 1992). Jun can also complex with 
c-Fos  family  members,  although  Fos  is  not  expressed  in  regenerating  facial  motor 
neurons. Jun‘s AP1 activity has been linked to increased neuronal sprouting (Pearson et 
al., 2003a; Nakagomi et al., 2003; Campbell et al., 2005; Kiryu-Seo et al., 2008; Seijffers et 
al., 2007, 2006), cellular response to stress (Chaum et al., 2009; Chen et al., 2009; Coffey 
et al., 2000; Donovan et al., 2002; Johnson and Nakamura, 2007) and survival (Raivich et 
al., 2004a; Haeusgen et al., 2009; Wang et al., 2009; Behrens et al., 1999; Brecht et al., 
2005a; Cuadrado et al., 2004) both in vivo and in vitro. This study investigated the role of 
neuronally  expressed  c-Jun  in  peripheral  regeneration.  It  revealed  that  c-Jun  is  an 
essential regulator of the cellular response to axonal injury and also resulting neuronal 
survival. Neuronal c-Jun deletion affects lymphocyte recruitment and phagocyte activation, 
as well as survival and successful reinnervation following injury.  
4.7  Increased Facial Motoneuron Number in c-Jun Deficient Mice 
Despite normal brain morphology, as indicated by Haematoxylin & Eosin staining of the 
hippocampus and thalamus, as well as NeuN staining of the same areas, brain-deficient c-
jun mice showed a 14% increase in baseline facial motoneuron number. This is similar to 
the findings of Raivich et al., who used Nestin-mediated Jun excision to show increased 
numbers  of  facial  motor  neurons  in  neuroepithelial  stem  cell  c-jun-deficient  animals, 
although  they  found  no  differences  in  learning,  fear  conditioning,  motor  performance, 
number of dorsal root ganglia (DRG) neurons or number of hypoglossal neurons (Raivich P a g e  | 100 
 
 
 
et al., 2004a). This increase in baseline facial motor neuron number could be attributable 
to a lack of cell death signalling during developmental pruning, as previous studies have 
shown decreased neuronal cell death both in vitro and in vivo following c-jun deletion or 
inactivation (Raivich et al., 2004a; Palmada et al., 2002). In light of this research, current 
studies are underway to explore the role of c-Jun deletion in relation to disease models 
that  show  high  levels  of  neuronal  cell  death  in  the  absence  of  reinnervation,  such  as 
amyotrophic lateral sclerosis (ALS). 
4.8  Cell-Type Specificity of c-Jun
S 
Previous  studies  from  Raivich  et  al.  using  Nestin::Cre  deleted  c-Jun  targeted  the  Jun 
deletion to neuroepithelial derived cells (Raivich et al., 2004a). These include Neurons, 
Astrocytes,  Oligodendrocytes  and  Schwann  Cells  –  as  well  as  some  other  cell  types 
(Minovi et al., 2010; Kohno et al., 2006; Zou et al., 2006; Vukojevic et al., 2009; Ueno et 
al., 2005; Toti et al., 2005; Saito et al., 2009; Rovira et al., 2009). However, it was unclear 
as to whether the cellular differences observed in that study were due to the actions of 
neuronal Jun, or Jun deletion in the other cells with neuroepithelial origin. Here, c-Jun 
deletion was specifically targeted to neurons to explore the role of c-Jun in peripheral 
regeneration. This experiment confirmed the previous hypothesis that neuronal c-Jun was 
indeed orchestrating the impaired regenerative response seen in c-Jun
N mice.  
Normally,  after  injury,  CD3+  T-Cells  are  recruited  from  the  local  microenvironment 
(Galiano et al., 2001; Ha et al., 2006). T-Cell infiltration to the site of injury was completely 
absent  in  c-Jun
S  mice,  illustrating  its  essential  role  in  the  chemoattractant  signalling 
cascades leading to successful T-lymphocyte recruitment. Given the fact that neuronal 
survival was also enhanced in c-Jun
N mutants, lack of effector migration could also be 
attributed to decreased levels of cell death. Vice versa, it could be argued that lack of T-P a g e  | 101 
 
 
 
Cell  recruitment  was  contributing  to  c-Jun  deficient  neurons‘  inability  to  die.  However, 
previous  investigations  with  Non-Obese  Diabetic  (NOD)  Severe  Combined 
Immunodeficiency (SCID) mice show that T-Cell deficient mice – which therefore do not 
show T-Cell recruitment following facial nerve injury – show enhanced motoneuron cell 
death  following  peripheral  injury  (Serpe  et  al.,  1999,  2000,  2002;  Byram  et  al.,  2004; 
Deboy  et  al.,  2006;  Xin  et  al.,  2008).  This  indicates  that  increased  cell  survival  or 
decreased cellular response – as a product of Jun ablation – caused impaired lymphocyte 
trafficking to the facial motor nucleus and not the other way around.  
Not only was CD3+ lymphocyte recruitment ablated in c-Jun mutant mice, but signalling by 
activated astrocytes was also affected by neuronal c-Jun deletion. Normally, astrocytes 
home to the site of injury, secrete reactive oxygen intermediates and other molecules used 
in  chemoattraction  and  participate  in  the  injury  response  as  antigen  presenting  cells 
(Farina et al., 2007). The absence neuronal cues led to impaired astroglial recruitment and 
activation,  as  well  as  decreased  response  to  peripheral  nerve  transection.  Phagocytic 
microglial transformation was also affected, as was microglial activation following injury. 
Synapsin 1 has previously been characterized as a neuron-specific promoter (Usukura et 
al., 1987; Zhu et al., 2001; Kügler et al., 2003; Sims et al., 2008) and does not target gene 
expression  to  monocytic  cell  types  such  as  microglia.  Therefore,  defects  in  microglial 
response  are  solely  attributable  to  defects  in  neuronal  signalling  conferred  by  neuron-
specific c-jun deletion. Microglial activation, as indicated by αM integrin immunoreactivity, 
was  impaired  within  4  days  following  injury  and  remained  so  throughout  the  injury 
response. This indicates that microglial activation depends closely on neuronal signals put 
forth by c-Jun and that defects in the microglial response result from impaired neuronal 
cues.  Additionally,  there  was  a  distinct  absence  of  injury-associated  αX  integrin 
immunopositive monocytic nodules in the FMN of Jun
S animals. This is probably due to 
the lack of cellular debris present in mutants, as a result of decreased cell death, which P a g e  | 102 
 
 
 
abolishes the need for phagocytic cells; thus the transition of Microglia into a phagocytic 
phenotype does not take place due to insufficient environmental cues.  
4.9   Impaired Target Reinnervation in Jun Deficient mice 
To determine the role of neuronally expressed c-Jun in successful target reinnervation, 
three methods were utilized; functional recovery was scored for thirty days following facial 
nerve transection using the whisker hair assessment approach and anatomical recovery 
was  gauged  thirty  days  after  nerve  cut  via  retrograde  labelling.  In  addition,  physical 
regeneration of the facial motor nerve was gauged via anatomical tracking of CGRP and 
galanin immunopositive axonal sprouts in the facial nerve 4 days following crush injury. 
Whisker function showed an almost 3 fold deficit in recovery of motor function of c-Jun
S 
mutants compared to wild type controls, which was consistent throughout the trial period. 
Other studies using a nestin mediated jun deletion showed that animals with more general 
neural deletion of jun do not recover function, even after 15 weeks, in a nonlinear manner. 
Likewise, anatomical assessment revealed an almost 8 fold decrease in reinnervation after 
30 days in c-Jun
S mice compared to control littermates. Previous data in c-Jun
N mice 
indicates that while functional recovery returned to normal after 15 weeks in neuronally 
jun-deficient animals, levels of anatomical recovery remained consistently lower and the 
predictive  value  of  the  whisker  hair  test  became  less  reliable  as  more  neurons 
reconnected to the original target (Raivich et al., 2004a) 
Crushed facial nerves normally exhibit a robust growth response following injury, with the 
extension of CGRP and galanin immunoreactive growth cones into local bands of Büngner 
to  reinnervate  neuromuscular  targets,  (Makwana  et  al.,  2009;  Williams  et  al.,  1971b, 
1971a;  Ghabriel et  al., 1979b,  1979a). Animals that were neuronally deficient in c-Jun 
showed a 60% reduction in the length of axons extruded distally from the injured portion of P a g e  | 103 
 
 
 
the neuron. This difference was consistent for both CGRP and galanin immunoreactive 
sprouts, which indicates that neuronal c-Jun has a regulatory role in neurite elongation 
following peripheral nerve injury. 
4.10  C-Jun is Essential for both Regeneration and Cell Death 
These  data  illustrate  the  previously  described  dual  role  of  c-Jun  in  both  neuronal 
regeneration and apoptosis (Raivich, 2008; Raivich et al., 2006; Herdegen et al., 1997; 
Shaulian  and  Karin,  2001;  Mechta-Grigoriou  et  al.,  2001).  Animals  lacking  c-Jun  in 
neurons showed decreased anatomical and functional recovery with increased levels of 
cell survival. Normally, neurons that do not reach the neuromuscular junction die due to 
insufficient trophic support, however in the absence of c-Jun they were unable to die and 
simply atrophied.  
4.11  The Cellular Response to Injury in c-Jun Null Mice– Molecular Mechanisms 
Lack of reinnervation can also be attributed to the failed cellular response exhibited by c-
Jun
S neurons. Without adequate sprouting and elongation signals, as well as participation 
from local non-neuronal effector cells, mutant neurons were not able to mount a sufficient 
cellular injury response. Previous studies highlight upregulation of and describe the role of 
pro-regenerative factors CD44 (Jones et al., 2000), α7β1 integrin (Werner et al., 2000), 
ATF3 (Pearson et al., 2003a; Fan et al., 2002), CGRP and Galanin (Makwana, Serchov, et 
al., 2009) in the injury response. In fact, CD44, α7 and Galanin have AP1 promoters (Lee 
et al., 1993; Anouar et al., 1999; Jones et al., 2000; Nishida et al., 1997) and ATF3 has 
been described as a downstream target of c-Jun (Mei et al., 2008a). As a result of growth-
enhancing adhesion molecule and neuropeptide expression from the neuronal cell body 
following injury, peripheral facial motor neurons are typically able to mount a successful P a g e  | 104 
 
 
 
and robust regenerative response. Jun
S animals showed no upregulation of any of these 
pro-regenerative  factors  following  facial  nerve  transection.  As  a  result,  regeneration  in 
these mutants was poor. Taken together, these data indicate that c-Jun plays a critical role 
in both neuronal regeneration and cellular commitment to die; future therapeutic strategies 
could exploit this fact to prolong neuronal survival or  enhance regeneration in disease 
models. 
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CHAPTER 5:  P0::JUN RESULTS: SCHWANN CELL – 
EXPRESSED C-JUN IS REQUIRED FOR MOTOR NEURON 
SURVIVAL AND SUCCESSFUL POST-INJURY PERIPHERAL 
REINNERVATION  
5.1  Generation of Mice Lacking c-jun in Schwann Cells 
To define the role of c-jun in the peripheral regenerative response, animals were created 
with a Schwann Cell specific deletion of c-jun. To do this, mice carrying a floxed c-jun 
allele (jun
f/f) were crossed with animals expressing cre recombinase under the control of 
the P0 promoter, which causes Schwann cell specific recombination (P0::Cre, Raivich et 
al. 2004; Lee et al. 1997; Rhona Mirsky et al. 2008; Behrens et al. 2002 and Tronche et al. 
1999) to make homozygous P0 x jun 
f/f and heterozygous P0 x jun 
f/WT mutants. Previous 
studies demonstrate the efficiency and Schwann-cell specificity of the P0::Cre transgenic 
line (Yamauchi et al., 1999). Furthermore, it has been shown that chromosomal location of 
recombination substrates  influences recombination frequencies in Cre/LoxP systems  of 
gene expression, and therefore differences in recombination efficiency between different 
floxed  genes  have  been  observed  (Vooijs  et  al.,  2001).  Thus,  recombination  was 
investigated in both homozygous P0 x jun 
f/f and heterozygous P0 x jun 
f/WT littermates to 
exclude  the  possibility  of  compensatory  mechanisms  resulting  from  homozygous  jun
f/f 
inactivation affecting the final result.  
Mice lacking c-jun in Schwann cells (P0 x jun 
f/f) were born with Mendelian frequency and 
were  viable  and  fertile.  Neuronal  cell  counts  of  the  facial  motor  nucleus  showed  no 
difference in baseline numbers of facial motor neurons between P0 x jun 
f/f animals and 
their wild-type littermates.  P a g e  | 106 
 
 
 
5.2  Glial c-jun is Required in the Periphery for Effective Axonal Regeneration and 
Reinnervation 
After nerve injury, neurons and peripheral glia upregulate several key factors involved in 
sprouting, elongation and growth; these factors act to establish and maintain a growth-
permissive  environment  that  supports  the  anatomical  and  functional  reinnervation 
commonly  seen  in  response  to  peripheral  nerve  injury.  First,  axons  must  successfully 
cross the site of injury toward the degrading peripheral nerve stump, and then they must 
form physical and functional connections at the neuromuscular junction. Schwann cells 
play a pivotal role in this peripheral response by engulfing axonal debris,  upregulating 
growth associated survival factors like RegIIIβ, LIF and CNTF and also separating from the 
Myelin sheath to create Bands of Büngner which provide physical structures along which 
axons are guided to their appropriate targets (Williams et al., 1971b, 1971a; Ghabriel et 
al., 1979a, 1979b; Tebar, Géranton, et al., 2008). Therefore, it is important to characterize 
the role, if any, that Schwann Cell – expressed c-Jun plays in this injury response. 
5.2.1  Functional Reinnervation of Peripheral Targets 
First, it was determined whether transected facial motor axons were able to regenerate 
through a Schwann Cell environment lacking c-Jun to form functional connections with 
target muscle. A reliable measure of this functional reinnervation – in particular with regard 
to that of the facial motor nerve – is the reestablishment of function of the whisker hair 
post-axotomy. Extent of whisker function was scored by five observers, on a scale of 0 (no 
movement) to 3 (strong, normal movement). As seen in Figure 5-1, twenty-eight days post-
injury, both control and mutant animals showed strong, normal movement on the uninjured 
side (3.0). On the injured side, control animals showed an average motor score of 2.2 ± 
1.0 (n = 9). Likewise, P0 x jun 
f/WT heterozygotes showed 2.3 ± 1.6 units of recovery (n=2).  P a g e  | 107 
 
 
 
Contrastingly, P0 x jun 
f/f mice 
showed  significantly  less 
functional  recovery  on  the 
injured  side  of  the  whisker 
pad (0.3 ± 0.2; n = 6, p < 0.01 
between jun
f/f and jun
f/f P0::cre 
in  uSTT).  Since  n=2  for 
heterozygotes,  for  the 
purpose of both functional and 
anatomical  recovery, 
student‘s T-Test between wild 
type  and  mutant  was  used 
instead of 3-way ANOVA.  
To  determine  whether 
defective  whisker  movement 
exhibited by P0 x jun 
f/f mice 
was  due  to  differences  in 
muscle  reinnervation,  the 
fluorescent  tracer  Fluorogold  was  introduced  under  the  whisker  pad  as  described  in 
Materials and Methods. Fluorogold implantation on the uninjured side served as an intra-
animal  control.  Similar  numbers  of  retrogradely  labelled  neurons  were  visible  on 
contralateral sides of control, heterozygote and mutant animals, but on the axotomized 
side, the number of retrogradely labelled neurons decreased proportionally with number of 
deleted  copies  of  c-jun.  Control  animals  showed  164±9  labelled  motoneurons  on  the 
contralateral side and 110±10 on the axotomized side (n=9); P0 x jun
f/WT heterozygotes 
exhibited 193±22 FG+ motor neurons on the uninjured and 54±3 on the injured sides  
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Figure 5-1: Charting the Post-Axotomy Regenerative Response – 
c-Jun in Schwann cells is essential for Functional Reinnervation. 
(A) jun
f/f P0::cre animals show impaired motor recovery following facial 
nerve transection. Posttraumatic whisker hair motor performance was 
measured  28  days  after  facial  nerve  axotomy,  on  a  scale  of  0  (no 
movement)  to  3  (normal  strong  movement  similar  to  that  of 
contralateral side); N = 5 for jun
f/f, N=2 for jun
f/WT P0::cre and N = 3 for 
jun
f/f P0::cre animals. Black Bars, WT; Checked Bars, Het; White Bars, 
KO. (B) Shorter average regeneration distance of CGRP and galanin 
immunopositive motor axon populations 4 days after facial nerve crush 
in jun
f/f P0::cre mutants (Error bars indicate mean +/-standard error of 
mean  (SEM),  n=4  animals  per  group).  *p  <  0.05,  **p<0.01  and 
***p<0.001 between jun
f/f and jun
f/f P0::cre in uSTT. Data collected in 
collaboration with D. Cuthill and M. Makwana. P a g e  | 108 
 
 
 
(n=2);  P0  x  jun 
f/f  mutants 
displayed  141±15  FG 
immunoreactive  neurons  on 
the  control  and  20±3  on  the 
axotomized sides (n=6, Figure 
5-2,  *  p  <  0.001  between 
Junf/f  wild  type  and  Junf/f  x 
P0::Cre  mutants  in  uSTT). 
Overall,  the  ratio  of  labelled 
neurons  on  axotomized 
versus  contralateral  sides 
(ax/co  ratio  or  specific 
reinnervation)  in  control 
animals was 66% ± 4% (n=9). 
In  heterozygotes,  specific 
reinnervation  was  29%±5% 
(n=2)  and  in  P0  x  jun 
f/f 
mutants,  it  was 
14%±2%(n=6),  more  than  4-
fold  lower  (*p  <  0.001 
between  Junf/f  controls  and 
Junf/f  x  P0::Cre  mutants  in 
uSTT),  which  suggests  that 
failure  to  recover  whisker 
movement in P0 x jun 
f/f mice 
is due to insufficient Schwann 
 
Figure  5-2:  Deletion  of  Schwann  cell  c-jun  using  p0::cre 
recombinase  interferes  with  the  reinnervation  of  the  peripheral 
target (Whisker Pad) 
FMN Fluorogold (FG) fluorescence in jun
f/f and jun
f/f P0::cre mice on 
control (co) and operated side (ax) 28 days post-facial nerve cut with 
72 hours for retrograde FG transport. (A-B) Animals with normal c-jun, 
(C-D)  heterozygote  excision  of  Schwann  Cell  (SC)  c-jun  and  (E-F) 
homozygote deletion. Scale bar, 250 µm. (G) Normal numbers of FG+ 
motoneurons were present in the contralateral side of WT, Het and KO 
animals, however after injury FG+ motor neuron number reduces by 
about 50% with each deleted copy of c-jun.(N = 5 for jun
f/f N=2 for 
jun
f/wt  P0::cre  and  N  =  3  for  jun
f/f  P0::cre  mice).  Contralateral  side, 
white bars; Ipsilateral side, black bars. (H) Ax/Co ratio of FG+ neurons 
is shown;again, note the graded decrease in FG+ motoneurons with 
decreasing  copy  numbers  of  c-jun;  jun
f/f  black  bars;  jun
f/wt  checked 
bars;  P0::cre  jun
f/f  P0::cre  mice,  white  bars.  ***p<0.001  between  in 
uSTT. Figure produced in collaboration with M. Makwana. P a g e  | 109 
 
 
 
Cell jun-associated signalling cues. 
5.2.2  4 Day Regeneration 
Within 1-2 days after injury, lesioned neurons extrude growth cones from their proximal 
neuronal tips. These sprouts show galanin and CGRP immunoreactivity and extend in a 
proximal  –  to  –  distal  direction  (Galiano  et  al.,  2001;  Werner  et  al.,  2000;  Makwana, 
Werner, et al., 2009). As seen in Figure 5-1, c-jun-deficiency in Schwann cells interfered 
with this axonal extension. Control, jun
f/f animals showed prominent sprouting of galanin- 
immunoreactive growth cones averaging 6.5±0.2mm following injury and mutants showed 
less  -  4.6±0.6mm  (n=4).  The  same  is  true  for  CGRP  immunoreactive  axons;  control 
animals‘  axons  grew  6.8±0.4  following  injury  and  mutants  averaged  4.4±0.5mm  (n=4). 
Neurons  that  lacked  trophic  support  from  c-jun  expressing  glia  showed  an  average 
reduction  in  length  of  35  percent  (*p  <  0.05  in  unpaired  Student‘s  T-test)  in  CGRP 
immunoreactive growth cones and 30 percent (*p < 0.05 in unpaired Student‘s T-test) in 
galanin reactive growth cones compared to wild type counterparts. 
5.2.2.1  Absence of Glial c-jun Increases Axotomy-Induced Cell Death 
Peripheral nerves display a robust regenerative response post-injury, whereas those of the 
CNS do not. This is, in part, may be due to the existence or absence of appropriate trophic 
support – since some CNS neurons will regenerate through a peripheral nerve graft but 
not through native CNS glia (Cajal, 1928). Despite this, twenty to thirty percent of facial 
motor  neurons  normally  fail  to  survive  following  nerve  transection  (Ferri  et  al.,  1998a; 
Hottinger et al., 2000). To determine whether glial c-Jun plays a role in axotomy-induced 
cell death, quantitative measurements were made of all motoneurons in the facial motor 
nucleus of the brainstem using cresyl violet (Figure 5-3). P a g e  | 110 
 
 
 
 
Figure 5-3: Decreased Cell Survival after Axotomy in junf/f P0::cre Motor neurons 
(A) Quantification of motoneuron number in facial nucleus of adult c-jun
f/f and jun
f/f P0::cre mice on the contralateral (white bars) and ipsilateral side (black bars), 30 days 
after facial nerve transection. *p < 0.01% in uSTT between jun
f/f P0::cre and c-jun
f/f groups (A and B), N = 5 for c-jun
f/f and N = 3 for jun
f/f P0::cre animals in (A) and (B). (B) 
Quantification of specific cell death Ax/Co in the facial motor nucleus of adult c-jun
f/f (black bars) and jun
f/f P0::cre (white bars) mice, 30 days after facial nerve axotomy. 
(C) Quantification of motoneuron number in facial nucleus of neonate c-jun
f/f and jun
f/f P0::cre mice on the contralateral (white bars) and ipsilateral side (black bars), 30 
days after facial nerve transection. *p < 0.01% in uSTT between jun
f/f P0::cre and c-jun
f/f groups (A and B), N = 5 for c-jun
f/f and N = 3 for jun
f/f P0::cre animals in (A) and 
(B). (D) Quantification of specific cell death Ax/Co in the facial motor nucleus of neonate c-jun
f/f (black bars) and jun
f/f P0::cre (white bars) mice, 30 days after facial nerve 
axotomy. P a g e  | 111 
 
 
 
Thirty days post- axotomy, 75% ± 6% of neurons were present in the injured facial motor 
nucleus of control mice (n=9), whereas only 19%± 2% were present in the facial motor 
nucleus of P0 x jun 
f/f animals (n=6, p <0.05 in unpaired Student‘s T-test). Total cell counts 
showed increased cell death on the axotomized side (p < 0.001 in unpaired Student‘s T-
test)  in  P0  x  jun 
f/f  animals,  compared  to  wild  type  littermates.  Control  animals  had 
2280±43 labelled neurons in the control nucleus and 1707±154 on the axotomized side 
(n=9), whereas their transgenic counterparts possessed 2207 ±100 cresyl violet-stained 
neurons on the control side and 416 ± 22 on the operated side (n = 6). However, this 
difference  in  survival  following  transection  was  dependent  on  stage  of  development; 
facially  transected  neonate  (P1)  animals  failed  to  show  the  same  distribution.  In  fact, 
although there was vast neuronal cell death associated with neonatal transection, there 
was no difference between wild type, heterozygotes and mutants in facial motor neuron 
survival 3 days following facial nerve cut. Control animals showed 50±13% motor neuron 
survival (N=7), heterozygotes displayed 43±20% (N=2) and mutants had 61±20% (N=3). 
On  the  contralateral  side,  Jun 
f/f  wild  types  had  1069±258  surviving  motor  neurons, 
compared  to  the  ipsilateral  side,  which  had  533±137.  Jun
f/wt  xP0::Cre  heterozygotes 
averaged 1567±0 on the contralateral side and 682±60 following injury. Similar levels of 
survival  were  seen  in  Jun
f/f  xP0::Cre  mutants,  who  averaged  1518±926  facial  motor 
neurons on the uninjured and 926±124 on the injured side respectively. This data suggests 
that glial c-jun expression creates trophic support from Schwann Cells which is essential 
for successful motoneuron survival in adult animals, but not during development.  P a g e  | 112 
 
 
 
5.3  Changes in Non-Neuronal Cell Activation after Facial Nerve Axotomy 
accompanying c-Jun deletion in Schwann Cells 
Peripheral nerve transection is accompanied by reactive changes in brain resident non-
neuronal cells such as astrocytes and microglia (Raivich et al., 1999, 1999; Schwaiger et 
al.,  1998; Werner  et  al.,  2001a;  Tichauer  et  al.,  2007).  Astrocytes  upregulate  reactive 
oxygen species (ROS) and GFAP and mobilize to the site of injury, where they exert their 
trophic  effects.  Microglia  undergo  morphological  changes  to  become  activated,  in  the 
presence of signalling cues, or to become phagocytic in response to cellular debris. There 
exists  accompanying  increase  in  markers  αM  integrin  subunit  and  αX  integrin  subunit 
respectively  in  activated  and  phagocytic  microglia.  Cell  survival  and  death  signals  are 
propagated both anterogradely, from the neuronal cell body to the regenerating proximal 
 
Figure 5-4: Increased Phagocytic Microglial Activation after facial nerve cut in junf/f P0::cre mice. 
(A  and  C)  Quantification  of  astrocytic  GFAP  immunoreactivity  at  day  14  (d14)  and  (C)  day  4  (d04)  after 
axotomy. (B and D) Quantification of activated microglial marker αM immunoreactivity at day 14 (d14) (B) and 
(D) day 4 (d04) after axotomy. A-D were quantified in OLV of luminosity. White bars, contralateral side; black 
bars, ipsilateral side. p >0.05 in uSTT between junf/f P0::cre mice and c-jun
f/f groups. N = 5 for c-jun
f/f and N = 
5 for jun
f/f P0::cre in (A) and (B); N = 3 for jun
f/f and N = 3 for jun
f/f P0::cre animals in (C); N = 2 for jun
f/f and N = 
3  for  jun
f/f  P0::cre  animals  in  (D).  (E)  Quantification  of  phagocytic  microglial  marker  αX  integrin 
immunoreactivity at day 14 (d14) after axotomy in jun
f/f (black bars) and jun
f/f P0::cre (white bars) animals. ***p 
< 0.001 in uSTT between jun
f/f P0::cre mice and jun
f/f groups. P a g e  | 113 
 
 
 
axonal tip and retrogradely, from Schwann Cells in the periphery and other environmental 
cues  into  the  soma;  there  exists  a  feedback  loop  throughout  the  entire  regenerative 
process. Therefore, the resultant changes in non-neuronal cell activation and recruitment 
associated with ablation of c-Jun-derived signalling from the periphery were investigated. 
First, the role of peripheral c-Jun signalling in clearing cellular debris after facial nerve 
transection  was  investigated.  In  the  presence  of  debris,  microglia  adopt  a  phagocytic 
phenotype,  as  indicated  by  presence  of  the  cell  surface  marker  αX  integrin,  and  form 
distinct nodal structures in the axotomized but not the contralateral brainstem facial motor 
nucleus (Streit et al., 1988; Aloisi, 2001; Bohatschek et al., 2004). These structures were 
counted  in  both  control  and  mutant  mice  and,  as  seen  in  Figure  5-4,  control  animals 
exhibited an average of  3.3±0.5  αX  immunopositive cells in the ipsilateral facial motor 
nucleus 14 days after facial nerve transection (N=5). P0 x jun 
f/f animals had higher levels 
of phagocytic microglia in the ipsilateral facial motor nucleus (11.5±1.5; n=5) compared to 
jun 
f/f controls (p < 0.01 in unpaired Student‘s T-test). Next, activation levels in microglia, 
as indicated by αM integrin immunoreactivity, were investigated. Schwann Cell deletion of 
c-Jun did not affect levels of activated microglia. 14 days post facial nerve axotomy, wild 
type animals exhibited 10.9±2.7 units of optical luminosity value (OLV) on the contralateral 
side and 44.1±4.0 on the ipsilateral side (N=5) and P0 x jun 
f/f animals exhibited 13.3±4.0 
OLV on the contralateral side and 50.9±5.4 on the injured side (N=5, p<0.05 in unpaired 
Student‘s T-test). Four days after facial nerve transection, control animals showed 9.3±1.7 
OLV on the contralateral side and 43.6±9.5 on the ipsilateral side (N=2) whereas mutants 
exhibited 11.6±0.4 OLV on the contralateral side and 48.9±5.6 on the ipsilateral side 4 
days post-axotomy (N=3, p<0.05 in unpaired Student‘s T-test). Lastly, astrocyte activation, 
as indicated by GFAP expression, was investigated. There were no differences between 
wild type and mutant animals in GFAP expression at 14 days post-axotomy, with control 
animals showing 18.2±1.8 OLV on the contralateral side and 44.8±2.6 on the ipsilateral P a g e  | 114 
 
 
 
side  (N=5)  and  mutants 
showing  17.6±2.2  on  the 
contralateral  side  and 
43.6±1.8  on  the  injured  side 
(N=5,  p<0.05  in  unpaired 
Student‘s  T-test).  There  were 
also  no  differences  4  days 
post-axotomy,  with  wild  type 
animals  exhibiting  21.2±3.5 
OLV on the contralateral side 
and  67.7±10.4  on  the 
ipsilateral side (N=3) and P0 x 
jun 
f/f animals showing 22.6±2.1 on the contralateral side and 59.7±2.0 on the ipsilateral 
side (N=3, p<0.05 in unpaired Student‘s T-test).  
Contrastingly, monocyte recruitment at the lesion site after crush injury was less in P0 x 
jun 
f/f animals than wild type controls (Figure 5-5). This difference became less prominent 
progressively further from the lesion site. At the crush area (0mm), macrophage numbers 
averaged 3.9±2.9 in control animals (n=4). Contrastingly, P0 x jun 
f/f mutants displayed 
19.1±4.3 macrophages, an almost 30% reduction, although this fell short of significance 
(P<0.1,  n=3).  2mm  from  the  lesion  site,  P0  x  jun 
f/f  mutants  showed  roughly  half  the 
infiltration of their wild type counterparts - counts were 14.9±1.3 for wild type jun 
f/f animals 
and 2.9±2.1 for P0 x jun 
f/f knock outs (n=4 and n=3 respectively, p <0.005 in unpaired 
Student‘s  T-test).  Lastly,  4mm  from  the  lesion  site,  jun 
f/f  animals  averaged  6.7±1.2 
macrophages and P0 x jun 
f/f animals averaged 1.7±1.1, again, almost fifty percent less 
than in wild type littermates (n=4 and n=3 respectively, p <0.05 in unpaired Student‘s T-
test).  
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Figure 5-5: Decreased Macrophage Infiltration in P0xJunf/f Mutant 
Facial Motor Nerves 
Quantification  of  Macrophages  homed  to  site  of  peripheral  injury  4 
days  following  facial  nerve  crush,  on  the  ipsilateral  side.  Data 
quantified in OLV of luminosity using the MEAN-SD algorithm (Moller 
et al., 1996). White bars, Jun f/f wild type animals; black bars (N=4), 
Jun  f/f  x  P0::Cre  mutants  (N=3).  *p<0.05  in  uSTT  between  junf/f 
P0::cre mice and c-jun
f/f groups. Data collected in collaboration with M. 
Makwana. P a g e  | 115 
 
 
 
Glial Expression of c-Jun 
does not Affect Neuronal 
Cell Body Response 
Reciprocal  interactions 
amongst  neuronal  systems 
are  common;  facial  motor 
neurons  are  affected  by 
homeostatic  changes  in  both 
the  axonal  and  the  somatic 
cellular  microenvironments. 
Therefore,  the  contribution  of 
c-Jun,  expressed  by 
peripheral glia,  to the cellular 
response  of  motor  neuron 
soma  in  the  facial  motor 
nucleus  was  investigated. 
Normally, nerve transection is 
accompanied  by  upregulation 
of  various  growth-associated 
transcription factors – such as 
CGRP  and  Galanin,  beta-1 
integrin  and  CD44  -  in  the 
neuronal cell body. These factors can act locally, or in the proximal nerve segment via 
axonal transport. No significant differences were observable between wild-type and mutant 
animals in CD44, CGRP, Galanin or β1 integrin expression levels either 4 or 14 days post 
facial nerve transection (Figure 5-6).   
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Figure  5-6:  No  Difference  in  Expression  Levels  of  Neuronal 
Factors after Facial Nerve Transection in junf/f P0::cre Mice 
No differences in CD44 (A–B), CGRP (C-D), Galanin (E-F) or α7β1 
integrin (Integrin β1, G) immunoreactivity in the facial nucleus of c-jun
f/f 
and jun
f/f P0::cre mice on the contralateral (white bars) and ipsilateral 
(black bars) side on post-surgical day 4 (d04, A, C, E, G) and day 14 
(d14, B, D, F). N=3 for c-jun
f/f and jun
f/f P0::cre in (A, C, E, G) and N=5 
for c-jun
f/f and jun
f/f P0::cre in (B, D, F); p>0.05 in uSTT between c-jun
f/f 
and jun
f/f P0::cre animals. P a g e  | 116 
 
 
 
P0::JUN DISCUSSION: THE ROLE OF SCHWANN CELL C-JUN 
IN REGENERATION 
Heightened expression of AP1 transcription factors such as c-Jun, c-Fos and ATF/CREB 
proteins are some of the most immediate, consistent and well characterized changes to 
take  place  following  neuronal  injury;  they  are  known  to  participate  in  the  sprouting 
response to injury, to mediate cell survival and to direct the cellular response to stress and 
damage (Raivich et al., 2006; Broude et al., 1999; Vaudano et al., 1998; Hüll et al., 1994; 
Canettieri et al., 2009; Han et al., 1992; Smeal et al., 1989; Chiu et al., 1988; Kobayashi et 
al., 2009). In the current study, we have explored the role of peripheral c-Jun using a 
conditional Cre:: LoxP Schwann Cell deleted mutant expressing a floxed c-jun allele and 
cre recombinase under the control of P0 promoter. These results show the integral role 
played by peripherally expressed c-Jun 
This study illustrates the importance of c-jun as a mediator of trophic factor signalling in 
peripheral  regeneration.  As  mentioned  previously,  axons  in  the  PNS  spontaneously 
regenerate whereas those in the CNS do not. However, retinal ganglion cells, medullary 
and pontine reticular neurons, as well as striatal, cerebellar and thalamic neurons, can 
extend axonal processes through a peripheral nerve graft (Campbell et al., 2005; Hüll et 
al., 1994; Schuetz et al., 2003; Tom et al., 2008; Houle et al., 2006; Zhang et al., 1995; 
Woolhead et al., 1998; Vaudano et al., 1995, 1998, 1996). This indicates that modulatory 
factors present in PNS and not CNS glia might play a key role in axonal regeneration and 
might also facilitate the functional recovery that is common with peripheral, but not central 
nerve injury. Furthermore, c-jun expression levels increase after nerve injury in both PNS 
and  CNS  tissue;  however,  they  only  show  prolonged  elevation  in  PNS  injury  models 
(Broude  et  al.,  1997).  This  elevation  corresponds  closely  to  the  period  of  regrowth 
exhibited by PNS neurons (Broude et al., 1997). Evidence from this study suggests that c-P a g e  | 117 
 
 
 
jun – in particular, that expressed by Schwann Cells – plays a key role in this differential 
ability to regenerate. 
5.4  Schwann cell c-Jun provides a Neuronal Survival Signal in Adulthood 
Adult  motoneurons  ensheathed  by  c-Jun  deficient  Schwann  cells  exhibited  a 
developmentally  regulated,  copy  number  dependent  decrease  in  motoneuron  survival 
following facial motor nerve axotomy. This suggests that c-Jun is an important signalling 
molecule in the Schwann Cell response to injury in adult animals. Studies investigating the 
molecular properties of c-Jun in Schwann cells indicate that it is an essential intermediate 
in Schwann Cell de-differentiation following injury; without it, Schwann cells were unable to 
de-differentiate from a myelinating to immature phenotype following injury and they also 
exhibited delayed demyelination in sciatic nerves after cut (Parkinson et al., 2008; Mirsky 
et al., 2008). Delayed demyelination results in increased myelin debris at the lesion site 
and  inhibitory  signalling  molecules  in  myelin  are  known  inhibitors  of  the  successful 
regenerative  response  (Giger  et  al.,  2008).  This  dysfunctional  regulation  of  the 
regenerative response can contribute to decreased cell survival.  
Interestingly, neonatal Jun
f/f x P0::Cre mutant animals failed to develop the copy number 
dependent cell death visible in adult Jun
f/f x P0::Cre motoneurons following facial nerve 
transection and instead, all showed similar, low levels of survival following cut. In general, 
neonates  displayed  only  50%  survival  3  days  following  injury  –  whereas  adult  motor 
neurons generally show only around 20-40% cell death 30 days following facial nerve cut 
(Ferri et al., 1998a; Serpe et al., 2003b; Makwana et al., 2009). This indicates that nerve 
section generally has more severe effects on developing rather than adult motor nerves 
and that this is c-Jun independent in neonates. P a g e  | 118 
 
 
 
5.5  The Role of c-Jun in Axotomy-Induced Monocyte and Non-neuronal 
Recruitment 
5.5.1  Effect of Junf/f x P0::Cre Deletion in the Facial Motor Nucleus 
The neuronal response to injury involves a series of precisely timed and monitored cellular 
events which are orchestrated by both neuronal and non-neuronal cells. T-cells invade 
from the vasculature and astrocytes become activated, hone to the site of injury, acquire 
antigen  presenting  properties  and  begin  to  secrete  reactive  oxygen  intermediates  like 
interleukin  (IL)-1β,  inducible  nitric  oxide  (NO)  synthase,  the  NO  metabolite  nitrite, 
superoxide (O2-) and the chemokine CX3CL1 (Tichauer et al., 2007; Ranaivo et al., 2009). 
Activated microglia contribute chemotactically to the injury response by  expressing cell 
surface  αM  integrin  subunit,  MHC  (either  type  I  or  II),  as  well  as  CD40,  CD11b,  Fc 
receptors I–III, complement receptors (CR1, 2, and 4), β2 integrins, the co stimulatory 
molecules CD80, CD86, and intercellular adhesion molecule-1 (ICAM-1, Matsumoto 1986, 
McGeer  1993,  Hickey,  1988,  Minagar  2002,  Woodroofe  1991).  At  the  site  of  injury, 
peripheral  macrophages  travel  down  a  chemotactic  gradient  to  participate  in  the 
regenerative response as phagocytes and professional antigen presenting cells (pAPCs).  
Activated macrophages can also act as pro- or anti-inflammatory mediators, dependent on 
the  means  by  which  they  are  activated  (DiPietro  et  al.,  1998;  Gallin  et  al.,  1992)  All 
monocytes share a common haematopoetic origin and studies show that microglia can 
develop from adult migratory peripheral macrophages (Priller et al., 2001; Flugel et al., 
2001; Bechmann et al., 2005). Deletion of c-jun from Schwann cells results in an altered 
monocytic  response,  although  lymphocyte  infiltration  and  astroglial  activation  remained 
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In the injured facial motor nucleus 14 days after axotomy, more phagocytic microglia were 
present in Junf/f x P0::Cre mutants than in Junf/f wild type animals. Increased phagocytic 
microglial infiltration was probably due to higher levels of motoneuron cell death and the 
increased need for phagocytic clearance of debris.  
5.5.2  Junf/f x P0::Cre Ablates Monocyte Recruitment at the Site of Injury 
Conversely, at the site of injury 4 days after facial motor nerve crush decreased levels of 
monocyte recruitment were present surrounding the injury site. As one progressed further 
from the site of injury, significantly fewer macrophages were present in Junf/f x P0::Cre 
transgenic  knock  outs  compared  to  Junf/f  wild  type  animals.  This  suggests  that 
peripherally expressed c-Jun plays a role in creating a cellular cascade that results in the 
chemotactic gradient through which infiltrating non-neuronal cells are attracted to the injury 
site.  Defects in Schwann cell expression of c-Jun led to impairments in their ability to 
attract pAPCs and phagocytic cells. 
5.6  Impaired Target Reinnervation in Schwann cell c-Jun Deficient Mice 
5.6.1  Copy Number-Dependent Decreases in Anatomical Reinnervation 
To  evaluate  the  role  of  glial  c-jun  in  the  periphery,  functional  recovery  and  target 
reinnervation were assessed in three ways – by using retrograde Fluorogold labelling, by 
observing whisker hair recovery and by gauging facial nerve regeneration four days after 
nerve  crush.  Retrograde  labelling  showed  a  strong  failure  to  restore  anatomical 
connectivity in P0 x jun 
f/f homozygote mice which was partially restored in heterozygote 
P0 x jun 
f/WT animals. However, full specific reinnervation, which is derived by dividing the P a g e  | 120 
 
 
 
number  of  remaining  Fluorogold  positive  neurons  by  the  number  of  surviving  neurons 
showed  little  difference  between  the  two  (null  and  wild  type)  groups.  The  observed 
decrease in anatomical reinnervation is thus likely due to the decreased motor neuron 
survival rather than deficits in regeneration in c-Jun deficient Schwann cell – associated 
neurons. Proportionally, surviving motoneurons were able to reconnect functionally, even 
in  the  absence  of  c-Jun,  and  were  reduced  by  approximately  40%.  However,  due  to 
substantial  motoneuron  cell  death,  there  were  much  fewer  surviving  motoneurons 
remaining for regeneration, which primarily caused the dire reduction in reinnervation rate. 
5.6.2  Copy Number Independent Impairments in Recovery of Whisker Vibrissae  
Motor performance – as measured by whisker assessment – was also affected by c-Jun 
deletion in Schwann Cells. Mutant P0 x jun 
f/f animals showed more than three fold less 
increases in motor performance compared to their wild type counterparts. Anatomically, 
there  was  a  linear  correlation  between  number  of  copies  of  c-jun  and  extent  of 
reinnervation. However, functional recovery did not show linearity and was affected by only 
complete excision of c-Jun. Thus, only one deleted copy of c-jun was necessary to affect 
survival and reinnervation but function was ablated only by homozygous deletion.  
5.6.3  Decreased Regeneration 4 Days following Crush Injury 
Lastly, axonal regeneration four days following facial nerve crush was severely affected in 
P0  x  jun 
f/f  mutants.  Axon  lengths  of  both  CGRP  and  galanin  immunoreactive  sprouts 
decreased by almost 30 percent in P0 x jun 
f/f animals, compared to their jun 
f/f controls. 
This indicates that peripheral Schwann Cell c-jun is an important mediator of the cellular 
response  that  results  in  Schwann  Cell-mediated  increased  tropism  associated  with 
successful functional recovery.   P a g e  | 121 
 
 
 
CHAPTER 6:  JNK RESULTS: C-JUN ACTIVATION STATE IN 
NEURONAL REGENERATION AND REPAIR 
As mentioned previously in this report, c-Jun protein presence is not the sole regulator of 
its function. Through N-terminal activation, by JNK phosphorylation of Serines 63 and 73 
(ser63&73) and Threonines 91 and 93 (thr91&93), c-jun can exhibit differential regulatory 
effects (Raivich, 2008). Indeed, activation can alter binding activity (Boyle et al., 1991) in 
the absence of de novo protein synthesis (Angel et al., 1987) and JNK has been found to 
have neuroprotective effects in several different injury models (for a detailed review, see 
Haeusgen et al. 2009). This study aimed at elucidating the role, if any, played by the Jun-
N-Terminal Kinases in facial nerve regeneration and repair following transection. 
6.1  Generation of Mice Lacking Jun N-Terminal Kinase (JNK) function 
To investigate the role of c-jun phosphorylation in regenerative response following facial 
nerve axotomy, two transgenic lines were investigated that ablated JNK function. The first, 
Jun AA, has been described previously (Behrens et al., 1999). Briefly, JNK function was 
inhibited  by  a  substitution  mutation  of  the  c-jun  N  terminus.  Serines  63  and  73  were 
replaced  by  Alanine  residues,  thereby  preventing  JNKs  from  interacting  with  and 
phosphorylating the active site. The second type of transgenic line that was investigated 
possessed global deletion of each of the major Jun N-Terminal Kinases, termed JNK1, 2 
and 3. Like Jun AA, creation of these mutants and efficiency of this mutation has been 
described  elsewhere  (Yang  et  al.,  1997;  Kuan et  al.,  1999a,  2003;  Dong  et  al.,  1998; 
Brecht et al., 2005a). 
Mice lacking the ability to phosphorylate c-jun (Jun AA, JNK1, JNK2 and JNK3) were born 
with Mendelian frequency and were viable and fertile.  P a g e  | 122 
 
 
 
6.2  Phosphorylation of c-jun Is Not Required During Axonal Regeneration and 
Sprouting 
It is well known that transected peripheral nerves commonly react by initiating an extensive 
regenerative response. During axonal elongation and sprouting, molecules like CGRP and 
Galanin are upregulated in growth cones of regenerating axons (Makwana, Werner, et al., 
2009). To observe the efficiency of axonal reinnervation in JunAA, JNK1, JNK2 and JNK3 
mutants, whisker hair movement, an indicator of functional recovery, was scored by two 
observers unaware of the genotypes, on a scale of 0 (no movement) to 3 (strong, normal 
movement).  
6.2.1  Functional Recovery 
Twenty-eight  days  after  facial  nerve  axotomy,  there  were  no  significant  differences  in 
functional  recovery  between  wild  types  WTAA,  WT1,  WT2,  and  WT3  (1.3±0.2;  N=17, 
1.88±0.16; N=9, 1.2±0.1; N=17 and 1.38±0.16; N=12 respectively) and mutants JunAA 
(1.2±0.1;  N=23),  JNK1  (1.64±0.14;  N=7),  JNK2  (1.2±0.0;  N=30)  and  JNK3  (1.39±0.12; 
N=18  (Figure  6-1).  However,  on  average,  JNK1  mutants  exhibited  delayed  functional 
recovery (1.07±0.19; N=10, p < 0.01 in unpaired Student‘s T-test) compared to controls 
(1.35±0.16;  N=11).  All  other  JNK  mutants  showed  no  average  variation  from  control 
animals  (WTAA  9.9±0.7;  N=17, WT2  8.7±0.8; N=20, WT3  10.92±0.1.26;  N=13,  JunAA 
8.5±0.8; N=23, JNK2 8.4±0.3; N=30, and JNK3 9.39±0.91; N=18 and WT3 10.92±0.1.26; 
N=13). P a g e  | 123 
 
 
 
6.2.2  Anatomical Reinnervation 
Furthermore, at day 28 post axotomy, neuronal cell bodies were fluorescently labelled via 
Fluorogold implantation under the whisker pad (as described in Materials and Methods). 
Fluorogold  implantation  on  the  contralateral  side  served  as  intra-animal  control.  JNK 
knock-out  and  JunAA  mutant  animals  had  similar  numbers  of  retrogradely  labelled 
motoneurons on both the contralateral and ipsilateral sides compared to their wild-type 
counterparts (refer to Figure 6-1).  
Per 20 μm section, WTAA control animals exhibited 68±6 (n=7) and 40±7 (n=7) on the 
control and injured side respectively, and JunAA mice had an average of 58±11 (n=7) 
Fluorogold positive neurons on the control side and 32±6 (n=7) on the axotomized side. 
WT1 control animals exhibited 51±8 (n=10) and 16±2 (n=10) on the control and injured 
side respectively, and JNK1 animals averaged 61±10 (n=9) Fluorogold positive neurons on 
the control side and 21±7 (n=9) on the axotomized side. WT2 control animals exhibited 
42±4 (n=5) and 19±3 (n=5) on the control and injured side respectively and JNK2 animals 
averaged 53±7 (n=6) Fluorogold positive neurons on the control side and 25±5 (n=6) on 
the axotomized side. Finally, WT3 control animals exhibited 44±7 (n=9) and 16±4 (n=9) on 
the  control  and  injured  side  respectively,  and  JNK3  animals  averaged  51±7  (n=6) 
Fluorogold positive neurons on the control side and 20±3 (n=6) on the axotomized side.  
Overall, the ratio of Fluorogold positive neurons on the axotomized vs. contralateral sides 
(ax/co ratio), as shown in Figure 6-1, was 57.5% ± 7.5% in WTAA and 55.6% ± 7.9% in 
JunAA.  Ax/co  ratio  was  35.7%  ±  3.9%  in  WT1  controls  and  31.6%  ±  5.3%  in  JNK1 
mutants.  Furthermore, WT2 mutants  showed  45.0%±4.9%,  and  JNK2 mutants  showed 
46%±4.6% ax/co ratio. Lastly, ax/co ratio for WT3 was 34.0%±5.1%, and for JNK3 mutants 
was 38.3%±3.1%.  
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Figure 6-1: Characterizing Post-Operative Regenerative Response  
c-Jun phosphorylation is Unnecessary for Functional and Anatomical Reinnervation. (A, D, G, J) Quantification 
of retrogradely labelled motoneurons in the facial motor nucleus of (A) JunAA (N=7) and WTAA (N=7) mice, (D) 
JNK1 (N=9) and WT1 (N=10) mice, (G) JNK2 (N=6) and WT2 (N=5) mice, and finally, (J) JNK3 (N=6) and WT3 
(N=9), using FluoroGold, performed 28 days post-operatively. Contralateral side, white bars; ipsilateral side, 
black bars. *P<0.05 in uSTT between all groups of animals. (B, E, H, K) Ax/Co ratio of FluoroGold positive 
neurons is shown; (B) WTAA, (E) WT1, (H) WT2 and (K) WT3 mice, black bars; (B) JunAA, (E) JNK1, (H) JNK2 
and (K) JNK3 animals, white bars. *p<0.05 in uSTT between all groups. (C, F, I, L) Posttraumatic whisker hair 
movement was measured 28 days after facial nerve transection, on a scale of 0 (no movement) to 3 (normal, 
strong  movement  -  similar  to  that  on  the  contralateral  side);  N  =  23  for  JunAA  animals,  N=17  for WTAA 
animals; N=7 for JNK1 animals, N=9 for WT1 animals; N=30 for JNK2 animals, N=17 for WT2 animals; N=18 
for JNK3 animals and N=12 for WT3 animals. *p < 0.02 between JNK1 and WT1 groups only, in unpaired 
Student's t test (uSTT). Data collected in collaboration with N. Staak. P a g e  | 125 
 
 
 
6.2.3  Facial Nerve Regeneration 
Additionally, axonal sprouting was studied four days after facial nerve crush. Enhanced 
sprouting is a common result of peripheral nerve injury; during which time axons extend 
galanin and CGRP immunoreactive growth cones anterogradely toward the neuromuscular 
junction (Galiano et al., 2001; Werner et al., 2000, 2001b). This growth response is absent 
on the contralateral side. As shown in Figure 6-2, no difference in the central sprouting 
response was observed between JNK 1-3 or JunAA animals and their respective wild type 
littermates.  Average CGRP positive growth cone lengths for  wild types  - WTAA, WT1, 
WT2  and  WT3-  were  5.3±0.2  (n=4),  5.9±0.1mm  (n=4)  WT2  6.1±0.1mm  (n=3)  WT3 
5.5±0.3mm (n=5) respectively. The mutant counterparts JunAA, JNK1, JNK2 and JNK3 
extended CGRP positive processes of 5.9±0.3mm (n=5), 5.8±0.2 (n=7), 5.9±0.1mm (n=2) 
and 5.9±0.2mm (n=5) respectively. Galanin positive growth cones were extended for WT1, 
WT2  and WT3  by  5.6±0.1mm  by  5.7±0.3mm  (n=4),  5.9±0.1mm  (n=3)  and  5.4±0.3mm 
(n=5)  respectively.  Mutants  extended  processes  of  JNK1  (n=6),  5.7±0.2mm  by  JNK2 
mutants (n=2) and 5.5±0.2mm by JNK3 mutants (n=5).  
Taken together, these data suggest that N-terminal phosphorylation state has little effect 
on anatomical and functional reinnervation. No differences were observed in anatomical 
reinnervation or sprouting. JNK1 deletion can delay functional recovery – suggesting it 
might play a small role in early regeneration. However, despite this overall delay in early 
reinnervation, JNK1 KO animals exhibit similar end-stage functional recovery as their wild 
type  counterparts.  Furthermore,  JNK2-3  and  JunAA  mutants  exhibit  no  difference  in 
functional recovery compared to their wild type controls. This suggests that regeneration is 
not heavily influenced by the Jun phosphorylation state. 
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6.3  Effect of c-jun Phosphorylation State on Neuronal Cell Death 
After facial nerve axotomy, there is considerable neuronal cell death; some studies have 
observed generally 20 to 30 percent motoneuron cell death post –axotomy in the facial 
nerve  model  (Ferri  et  al.,  1998a;  Hottinger  et  al.,  2000).  Survival  data  has  shown 
previously  that  JNK1-3  and  JunAA  mutations  have  no  effect  on  facial  motor  neuron 
survival following axonal transection (Brecht et al., 2005a). 
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Figure 6-2: No Difference in 4 day post-axotomy Sprouting Response in JunAA, JNK1, JNK2 and JNK3 
animals after Facial Nerve Axotomy.  
(A-D) CGRP immunoreactive growth cone length on the axotomized side in JNK1 (A), JNK2 (B), JNK3 (C) and 
JunAA (D) animals (in mm). (E-G) Galanin immunoreactive growth cone length on the axotomized side in JNK1 
(E), JNK2 (F) and JNK3 (G) animals (in mm). Black bars, mutants; white bars, control animals. N=17 for WTAA 
animals; N=7 for JNK1 animals, N=4 for WT1 animals; N=2 for JNK2 animals, N=3 for WT2 animals; N=5 for 
JNK3 animals and N=5 for WT3 animals. P a g e  | 127 
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Figure  6-3:  No  Major  Difference  in  Non-Neuronal  Cell  Reaction  in  JunAA,  JNK1,  JNK2  and  JNK3 
animals after Facial Nerve Axotomy. 
(A-H) Quantification of microglial αM Immunoreactivity (IR) at day 4 (d04, A-D) and day 14 (d14, E-H) in JNK1 
(A, E), JNK2 (B, F), JNK3 (C, G) and JunAA (D, H) animals after axotomy using the MEAN-SD algorithm 
(Moller et al., 1996). (I-P) Quantification of GFAP IR – an indicator of Activated Astroglia - at day 4 (d04, I-L) 
and day 14 (d14, M-P) in JNK1 (I, M), JNK2 (J, N), JNK3 (K, O) and JunAA (L, P) animals after axotomy. (Q-T) 
Quantification of CD3 T-Cell IR at day 14 in JNK1 (Q), JNK2 (R), JNK3 (S) and JunAA (T) animals after 
axotomy. (U-W) Quantification of microglial B7.2 IR at day 14 in JNK1 (U), JNK2 (W) and JNK3 (W) animals 
after facial nerve transection. White bars, contralateral side; black bars, axotomized side. *p< 0.05, **p< 0.01 in 
uSTT between KO and WT mice. N = 23 for JunAA animals, N=17 for WTAA animals; N=7 for JNK1 animals, 
N=9 for WT1 animals; N=30 for JNK2 animals, N=17 for WT2 animals; N=18 for JNK3 animals and N=12 for 
WT3 animals. JunAA data collected in collaboration with N. Staak. P a g e  | 128 
 
 
 
6.4  Effects of inhibited Jun Phosphorylation on Non-Neuronal Cells 
Nerve transection results in robust changes - not only to the neuron itself, but also to the 
local microenvironment. T-cells and other lymphocytes are recruited from the periphery. 
Also brain-resident non-neuronal cells such as astrocytes and microglia become activated; 
thereby  releasing  reactive  intermediates  to  mediate  the  neuronal  response  to  injury. 
Animals with global deletion of the JNK isoforms and also JunAA animals show very little 
variation in non-neuronal cell upregulation and activation from their wild-type counterparts  
Figure 6-3. Early microglial activation, as measured by αM integrin subunit (also known as 
MAC-1)  immunoreactivity,  revealed  no  differences  between  WT  and  mutant  animals. 
Please refer to Table 5 of the Appendix for a detailed summary of αM integrin subunit 
expression at 4 and 14 days post-axotomy in JNK1-3 and JunAA deficient animals. In 
addition to MAC-1, B7.2 – which is another microglial marker – was also used to further 
characterize the microglial response in c-Jun phosphorylation-deficient animals. Similarly 
to what was observed with MAC-1, there were no significant differences between any of 
the  phosphorylation-deficient  mutants  and  their  wild-type  counterparts  (Table  8  of  the 
Appendix,  
Figure  6-3)  at  14  days  post-axotomy.  Furthermore,  GFAP  is  expressed  by  activated 
Astroglia in response to neuronal stress. For the most part, there is no difference between 
JNK 1-3 mutants and JunAA mutants and their wild-type counterparts in GFAP expression 
four and 14 days post-facial nerve transection. Small increases in astrogliosis are visible, 
however, at day four post-axotomy in JNK3-deficient mutants and also at day 14 in JunAA 
deficient mutants (p<0.05 in unpaired Student‘s T-test, refer to Table 6 of the Appendix 
and  
Figure 6-3), which are not visible at their respective alternative timepoints. Please refer to 
Table 6 of the Appendix for detailed statistical data.  P a g e  | 129 
 
 
 
Moreover, CD3 is a marker for lymphocytes – in particular, it identifies infiltrating T-Cells. 
As revealed in  
Figure 6-3, no major differences were observed between wild type animals and JNK1, 
JNK2 and JunAA mutants  in CD3 positive T-Cell infiltration as a result of facial nerve 
axotomy. JNK3 mutants showed significantly lower baseline rates of CD3 positive T-Cell 
infiltration (Refer to Table 7 of the Appendix), as well as lower T-Cell presence in response 
to nerve transection ( 
Figure  6-3,  p<0.05  in  unpaired  Student‘s  T-test),  but  this  difference  after  axotomy  is 
probably due to reduced basal T-Cell levels rather than a result of the injury. Please refer 
to Table 7 of the Appendix for statistics.  
6.5  Jun N-Terminal Phosphorylation is Not Necessary for the Cell Body Response 
to Injury 
The cell body – or chromatolytic - response to injury involves the upregulation of various 
transcriptional factors and the initiation of a complex cellular cascade of events. Nuclear 
expression of various growth-related markers - such as neuropeptides CGRP and galanin, 
CD44 hyaluronic acid receptor and transcription factors c-Jun and ATF3 – is common in 
regenerating cell somas (Jones et al., 1997, 2000; Tsujino et al., 2000; Shadiack et al., 
2001b). Such expression was characterized in JNK1-3 mutants and also in JunAA animals 
and their wild-type counterparts. As illustrated in Table 9 of the Appendix and Figure 6-4, 
CD44 expression shows no major differences between mutants and wild-type animals. A 
small decrease in immunoreactivity was seen at day four in JunAA animals and at day 14 
in JNK3 animals compared to WT controls (p<0.05 in unpaired Student‘s T-test), but those 
differences were not repeated at alternative time points. For the most part, mutants with 
the inability to phosphorylate c-Jun show no difference in levels of CD44 expression.  P a g e  | 130 
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Figure 6-4: No Major Difference in Neuronal Cell Reaction in JunAA, JNK1, JNK2 and JNK3 animals after 
Facial Nerve Axotomy.  
(A-H) Quantification of CD44 Hyaluronic Acid immunoreactivity (IR) at day 4 (d04, A-D) and day 14 (d14, E-H in 
JNK1 (A, E), JNK2 (B, F), JNK3 (C, G) and JunAA (D, H) animals after axotomy using the MEAN-SD algorithm 
(Moller et al., 1996). (I-P) Quantification of CGRP IR at day 4 (d04, I-L) and day 14 (d14, M-P) in JNK1 (I, M), 
JNK2  (J,  N),  JNK3  (K,  O)  and  JunAA  (L,  P)  animals  after  axotomy  using  the  MEAN-SD  algorithm.  (Q-W) 
Quantification of ATF3 IR at day 4 (d04, Q-S) and day 14 (d14, U-W) in JNK1 (Q, U), JNK2 (R, V) and JNK3 (S, 
W) animals after axotomy using the MEAN-SD algorithm. White bars, contralateral side; black bars, axotomized 
side. *p< 0.05 in uSTT between WT and KO mice. N = 23 for JunAA animals, N=17 for WTAA animals; N=7 for 
JNK1 animals, N=9 for WT1 animals; N=30 for JNK2 animals, N=17 for WT2 animals; N=18 for JNK3 animals and 
N=12 for WT3 animals. JunAA data collected in collaboration with N. Staak. P a g e  | 131 
 
 
 
Next, levels of CGRP expressed by regenerating facial motor neurons were compared. 
CGRP  is  produced  in  the  cell  body  and  transported  into  growth  cones  in  the  growing 
axonal tip (Makwana, Werner, et al., 2009). As shown in Table 10 of the Appendix and 
Figure 6-4, no differences were observed between JNK1-3 mutants and wild type animals 
either  four  or  14  days  after  facial  nerve  transection.  Lastly,  ATF3  expression  was 
quantified in the nucleus. ATF3 belongs to the ATF family of AP1 transcription factors and 
commonly  heterodimerizes  with  c-Jun  in  regenerating  cells  (Pearson  et  al.,  2003b). 
However, ATF3 levels were unchanged at both four and 14 days post-axotomy in JNK1-3 
and  JunAA  animals  (Figure  6-4,  Table  11  of  the  Appendix).  This  would  indicate  that 
phospho-Jun does not interact with ATF3 during its regenerative function. 
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JNK DISCUSSION: C-JUN N-TERMINAL PHOSPHORYLATION 
HAS NO MAJOR AFFECT ON FACIAL NERVE REGENERATION  
C-jun is an immediate early gene that is consistently upregulated after neuronal injury; 
previous studies link it to both pro-regenerative and pro-apoptotic pathways (Herdegen et 
al., 1997). As described earlier in this report, its phosphorylation state can influence dimer 
stability and can affect its biological role in regeneration, both in vivo and in vitro. This 
study aimed to investigate whether ablation of JNK function, either through global deletion 
of  JNK  or  through  inactivation  via  substitution  mutation,  plays  a  role  in  the  neuronal 
regenerative response. Based on data characterizing survival, regeneration and cellular 
response  of  JNK1,  JNK2,  JNK3  and  JunAA  mutants  following  facial  nerve  injury,  it  is 
evident that N-Terminal phosphorylation of c-jun does not play a major role in neuronal 
regeneration after facial nerve axotomy. 
6.6  Non-Neuronal Reaction to Facial Nerve Injury in JNK1-3 and JunAA Mutants 
Few differences were observed between animals deficient in Jun phosphorylation and their 
wild-type counterparts. This indicates that activated c-Jun is not essential for the peripheral 
response to facial nerve transection. Furthermore, c-Jun phosphorylation does not affect 
microglial  infiltration to the  site  of  injury,  nor  does  it  affect  astrogliosis.  Levels  of  CD3 
reactive T-Lymphocytes were lower in JNK3 mutant facial motor nuclei following injury 
compared to wild type littermates; however, baseline expression of these non-neuronal 
cells was also lower – indicating that this decrease was not due to injury, but due to a 
JNK3 mutation-specific defect in T-Cell maturation or production. It seems that c-Jun, in its 
phosphorylated state, is not a major transcriptional regulator of the non-neuronal response 
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6.7  Phospho-Jun is a non-essential regulator of the motor neuron injury response 
It is known that a successful cellular response to injury – such as that seen peripherally - 
necessitates  the  expression  and  temporal  synchronization  of  several  growth-related 
transcription factors. These factors can be upregulated immediately after injury – as is the 
case with ATF3 (Tsujino et al., 2000)– or slightly later and the cellular response peaks 
around day 4 post-axotomy, while the inflammatory response in the facial motor nucleus 
reaches a maximum 14 days after injury (Makwana, Werner, et al., 2009; Raivich, 2008; 
Raivich et al., 2007). Expression levels of several of the most important of these factors 
were measured at two separate time points to characterize the neuronal response; data 
indicated that phosphorylation of c-Jun plays no role in successful upregulation of growth-
related molecules CD44, CGRP and ATF3. Since all of these molecules are known to be 
upregulated in the successful regenerative response (Seijffers et al., 2007; Pearson et al., 
2003b; Jones et al., 2000; Kalousa and Keast, 2009), this data shows that phospho-jun is 
not the major regulator of transcriptional events leading to and maintaining the cellular 
response. 
6.8  Assessment of Target Reinnervation 
Target reinnervation was assessed using three paradigms; for thirty days following injury, 
whisker hair performance assessed functional recovery and, at thirty days following facial 
nerve  transection,  Fluorogold  retrograde  labelling  illustrated  anatomical  reinnervation. 
Peripheral axonal sprouting was quantified four days following facial nerve crush injury to 
quantify the length of neuropeptide-rich growth cones extending from the injured proximal 
axonal  tip.  Retrograde  labelling  showed  no  differences  in  anatomical  reinnervation 
between JNK1-3 or JunAA mutants and their wild type counterparts. This was echoed by 
similar motor performance, except with JNK1 mutants – whose motor performance was P a g e  | 134 
 
 
 
delayed. Whisker function was restored in a linear fashion in all cases except JNK1  – 
whose  restoration  of  function  was  parabolic.  This  indicates  that  most  anatomical  and 
functional  regeneration  takes  place  via  a  phospho-jun  independent  mechanism. 
Phosphorylation by JNK1 plays a minor role in early functional regeneration, however its 
absence  is  eventually  compensated  for  and  JNK1  mutants  reach  wild  type  levels  of 
functional  recovery  by  day  30.  4  days  following  crush  injury,  there  were  again  no 
differences between any JNK mutant and their wild type littermates in either CGRP or 
Galanin immunopositive axon length. 
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CHAPTER 7:  ATMIN RESULTS: ATMIN’S ROLE IN THE 
NEURONAL CELL STRESS RESPONSE 
Upregulation of growth-associated molecules is essential for an effective post-traumatic 
regenerative response; cells that are deficient in pro-regenerative transcription factors or 
neuropeptides  consistently  fail  to  enter  into  the  regenerating  phenotype  that  enables 
successful neuromuscular target reinnervation (Galiano et al., 2001). In particular, ATF3 
and c-Jun are growth-related peptides that combine to form the AP1 transcription complex. 
Studies  show  that  expression  of  both  ATF3  and  c-Jun  are  under  ATM  control  (mice 
deficient in upstream ATM show increased AP-1 activation, Weizman et al. 2003) and that 
ATF3 over-expression in particular can negatively regulate cell cycle progression from G1 
to  S  phase  (Fan  et  al.,  2002).  ATF3  and  c-jun  co-expression  have  previously  been 
associated in vivo with increased axonal sprouting (Campbell et al., 2005; Pearson et al., 
2003a) and ATF3 upregulation, in particular, has been attributed to increased branching in 
Dorsal Root Ganglia (DRG) cells (Seijffers et al., 2006). 
7.1  Generation of Mice Lacking ATMIN in the CNS 
To examine and characterize the role of ATMIN in the axonal response to neuronal injury, 
transgenic mice expressing the nestin promoter-driven Cre recombinase (nestin::cre) were 
crossed with mice carrying a lox P tagged (floxed) ATMIN gene (ATMIN
F/F). The resulting 
F1 generation, ATMIN
N/WT, were again crossed with the ATMIN
F/F animals, to produce a 
homozygous deletion of ATMIN in central neuroepithelium-derived cells, in the brain and 
spinal cord (Behrens et al. 2002 and Tronche et al. 1999). Previous studies demonstrate 
the efficiency and neuroepithelial specificity of the nestin-cre transgenic line (Gass et al. 
2000; Knoepfler et al. 2002; Mantamadiotis et al. 2002 and Tronche et al. 1999). As shown 
in Figure 7-1, homozygous deletion of ATMIN led to the disappearance of ATMIN mRNA 
as well as most of the ATMIN protein immunoreactivity throughout the brain. These  P a g e  | 136 
 
 
 
 
Figure 7-1: ATMIN mRNA and protein immunoreactivity is expressed throughout the brain  
(A-F), increases in facial motoneurons following axotomy (G-N) and disappears in the ATMIN
ΔN mutants (D-F, I,J,M,N), compared with the ATMIN-competent, f/f control 
littermates (ATMIN
F/F) (A-C, G,H,K,L). A-F: Sagittal brain sections, G-N: Coronal sections of facial motor nucleus. A,B,D,E, G-J: Darkfield illuminated radioactive in situ 
hybridisation (ISH) for ATMIN mRNA (A,D), the respective bright-field counterstain for methylene blue (B,E), and non-radioactive in situ in the axotomized (ax) and 
contralateral (co, uninjured) facial motor nuclei, 14 days after facial nerve cut (G-J). C,F,K-N: Immunohistochemistry (IHC) for ATMIN specific JCro-antibody, in forebrain 
cerebral cortex and hippocampus (C,F), and facial motor nucleus (K-N). The inserts in C&F show higher magnification of cerebral cortex. Note the prominent ATMIN 
mRNA expression in cerebellum (cbl) and hippocampus (hip), and on the immunoreactivity level, particularly in the hippocampal CA3 region, as well  as the 80-85% 
reduction in the number of ATMIN-immunoreactive neurons in the ATMIN
ΔN mutants, compared with the ATMIN-competent control littermates. Scale bar: A,B,D,E - 4mm 
(A,B,D,E), C,F - 0.6mm, E-H - 0.5mm, C,F inserts - 0.25mm, and I-L - 0.1mm. Data collected in collaboration with N.Kanu. P a g e  | 137 
 
 
 
ATMIN
N  animals  were  born 
with  Mendelian  frequency, 
although they were smaller in 
size  than  their  wild-type 
counterparts. 
Under  higher  magnification, 
normal,  ATMIN
F/F  animals 
revealed  moderate  neuronal 
immunoreactivity  throughout 
the  cytoplasm,  and  slightly 
more in the nuclei, throughout 
the  brain,  including  the 
cerebral  cortex,  hippocampus 
and cerebellum (Figure 7-1A-
C).  Particularly  high  levels 
were  observed  in  the 
cerebellar  granular  layer  and 
in  the  hippocampal  CA3 
region (Figure 7-1A-C); a strong increase in ATMIN mRNA and immunoreactivity was also 
observed in axotomized motoneurons, 14 days after facial nerve cut (Figure 7-1G,H,K,L). 
Homozygous, ATMIN
N mutants showed an almost complete loss of immunoreactivity in 
the hippocampus (Figure 7-1-C), as well as an 80-85% reduction in the number of positive 
neurons in the cerebral cortex (compare Figure 7-1F and Figure 7-1C, inserts) and in the 
control as well as in the axotomized facial motor nuclei (Figure 7-1G-N). ATMIN‘s Role in 
the Neuronal Response to Nerve Injury 
 
 
Figure  7-2:  ATMIN  deletion  causes  strong  increase  in  neuronal 
ATF3 (A-D), but not c-Jun (E,F) immunoreactivity in the cerebral 
motor cortex. 
A,C,E: ATMIN
F/F, B,D,F: ATMIN
ΔN mice, scale bar: A,B – 0.5mm, C-F 
– 80um. Figure produced in collaboration with N. Kanu. P a g e  | 138 
 
 
 
After transection, non-neuronal cells like microglia and astrocytes are recruited from the 
local micro-environment, become activated and – in the case of microglia – can act to 
phagocytose neuronal debris. T-cells invade from the periphery through the vasculature to 
the site of injury and help to orchestrate the damage response. Simultaneously, in the 
neuronal cell body, changes take place that result in upregulation of growth-associated 
molecules that are essential for cell survival and successful neuromuscular reinnervation. 
ATMIN‘s role in regeneration was explored after nerve transection using the facial nerve 
axotomy paradigm. Cellular response was explored at 14 days post-axotomy; cell survival 
was explored 30 days post-axotomy; functional and anatomical reinnervation was explored 
30 days post-axotomy.  
7.1.1  Effects of ATMIN deficiency on neuronal cells.  
Since facial axotomy caused strong increase in the ATMIN mRNA expression and protein 
immunoreactivity, we first explored the effects of ATMIn deletion on neuronal response. 
Neuronal  axotomy  normally  results  in  the  upregulation  of  regeneration  associated 
transcription factors (c-Jun, ATF3), adhesion molecules (e.g. CD44 hyaluronate receptor) 
and the neuropeptides Calcitonin Gene-Related Peptide (CGRP) and Galanin (Campbell 
et al., 2005; Makwana, Serchov, et al., 2009; Pearson et al., 2003a; Jones, Kreutzberg, et 
al., 1997; Jones et al., 2000; Werner et al., 2000; D. Wynick et al., 2001; Lin et al., 2003).  P a g e  | 139 
 
 
 
   
 
 
Figure  7-3:  ATMIN
ΔN  mutants  reveal  increased  neuronal  response  to  axotomy,  compared  with  the 
ATMIN
F/F littermate controls 14 days after nerve cut.  
The  facial  motor  nuclei  from  the  ATMIN
F/F  littermate  controls  are  shown  in  the  1st&2nd  columns 
(A,B,E,F,I,J,M,N), those from the ATMIN
ΔN mutants are n the 3rd&4th column (C,D,G,H,K,L,O,P). Second and 
4th  columns  are  axotomized,  1st&3th  columns,  contralateral  sides,  respectively.  A-H:  Effects  of  ATMIN 
deletion on axotomy-induced increase in neuronal nuclear c-Jun (A-D) and ATF3 (E-H) immunoreactivity, with 
enhanced c-Jun staining in axotomized side, as well as a bilateral increase for ATF3 in the ATMIN
ΔN facial 
motoneurons.  I-P:  Axotomy-induced  central  sprouting  of  CGRP-immunoreactive  (I-L)  and  galanin-
immunoreactive (M-P) motor neurites. Note the absence of sprouts on the uninjured side and the increased 
sprouting density in ATMIN
ΔN mutants. The inserts in I, K, M and O show the sprouting response on the injured 
side at 5x fold higher magnification. Scale bar. 40um in the inserts and 0.2mm for all other micrographs. P a g e  | 140 
 
 
 
Baseline and Injury-Induced ATF3 Upregulation 
Deletion of ATMIN produced prominent changes in this neuronal response, with clearly 
enhanced ATF3 immunoreactivity on the uninjured as well as the axotomized side (Figure 
7-4A, Figure 7-5A-D), and a significant increase in the number of ATF3+ motoneurons with 
strong cytoplasmic (Figure 7-4B) and nuclear (Figure 7-4C) immunostaining. Total ATF3 
positive  cells  were  45.3±14.0  on  the  contralateral  side  of  wild  type  animals,  of  which 
44.2±13.7 cells expressed it solely in the cytoplasm and 1.1±0.9 cells expressed ATF3 
nuclearly (N=7). In ATMIN null mutants, 52.4±16.2 facial motor neurons expressed ATF3 
on  average  on  the  control  side,  of  which  49.0±15.2  expressed  it  cytoplasmically  and 
3.4±2.6 expressed ATF3 in the nucleus (N=5). Average numbers of ATF3 positive cells in 
the injured facial motor nucleus of control animals were 66.4±6.4 (N=7) and were 108.7 ± 
5.4 (N=5) for their mutant littermates (p<0.01 in unpaired Student‘s T-test). Of those cells, 
the quantity stained solely cytoplasmically – 10.4 ± 4.0 in wild type (N=7) and 27.3±5.5 in 
ATMIN
N animals (N=5) - reveal a significant increase in cytoplasmic expression of ATF3 
in mutant mice but not wild-type (p<0.02 in unpaired Student‘s T-test). Lastly, motoneurons 
expressing ATF3 in the nucleus only or in the nucleus and cytoplasm were more prevalent 
in mutant animals than in their wild type counterparts; wild type animals exhibited 56.0±4.9 
(N=7)  immunopositive  cells  and  mutants  displayed  81.4±6.3  (N=5)  per  facial  motor 
nucleus (p<0.05 in unpaired Student‘s T-test). Luminosity revealed 0.3±0.1 units of OLV 
on the control side of wild type animals, with upregulation of ATF3 following injury to 7±1.2. 
Mutants,  however,  showed  increased  baseline  measures  of  ATF3  immunoreactivity 
(2.6±0.9),  with  accompanying  increases  following  injury  to  13±1.2  units  of  optical 
luminosity  value  (OLV,  N=5  for  control  and  transgenic  animals,  p<0.05  in  unpaired 
Student‘s  T-test).  Upregulation  of  ATF3,  but  not  c-Jun,  was  also  observed  in  other, 
uninjured parts of the brain of ATMIN
N mutant mice, for example in cerebral motor cortex 
(see Figure 7-2A-F). P a g e  | 141 
 
 
 
 
Figure 7-4: Quantitative effects of neural ATMIN deletion on the cellular response in the axotomized 
facial motor nucleus, 14 days after nerve cut.  
A-C:  ATF3  Immunoreactivity,  showing  increase  in  the  number  of  cytoplasmic  (A)  and  nuclear  (B)  ATF3+ 
profiles, and the overall, facial nucleus ATF3-immunoreactivity (C) in the ATMIN
ΔN mutants. A milder increase 
in the overall ATF3-immunostaining was also observed on the contralateral side. D: Increased number of c-
Jun+  axotomized  motoneurons.  E,  F:  Total  number  of  CGRP+  sprouts  (E)  and  the  overall  nucleus 
immunoreactivity (F). G: Total number of Galanin+ sprouts. H-J: Neuronal CD44 (H), astrocyte GFAP (I) and 
microglial αM (J) immunoreactivity is strongly increased after axotomy, but not affected by ATMIN deletion. K, 
L:  αX+  phagocytic  microglial  clusters  (K)  and newly  recruited,  CD3+  T-cells  (L)  are  only  observed  on  the 
axotomized side. Again, their numbers are not affected by neural deletion of ATMIN. Mean +/- standard error of 
the  mean  (SEM)  in  this  and  following  graphs,  n=5  animals  per  group,  filled  bar:  axotomized,  empty  bar: 
contralateral side. *p<0.05, **p<0.01 and ***p<0.001 in unpaired Student t-test between ATMIN
ΔN mutants and 
ATMIN
F/F controls, for the axotomized (B-E, G) and/or contralateral side (A, C, F). P a g e  | 142 
 
 
 
7.1.1.1  c-Jun upregulation following injury 
Furthermore, the number of c-jun immunopositive cells post-injury was greater in ATMIN 
deficient animals than in their wild-type littermates (p<0.05 in unpaired Student‘s T-test, 
Figure 7-4D, Figure 7-5E-H). Although baseline expression levels were similar - control 
animals averaged 43.2±15.7 c-jun immunopositive neurons in the contralateral facial motor 
nucleus (N=5) and ATMIN null littermates showed 60.4±44.1 (N=5) – the number of c-jun 
immunoreactive neurons was increased in mutants compared to controls after injury. Wild 
type animals exhibited 76.6±9.5 c-Jun immunopositive motor neurons on the axotomized 
side (N=5). ATMIN mutants had 100.6±7.0 c-Jun immunopositive motor neurons on the 
axotomized side (N=5). These data, taken together, propose a regulatory role for ATMIN in 
neurite outgrowth, elongation and guidance. 
7.1.1.2  No  Injury-Induced  Difference  in  Cell  Neuropeptide  or  Adhesion  Molecule 
Expression 
With respect to general immunoreactivity, facial axotomy elicited a pronounced increase in 
the  overall  immunostaining  density  for  CD44  (Figure  7-4E),  CGRP  (Figure  7-4F)  and 
Galanin (not shown). However, compared to the ATMIN
F/F controls, there was no ATMIN
N 
induced, overall change for CD44 or galanin, and even a reduction in the constitutively 
present CGRP-immunoreactivity in the uninjured, facial motoneurons. In wild type animals, 
CGRP contralateral expression was 7.1±0.2 and ipsilateral expression was 10.6±1.3 OLV 
(N=7). Mutants showed contralateral expression of 4.9±0.9 and ipsilateral expression of 
9.2±1.1  OLV  (N=5).  Galanin  contralateral  expression  was  18.1±1.0  and  ipsilateral 
expression  24.0±1.6  OLV  for  littermate  controls  (N=7)  and  transgenic  contralateral 
expression was 16.7±3.6, with ipsilateral expression of 23.5±4.9 OLV (N=5). Lastly, CD44 
levels  were  3.5±0.3  on  the  contralateral  side  of  wild  type  animals  and  24.9±3.5  OLV P a g e  | 143 
 
 
 
following  facial  nerve  injury  (N=7)  and  mutant  baseline  expression  did  not  differ: 
contralateral expression was 3.8±0.7and ipsilateral expression was 22.0±3.8 OLV; (N=5).  
7.1.1.3  Increased Central sprouting in ATMIN
N Mutants 
In addition to the enhancement of growth-related transcription factors, ATMIN
N mutants 
presented  increased  levels  of  Galanin  (Figure  7-4G,  Figure  7-5I-L)  and  CGRP  (Figure 
7-4H,  Figure  7-5M-P)  immunoreactive  sprouts  following  injury.  The  number  of  Galanin 
immunopositive  central  sprouts  in  injured  ATMIN
F/F  facial  motor  nuclei  was,  249±18. 
ATMIN
N mutants showed an almost 70 percent increase, with 366± 29 in injured nuclei. 
Likewise, CGRP showed an almost twofold upregulation in ATMIN
N mutants. Following 
injury, neurite number for ATMIN
F/F was 51±11 and ATMIN
N mutants averaged 90± 11 per 
nucleus. 
7.1.2  Neuronal survival and functional recovery.  
Since 20-40% of adult axotomized mouse facial motoneurons die within 4 weeks of nerve 
cut (Ferri et al., 1998b; Serpe et al., 2003a; Makwana, Serchov, et al., 2009), we next 
explored  the  effect  of  ATMIN  deletion  on  neuronal  survival  by  counting  cresyl-violet 
stained motoneurons in 20um serial sections throughout the facial nuclei, 28 days after 
transection (Figure 7-6A,B). ATMIN
F/F controls showed a 23+/-3% cell loss (n=13 mice, 
mean+/-standard error of mean/SEM here and in all following sets of data), with 2251+/-89 
motoneurons in the facial nucleus on the uninjured, and 1716+/-77 on the axotomized 
side. Very similar numbers were also observed in the ATMIN
N mice, with 21+/-2% cell 
loss, and with 2141+/-78 motoneurons on the uninjured and 1695+/-73 on the injured side.  P a g e  | 144 
 
 
 
As  with  neuronal  survival, 
neural  deletion  of  ATMIN  did 
not  affect  functional  recovery 
after facial nerve cut using the 
whisker  hair  test.  Briefly, 
extent  of  whisker  movement 
was  scored  by  three 
observers  unaware  of  the 
genotypes, on a scale of 0 (no 
movement)  to  1  (barely 
observable), 2 (moderate) and 
3  (strong,  normal  movement, 
as  on  the  control  side).  As 
shown  in  Figure  7-6C,  no 
differences  were  observed  at 
any  of  the  time  points  6  to  27  days  post  axotomy.  Twenty-six  days  after  facial  nerve 
transection,  both  control  and  mutant  mice  showed  strong  normal  movement  on  the 
uninjured side (3.0). On the ipsilateral side, control animals had an average motor score of 
2.13 ± 0.09 (n = 14). ATMIN
N mice showed no significant difference in motor performance 
to their wild-type counterparts and exhibited an average motor score of 2.16 ± 0.09 (n=8).  
7.1.3  Non-neuronal cell response.  
The  neuronal  response  is  normally  accompanied  by  glial  and  immune  activation,  with 
increased  number  of  αM  immunopositive  microglia,  de  novo  expression  of  GFAP-
immunoreactivity in reactive astrocytes, and the influx of CD3 immunopositive T-cells into 
 
Figure  7-5:  Neural  deletion  of  ATMIN  does  not  affect  neuronal 
survival  
(A,  B)  or  functional  recovery  (C)  following  facial  nerve  cut.  A,  B: 
Number  of  facial  motoneurons  on  the  uninjured,  contralateral  and 
axotomized  side  (A)  and  axotomized/contralateral  ratio  (B),  30  days 
after  facial  nerve  cut.  C:  Recovery  of  whisker  hair  movement,  on  a 
scale of 0 (no movement) to 3 (normal strong movement similar to that 
of contralateral side). N = 13 ATMIN
F/F and 11 ATMIN
ΔN mice in A&B, 
and 12 and 12, respectively, in C. P a g e  | 145 
 
 
 
the injured part of the central nervous system. In the presence of neuronal cell death, in 
the mouse facial motor nucleus this reaches its maximum 14 days after nerve cut (Moller 
et  al., 1996), local microglia will transform into brain macrophages that remove neural 
debris and express high levels of phagocyte specific markers such as the αXβ2 integrin 
(Kloss et al., 1997; Kalla et al., 2001; Raivich et al., 1999; Schwaiger et al., 1998). As 
shown in Figure 7-4I-L, the deletion of neural ATMIN did not affect the increase in the 
immunoreactivity for astrocyte GFAP (Figure 7-4I) and microglial αM (Figure 7-4J), the 
influx  of  CD3  positive  T-cells  (Figure  7-4L)  and  the  number  of  αX  immunoreactive 
phagocytic microglial clusters (Figure 7-4K), 14 days post-axotomy, which corresponds 
with  the  lack  of  effect  of  ATMIN  on  neuronal  survival.  The  average  number  of  CD3 
immunopositive  T-cells  on  the  contralateral  side  was  0.3±0.1  (N=7)  for  controls  and 
0.4±0.2 for mutants (N=5); on the ipsilateral side,  wild types averaged 30.3±15.2 CD3 
positive T-cells (N=7) and mutants exhibited 18.8±5.9 (N=5). Baseline astrocyte activation, 
as measured by GFAP immunoreactivity on the contralateral side, was 6.8±0.6 for wild 
type animals (N=5) and 9.8±1.7 for mutants (N=5); on the injured side, controls exhibited 
28.2±1.4 average pixel values  while ATMIN null mutants averaged 34.4±3.3. Activated 
microglial marker  αM baseline activation  was  10.7±1.2 in wild type animals (N=6) and 
16.9±3.5 in mutants (N=5). After injury, there was no difference between wild type and 
mutant animals – controls showed 50.6±5.1 pixels and mutants showed upregulation to 
71.7±11.4 pixels. Lastly, phagocytic microglial marker αX integrin showed no differences 
between ATMINF/F and ATMINN animals. While phagocytic microglia were not present 
in the uninjured facial motor nuclei of either wild type or  mutant animals, 3.5±0.6 and 
3.85±0.7 immunoreactive cells were present  in the axotomized facial motor nucleus of 
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7.2  The Role of ATMIN in Peripheral Target Reinnervation 
Reinnervation of the peripheral target was determined by a 48 hour retrograde labelling of 
facial motoneurons with FluoroGold (FG) injected into the facial whisker pad 28 days after 
nerve cut. Retrograde FluoroGold labelling of intact motoneurons on the uninjured, contra-
animal side  served as  an intra-animal control. Under  normal conditions,  using a  1/64x 
intensity  filter,  to  observe  just  the  brightly  fluorescent,  FluoroGold  immunoreactive 
motoneurons  (Figure  7-6B),  facial  nucleus  sections  from  control  ATMIN
F/F  animals 
revealed  159±13  FluoroGold  motoneurons  on  the  uninjured  (contralateral)  side  and 
101±16  on  the  ipsilateral,  formerly  axotomized  side  (n=12  mice).  Relatively  similar 
numbers were also observed for the ATMIN
ΔN mutants (n=12), with 170±9 retrogradely 
labelled motoneurons on the uninjured side and 130±15 following facial nerve cut (p= 49% 
and 20%, respectively, compared to ATMIN
F/F, unpaired Student‘s t-test).  
A further 4-fold increase in fluorescence intensity using 1/16x filter to also allow detection 
of moderately and weakly fluorescent neurons did reveal ATMIN-specific differences. As 
shown in Figure 7-6C, ATMIN
F/F controls displayed 186± 15 FluoroGold immunopositive 
motoneurons  on  the  contralateral  and  169±23  on  the  axotomized  side;  the  ATMIN
ΔN 
mutants  showed  a  similar  number  of  196±13 motoneurons  on  the  uninjured  side  (p = 
59%), but 251± 23 on the axotomized side (p=2%), an approx 50% increase compared 
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Figure 7-6: Deletion of ATMIN enhances the reconnection of weak and aberrant regenerating axons with their peripheral targets.  
A-D: Number of retrogradely labelled facial motoneurons following application of MiniRuby (MR) into the eyelid (B) and FluoroGold (FG) into the whisker pad (C,D) 28 
days after facial nerve cut, followed by 48 hours of retrograde transport. A shows a schematic summary of the procedure. Co-injection of retrograde tracers on the 
contralateral side was used to provide intra-animal uninjured control. ATMIN
ΔN mutants showed a slight trend towards higher numbers for Mini-Ruby labelled motoneurons 
(B), and the strongly FluoroGold labelled ones, observable with the 1/64x filter (C). However, there was a clear and significant increase in the number of faintly FG-labelled 
motoneurons, observable with the 1/16x filter, in ATMIN
ΔN mutant mice compared with the ATMIN
F/F controls, following axotomy and ensuing regeneration. E, F: Number 
of the double-labelled FG+/MR+ motoneurons, with projections to the eyelid (MR) and whisker pad (FG) as a fraction of all MR+ motoneurons is increased in ATMIN
ΔN 
mice, for brightly FG+ labelled motoneurons on the axotomized (E), and for the faintly labelled ones on the uninjured side (F). In both cases, there was a similar trend on 
the contralateral side, but this did not reach statistical significance of 5%. C&D are the results of two separate experiments. *p<5% in unpaired Student t-test, n = 8 
ATMIN
ΔN and 8 ATMIN
F/F mice in B, E&F; n = 12 ATMIN
ΔN and 12 ATMIN
F/F mice in C&D). G-J: Tracer Fluorescence for FluoroGold (FG – red pseudocolour) and 
MiniRuby (MR - green pseudocolour) on the uninjured (G, I) and previously axotomized (H, J) side. The arrows point to 2 faint to moderately double labelled neurons on 
the uninjured, and a brightly double labelled neuron on the previously axotomized side in the ATMIN
ΔN mutant mouse. P a g e  | 148 
 
 
 
To investigate whether this increase in faint labelling was due to augmented branching of 
neurons  before  or  following  axonal  injury,  we  next  carried  out  a  double  labelling 
experiment  where the axons innervating the eye muscles were labelled  with  MiniRuby 
(MR) and those for the whisker hair pad with FluoroGold. As shown in Figure 7-6A, total 
MiniRuby  counts  did  not  differ  between  wild  type  and  mutant  mice  on  the  injured  or 
contralateral side. However, ATMIN
N animals exhibited a greater, overall number of FG+ 
MR+ double labelled motoneurons as a fraction of all MR+ neurons. This increase of the 
double  labelled  fraction  reached  statistical  significance  using  unpaired  t  test  on  the 
ipsilateral side at 1/64X filter for the brightly fluorescent motoneurons (Figure 7-6D), and at 
1/16x filter for the moderately/faintly labelled cell bodies on the contralateral side (Figure 
7-6E). Similar, but borderline changes were also observed for the contralateral (uninjured), 
brightly fluorescent neurons (p=15%) and the ipsilateral (formerly axotomized) neurons 
with weak FG fluorescence (p=11%). 
7.3  The Role of ATMIN in Central Regeneration 
As shown in Figure 7-3, Figure 7-4, Figure 7-5 and Figure 7-6, deletion of ATMIN did not 
affect functional recovery following facial nerve cut, but it did produce a significant increase 
in peripheral branching as well as central post-traumatic sprouting. Since the facial motor 
nerve regenerates well (Werner et al., 2000; Makwana et al., 2009), we postulated that 
any small advantages conferred by the absence of ATMIN may be masked by the already 
robust peripheral response, and decided to investigate the deletion effects following spinal 
cord  injury,  a  system  without  spontaneous  axonal  regeneration  and  very  moderate 
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7.3.1  Dorsal hemisection: Enhanced Number of Aberrant CST sprouts.  
ATMIN
ΔN  mice  and  their  littermate  ATMIN
F/F  controls  underwent  left  dorsal  spinal  cord 
hemisection at the 5
th cervical vertebra (C5) level, injected stereotactically with MiniRuby 
(MR) into the right motor cortex after 30 days, followed by anterograde transport in the 
corticospinal tract (CST) axons for further 12 days, perfusion fixation and embedding in 
OCT. Labelled CST axons were quantified in horizontally (longitudinally) cut spinal cord 
sections  of  40um  thickness,  counting  MiniRuby  immunoreactive  axons  crossing  a  line 
perpendicular  to the  longitudinal  axis,  starting  at  1.5mm  Rostral to  the  lesion  site  and 
proceeding in 0.5mm increments throughout of the entire depth of the cord tissue, in every 
5
th consecutive section.  
As shown in Figure 7-7, although overall, there was little difference between the ATMIN
ΔN 
and the ATMIN
F/F groups in the total number of MiniRuby immunopositive axons in the 
ipsilateral CST above the lesion site (+1.5 to +0.5mm), the ATMIN
ΔN mice exhibited a 2-10 
fold higher density in other parts of the spinal cord. When these numbers were corrected 
for the average number of MiniRuby immunoreactive axons in the ipsilateral CST +1.5 to 
+0.5mm  for  each  individual  animal,  and  then  normalized  using  log  (x+0.01)  algorithm, 
statistical  analysis  using  unpaired  t-test  revealed  a  significant  change  (p<0.05)  in  the 
contralateral CST at +1.5, +1.0 and +0.5mm, the contralateral grey matter (+1.5, +1.0) and 
even in the ipsilateral CST just above the lesion site (+0.5mm). Borderline changes with a 
p-value between 0.05 and 0.1 were also observed in the ipsilateral (+1.0) and contralateral 
(+0.5) lateral white matter, and in the ipsilateral dorsal horn and white matter immediately 
below the lesion site (-0.5). Results are summarized in Table 12 of the Appendix. 
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Figure 7-7: ATMIN
ΔN mutants show increased branching of corticospinal tract (CST) axons above the spinal cord lesion site to ipsilateral dorsal horn grey 
matter and contralateral spinal cord.  
Effects following over-midline spinal cord hemisection at C5, transversing ipsilateral CST, dorsal funiculus and dorsal horn, but sparing lateral white matter. CST axons 
were anterogradely traced for 12 days by MiniRuby injection into contralateral motor cortex 30 days after hemisection. A-F: MiniRuby fluorescence in longitudinal (A-D) 
and transversal sections (E, F) of spinal cord above lesion site at low (A, B) and high (C-F) magnification. In E&F, autofluorescence, additionally shown in red and higher 
in grey matter tissue, is used to demarcate grey (dorsal horn) from white (dorsal funiculus) matter, the demarcation between the two is indicated by a stippled magenta 
line. Note the numerous CST fibers crossing into the ATMIN
ΔN grey matter. Scale bar (in F): A,B - 0.5mm, C,D - 0.1mm, E,F – 50um. G-L: Number of MR+ axons crossing 
a hairline, placed perpendicular to the longitudinal spinal axis, at 1.5mm above to 1.5mm below the lesion site, in the corticospinal tract in the dorsal funiculus (G,H), 
adjacent grey matter P a g e  | 151 
 
 
 
As illustrated in Figure 7-2, like facial motor neurons, ATMIN
ΔN corticospinal neurons that 
show  enhanced  branching  also  exhibit  increased  levels  of  nuclear  ATF3,  without 
concomitant increases in baseline c-Jun expression, compared to wild-type littermates.  
7.3.2  Poorer Fine Motor Performance following Dorsolateral Hemisection.  
Since  dorsal  hemisection  only  severs  the  corticospinal  tract  and  the  ascending  dorsal 
sensory fibres resulting in relatively moderate motor deficits, we next explored the effects 
of  the  C5  dorsolateral  hemisection  that  also  cuts  the  rubrospinal  tract  (Figure  7-8A), 
producing a major impairment in gross motor function as well as in the precision of their 
paw placement. As shown in Figure 7-8B, both ATMIN
ΔN and the ATMIN
F/F mice revealed 
very similar loss of ipsilateral forepaw use in rearing in the cylinder rearing test directly 
after injury, followed by a moderate recovery in the gross motor function to 20-30% of 
normal values after 2-4 weeks. In contrast, deletion of ATMIN strongly affected fine motor 
coordination using paw placement while moving along a horizontally suspended wire grid. 
Compared with the ATMIN
F/F controls, ATMIN
ΔN mutants revealed a significant increase in 
the  number  of  forepaw  footslips  on  the  ipsilateral  (Figure  7-8C)  as  well  as  on  the 
contralateral  (Figure  7-8D)  side.  Interestingly,  deletion  of  ATMIN  did  not  affect  the 
precision of the hindpaw placement, on the injured or the contralateral side (Figure 7-8E, 
F). Results are summarized in Table 13 of the Appendix. P a g e  | 152 
 
 
 
 
Figure 7-8: ATMIN deletion impairs coordinated functional motor behaviour following dorsolateral C5 hemisection. 
A: Schematic summary of the surgical intervention, showing transversal section not only of the dorsal corticospinal tract, dorsal funiculus and dorsal horn, but also of the 
rubrospinal and lateral corticospinal tracts in the adjacent white matter. B: Forepaw usage in rearing on the injured side is not affected by ATMIN deletion. The Y axis 
shows fraction of ipsilateral usage as percentage of all rearing attempts. For each attempt, contralateral usage alone was given 0 points, bilateral usage 1 and ipsilateral 
usage alone 2 points. C-F: Incorrect foot placement (footslips) in wire grid test, as a fraction of all placements for the left (C) and right forepaw (D), and left (E) and right 
hindpaw (F). Dorsolateral hemisection was on the left side. *p<5% in unpaired Student t-test, n= 6 ATMIN
F/F and 8 ATMIN
ΔN mice. Data collected 1 day prior (-1) to 
dorsolateral hemisection served as the pre-trauma control. P a g e  | 153 
 
 
 
ATMIN DISCUSSION: ATMIN IN SPROUTING AND BRANCHING 
The 88kD ATMIN protein is newly identified target of ataxia telangiectasia mutated kinase 
involved in response to stress induced by hypo-osmolarity, UV exposure or hydroxyurea, 
causing  a  halt  to  cell  cycle  progression,  activating  checkpoints  and  promoting  cellular 
repair (Kanu and Behrens 2007; Kanu and Behrens 2008). In the current study, tissue-
specific  deletion  of  ATMIN  in  the  nervous  system  using  nestin-promoter  driven  cre 
recombinase  strongly  increases  axonal  sprouting  and  branching.  These  effects  were 
observed in both central and peripheral nervous system, but were also associated with 
more  errors  in  fine  motor  coordination,  and  aberrant  multi-target  innervation.  Neural 
deletion of ATMIN did not affect speed of peripheral regeneration and gross functional 
recovery,  neuronal  cell  survival,  glial  or  immune  reaction,  or  most  components  of  the 
molecular response. However, mutant mice did show a strong neuronal expression of the 
c-Jun and ATF3 transcription factors that could contribute to the enhanced and frequently 
aberrant sprouting response, which is normally counteracted in the presence of ATMIN. 
7.4  Axonal Projections and Functional Recovery 
Neural deletion of ATMIN augmented axonal sprouting and branching in the periphery, as 
well as in the central part of the nervous system. Compared with the ATMIN
F/F controls, 
mutant  mice  showed  a  clear  increase  in  the  number  of  just  moderately  or  faintly 
retrogradely labelled motoneurons following application of FluoroGold into the whisker pad 
area  30  days  following  facial  nerve  cut  and  an  increase  in  the  number  of  CGRP-
immunoreactive  and  galanin-immunoreactive  motor  axon  sprouts  in  and  around  the 
axotomized facial motor nucleus, that are known to appear transiently 2 weeks after injury 
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augment  neuropeptide  expression.  In  fact,  ATMIN
ΔN  mutants  even  exhibited  reduced 
overall CGRP immunoreactivity, suggesting that the increased number of sprouts was not 
due to the increases in survival or neuropeptide immunostaining, but enhanced branching. 
A similar, but even stronger, 2-10 fold increase was also observed for the anterogradely, 
MiniRuby-labelled corticospinal tract axons sprouting into the ipsilateral dorsal horn and 
projecting into the contralateral CST in the ventral part of the dorsal funiculus above the 
lesion site. This was accompanied by less retrograde retraction of CST neurites above the 
lesion site,  as well as a trend (5<p<10%) towards higher number of MiniRuby-positive 
axons, in the dorsal horn and lateral white matter just below the lesion.  
Surprisingly,  this  augmented  branching  was  not  associated  with  improved  functional 
performance. Recovery of gross motor function was unchanged, as illustrated by the more 
or  less  identical  time  course  of  whisker  hair  movement  improvement  in  the  ATMIN
ΔN 
mutant mice and their littermate controls following peripheral nerve injury (Figure 7-5C), or 
the use of affected forelimb in rearing following central injury after the dorsolateral C5 
spinal cord hemisection (Figure 7-8B). However, mutant mice showed actual deterioration 
in forepaw footslips on both the injured and the contralateral side in the grid walking, a test 
used to assess fine motor coordination. It is possible that the overall motor function was 
not impeded because the threshold in absolute number of axons for gross function was 
reached in both control and mutant mice, or that that the higher ratio of improper/proper 
connections detracted from beneficial effects of enhanced neurite outgrowth. 
Although  improved  sprouting  in  the  CNS  is  normally  associated  with  a  much  better 
functional recovery (Jiang et al., 2007; Karimi-Abdolrezaee et al., 2006; Tysseling-Mattiace 
et al., 2008; Xiao et al., 2007), the current study suggests that the generation of and failure 
to prune imprecise connections will impair fine motor performance and coordination. For 
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firing  action  potentials  onto  extensor  and  flexor  muscles  or  onto  muscles  innervating 
opposite limbs, resulting in defects in co-ordinated behaviour. Here, the higher number of 
CST axons projecting into  the anatomically inappropriate, contralateral dorsal funiculus 
could also contribute to the increased number of forepaw footslips on the uninjured side. 
Precision defects were also observed in the peripheral, facial nerve projections of mutant 
mice.  Peripheral  nerve  injury  is  known  to  increase  number  of  axons  projecting  into 
inappropriate  nerves  (e.g.  motor  axons  in  cutaneous  nerves)  or  the  appearance  of 
exuberant innervation of 2 or more disparate targets through the same motoneuron (Melle 
et  al.,  2009;  Skouras  et  al.,  2009;  Suarez  et  al.,  2006;  Guntinas-Lichius  et  al.,  2005; 
Streppel  et  al.,  2002a).  However,  the  multi-innervation  of  two  disparate  targets,  in  the 
current case, the eye lid and whisker hair projections, was significantly increased in the 
ATMIN
ΔN  mutant  mice,  identifying  ATMIN  as  a  regulatory  element  that  mediates  the 
removal of some, even if not all of the exuberant and imprecise posttraumatic innervation. 
Interestingly, similar  projection imprecision in mutants was also observed on a smaller 
scale on the contralateral side, which could suggest the involvement of ATMIN not only 
after  injury  but  also  in  the  initial  axonal  guidance  and  the  postnatal  ―sharpening‖  of 
somatotopic projection maps in the peripheral nervous system. 
7.5  Molecular Mechanisms 
At present, the molecular mechanisms of ATMIN are just beginning to be understood. As 
shown in the present study, ATMIN did not affect neuronal survival, astrogliosis, microglial 
activation or T-cell recruitment. It also did not affect some prominent components of the 
molecular  response  of  the  injured  neuron,  for  example  the  post-traumatic  increase  in 
CD44  and  galanin.  However,  in  addition  to  its  enhanced  and  imprecise  sprouting  and 
worsened fine motor coordination, ATMIN
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transcription factors, with augmented expression of the former in the injured, and of the 
latter in both the axotomized and the contralateral, uninjured facial motoneurons. Both c-
Jun and ATF3 are AP1 transcription factors that  have been shown to mediate in vitro 
neurite outgrowth (Pearson et al., 2003a; Nakagomi et al., 2003; Campbell et al., 2005; 
Kiryu-Seo et al., 2008) and cellular response to stress (Chaum et al., 2009). In vivo, forced 
neuronal expression of ATF3 will strongly improve DRG neurite outgrowth in the injured 
spinal  cord  (Seijffers  2007).  Neuronal  deletion  of  c-Jun  will  also  abolish  post-axotomy 
neuronal  cell  death,  and  strongly  reduce  peripheral  regeneration  and  central  axonal 
sprouting  (Raivich  et  al.,  2004a;  Makwana,  Werner,  et  al.,  2009).  Although  both 
transcription factors could be implicated in promoting sprouting, experiments so far only 
revealed  increased  ATF3,  but  not  c-Jun  expression  in  the  cerebral  motor  cortex  of 
ATMIN
ΔN  mutant  mice  Figure  7-2);  this  pattern  did  not  change  following  cervical 
transection of the corticospinal tract (data not shown). 
Axonal regeneration in the adult CNS is normally very poor. However, it can be improved 
by increasing the robustness of neuronal injury response (Lu et al., 1991; Smith et al., 
2009; Kalousa et al., 2009; Gordon et al., 2009), removal or neutralisation of extrinsic 
inhibitory signals including CSPG, NOGO, MAG or OMG (Shen et al., 1998, 2009; Tang et 
al., 1997; Bradbury et al., 2002; Galtrey et al., 2007; McGee et al., 2003; Robak et al., 
2009;  Hossain-Ibrahim  et  al.,  2007),  or  blocking  intracellular  signals  such  as  RhoA, 
involved in growth cone collapse following contact with chemorepellant cues (Dergham et 
al., 2002; Ellezam et al., 2002; Fournier et al., 2003; Wu et al., 2005, 2009). Any one or a 
combination of these pathways could be affected to produce a combination of more and 
imprecisely connected new neurite sprouts. However, it is interesting that those pathways, 
at  least  those  under  the  control  of  ATMIN,  apparently  regulate  the  fidelity  of  axonal 
connections in the central, as well as in the peripheral system, possibly on a side by side P a g e  | 157 
 
 
 
basis. Here, identifying these downstream targets of ATMIN involved in axonal guidance 
and pruning could help to improve functional recovery following nerve injury. 
CHAPTER 8:  SUMMARY OF RESULTS 
The neuronal regenerative response relies on transcriptional regulation at several different 
levels. Interactions involving transcription factors, not only in the neuronal cell body, but 
also in local supporting cells, orchestrate the successful peripheral injury response. These 
data illustrate that neuronal c-Jun regulates the cellular response to damage; without it, 
neurons  are  unable  to  upregulate  several  key  transcription  factors,  neuropeptides  and 
adhesion molecules associated with successful regeneration. In addition, c-Jun deficient 
neurons are less able to recruit and activate non-neuronal cells such as CD3+ T cells, 
astrocytes and microglia, and also show decreased levels of cell death with accompanying 
neuronal atrophy of many surviving cells. Although N-terminal phosphorylation does not 
play a role in the neuronal response to facial motor nerve injury, c-Jun deletion targeted to 
peripheral Schwann Cells shows downstream opposite effects on survival, with neurons 
showing increased cell death without Jun-mediated Schwann Cell signals.  
Jun is also involved in ATMIN regulation of sprouting and branching following nerve injury. 
ATMIN-deficient motor neurons display increases in growth-related transcription factors, 
such as c-Jun and ATF3, as well as increased central sprouting of CGRP and Galanin 
immunopositive  neurites.  Anatomically,  ATMIN  deletion  causes  increased  branching  of 
corticospinal and facial motor nerve axons, both during development and following injury. 
This increased branching leads to differences in fine, but not gross motor co-ordination. P a g e  | 158 
 
 
 
CHAPTER 9:  C-JUN CONCLUSIONS 
9.1  Neuronally Expressed c-Jun Regulates the Cellular Response to Injury and is 
Essential for Cell Death 
Neuronal c-Jun is an integral modulator of the peripheral response to Facial motor nerve 
injury.  Genetic  ablation  of  its  expression  in  neurons  led  to  a  heavily  impaired  cellular 
response, lack of lymphocyte and phagocytic monocyte recruitment to the injured facial 
motor nucleus, virtually no astrocytic activation and very mild microglial activation following 
facial  nerve  section.  Upregulation  of  all  of  these  factors  has  been  implicated  in  the 
successful response to peripheral nerve injury, (Butovsky et al., 2006; Jones, Banati, et al., 
1997; Jones et al., 2000; Bramanti et al., 2010; Ha et al., 2008; Kloss et al., 1999; Werner 
et  al.,  2000;  Vogelezang  et  al.,  2001;  Raivich  et  al.,  2002;  Ekstrom  et  al.,  2003; 
Gschwendtner  et  al.,  2003;  Wallquist  et  al.,  2004).  Resultant  regeneration  was  also 
impaired – both anatomically and functionally  -  as well as sprouting from the proximal 
portion of the axotomized nerve stump. Lack of regeneration is probably due to inadequate 
signalling from injured motoneurons during the cellular response, as well as poor trophic 
signalling from non-neuronal cells. Perhaps most importantly, despite the lack of cellular 
response and the vast cell damage resulting from axotomy, injured Jun
S motor neurons 
were  unable  to  die  following  facial  nerve  transection.  In  addition  to  increased  survival 
following injury, there seems to also be enhanced survival of Jun
S motor neurons during 
development – as indicated by a roughly 20% increase in baseline facial motor neuron 
number in Jun
S mutants. This illustrates the integral regulatory role of jun in the neuronal 
death response and highlights its potential neuroprotective role in chronic degenerative 
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9.2  Schwann Cell c-Jun Is an Important Regulator of Peripheral Nerve Growth that 
is Necessary for Neuronal Survival 
This research indicates that c-jun expressed in supporting glia plays an important role in 
post-traumatic  axonal  regeneration.  The  pro-regenerative  peripheral  cellular  injury 
response is strongly ablated in its absence. In addition to its role in survival signalling to 
the neuron, Schwann cell c-Jun is an integral component of the chemotactic signalling 
gradient created after injury and macrophage recruitment is affected by Schwann cell-
specific ablation of c-jun. This data describes how Jun-mediated retrograde signalling to 
the  neuron  is  an  import  factor  in  motoneuron  survival  and  that  in  the  absence  of  a 
proliferative Schwann cell signal, injured motoneurons cannot survive.  
Since regeneration and cell survival are so strongly affected by trophic withdrawal of c-jun, 
establishment and upregulation of an appropriate c-jun response in central supporting cells 
-  oligodendroglia  and  astrocytes  -  might  be  a  possible  future  treatment  strategy  for 
neuronal  damage.  This  study  illustrates  that  c-Jun  expression  by  Schwann  cells  is 
essential  for  regulating  cellular  response  to  injury  and  establishing  a  successful 
regenerative system. 
9.3  c-Jun N-Terminal Phosphorylation Plays no Role in Facial Nerve Regeneration 
The pro-regenerative/pro-apoptotic role of c-jun has been heavily discussed in literature 
(Suh et al., 2005; Kuan et al., 2003; Raivich et al., 2002; Sun et al., 2006; Herdegen et al., 
1991; Ham et al., 1995); however, the in vivo role of phospho-jun in the facial motor nerve 
regenerative response has been previously uncharacterized. Taken together, these data 
indicate  that  phosphorylated  Jun  is  not  the  key  c-Jun  isoform  that  regulates  its  pro-
regenerative or pro-apoptotic role after facial nerve transection. This begs the question as 
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this  report,  activation  of  the  c-Jun  mediated  transcriptional  apparatus  appears  to  be 
affected by interactions at 3 major sites: N-Terminal phosphorylation at Ser 63&73 and Thr 
91&93 (Smeal et al., 1994; Morton et al., 2003), dephosphorylation of Thr239 (Morton et 
al.,  2003)  and  C-terminal  lysine  acetylation  near  aa257-276  (Vries  et  al.,  2001).  This 
investigation  eliminates  the  former  of  these  three  options  as  the  interaction  primarily 
responsible  for  c-Jun‘s  role  in  the  neuronal  response  to  facial  nerve  axotomy.  It  is 
commonly said that when a door closes, a window opens; this evidence suggests that 
perhaps the window of opportunity for exploring the latter two alternative pathways has 
now opened a little wider. Future studies will characterize the role of alternative c-Jun 
activation in facial nerve regeneration. 
9.4  Overall Implications of c-Jun in Neuronal Regeneration and Repair 
C-Jun  is  an  important  regulator  of  the  neuronal  response  to  injury.  Thus,  c-junf/f, 
Synapsin::Cre animals exhibit defects in functional and anatomical reinnervation following 
facial nerve transection.  Schwann cell  c-jun  deletion shows a copy number dependent 
decrease in specific reinnervation (ax/co) – each copy of deleted c-jun halves the number 
of anatomical connections made. Animals lacking neuronal c-Jun are resistant to neuronal 
cell death following injury and exhibit severely impaired non-neuronal cell recruitment and 
a much reduced molecular response compared to wild type controls. c-Jun in Schwann 
Cells  shows  reverse  function  in  neuronal  cell  survival.  Without  Schwann  cell  c-Jun 
signalling, injured facial motoneurons had lower levels of survival. Although Schwann cell 
c-Jun  has  no  affect  on  neuronal  cellular  response,  it  enhances  successful  target 
reinnervation. After injury, facial axons are less able to form functional connections in its 
absence. Evidence involving Nestin::Cre mediated neuroepithelial excision of jun in both 
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Synapsin::Cre  mediated  neuronal  excision  –  indicating  that  neuronal  Jun  signalling  is 
upstream  of  Schwann  cell  mediated  Jun  survival  signals.  Interestingly,  c-Jun 
phosphorylation state does not seem to play a major role in the regenerative response to 
facial motoneuron injury. There were no major differences in survival, cellular response or 
reinnervation after facial nerve axotomy between JNK1-3 and JunAA mutants and their 
wild  type  controls.  Taken  together,  these  data  indicate  that  c-Jun  is  a  powerful 
Transcriptional  regulator,  both  in  the  periphery  and  the  central  nervous  system,  that 
controls trophic propensity in Schwann cells and upstream cellular response, regeneration 
and survival in neurons. 
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CHAPTER 10:  ATMIN CONCLUSIONS 
10.1  ATMIN is an Important Guidance Molecule in Neuronal Regeneration 
Nestin::Cre  targeted  ATMIN  deletion  results  in  altered  cell  body  response  to  neuronal 
injury  and  is  associated  with  increased  branching  of  previously  intact,  as  well  as 
regenerating, facial motoneurons. 14 days after FNA, ATMIN mutants upregulate c-Jun & 
ATF3  in  the  Facial  motor  nucleus–  co-expression  of  these  transcription  factors  has 
previously  been  associated  with  increased  sprouting  in  vitro  (Pearson  et  al.,  2003a; 
Nakagomi et al., 2003; Campbell et al., 2005; Kiryu-Seo et al., 2008) and cellular response 
to stress (Chaum et al., 2009). Indeed, Furthermore, double labelling of distal temporal 
and  zygomatic  (with  MiniRuby),  and  buccolabial  (with  Fluorogold)  facial  motor  nerve 
branches results in increased numbers of facial motor nerve cell bodies expressing both 
MiniRuby  and  Fluorogold  in  mutant  animals.  Despite  an  increase  in  growth  marker 
expression  and  anatomical  reinnervation,  30  day  functional  recovery  and  motoneuron 
survival remained unaffected in PNS facial motor nerves. Further studies carried out in the 
CNS after Dorsal and Dorsolateral Spinal Cord Hemisection show increased anatomical 
cross-innervation (more axons in ipsilateral grey matter and contralateral white matter) in 
ATMIN
n  mutants  compared  to  wild  type  controls.  This  correlates  with  an  increased 
number of both contralateral and ipsilateral forepaw slips from these animals on a grid test. 
Despite deficits in fine motor placement, weight bearing and gross co-ordination of motor 
movement,  as  demonstrated  by  the  cylinder  rearing  test,  remain  unaffected.  This 
highlights the inhibitory role of ATMIN in axonal trafficking both after injury and during 
development.  
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CHAPTER 11:  GENERAL CONCLUSIONS 
  Survival  Gross 
Motor 
Recovery 
Fine 
Motor 
Recovery 
Neuronal 
Response 
Non-Neuronal  
Response 
c-Jun  CNS 
deletion 
(Raivich  et  al., 
2004) 
 Atrophic       to Absent  Astrocytes  
Phagocytes X 
Lymphocytes X 
c-Jun  Neuronal 
Deletion 
 Atrophic       to Absent  Astrocytes  
Phagocytes X 
Lymphocytes X 
c-Jun  Schwann 
Cell Deletion 
      No Difference  No Difference 
(  phagocytes 
to clear up  cell 
death) 
c-Jun 
Phosphorylation 
Deficiency 
No 
Difference 
No 
Difference 
No 
Difference 
No Difference  No Difference 
c-Jun 
upregulation 
(via  ATMIN 
deletion) 
No 
Difference 
No 
Difference 
 
Sprouting, 
  co-
ordination 
  Growth-
Associated 
TFs and NPs 
( C. Sprouting) 
No Difference 
 
This  series  of  experiments  shows  the  complex  and  multi-faceted  role  of  c-Jun  in  the 
neuronal  response  to  injury  and  stress.  c-Jun  is  needed  for  neuronal  cell  death  and 
lymphocyte influx following injury, as well as the neuronal signalling response to stress. 
These  experiments  show  that,  in  particular,  neuronal  c-Jun  is  the  most  prominent  or 
upstream orchestrator of this response, since Neuronal+Schwann Cell deletion (via the 
Nestin Promoter) shows the same injury phenotype as Neuronal deletion alone (via the 
Synapsin  promoter).  This  phenotype  is  different  from  that  displayed  by  Schwann  Cell-
specific  deletion  (via  P0  promoter).  Although  Schwann  Cell  Jun  has  no  effect  on  the 
neuronal  cell  response  to  stress,  neuronal  survival  is  decreased  in  its  absence; 
contrastingly,  neuronal  survival  is  enhanced  by  Jun  deletion  in  the  Neuron. 
Phosphorylation  state  does  not  have  an  affect  on  c-Jun  function  in  peripheral  facial 
motoneuron regeneration. These experiments also show that c-Jun signalling – in both 
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neurons and Schwann cells - is necessary for functional axonal recovery following injury, 
as mutants show decreased reinnervation following facial nerve injury in both instances.  
In  agreement  with  c-Jun  deletion  data,  upregulation  of  injury-induced  c-Jun  via  neural 
deletion  of  ATMIN  shows  complementary  results.  ATMIN  deficient  animals  showed 
upregulation of growth associated transcription factors and neuropeptides both baseline 
(ATF3) and following facial nerve injury (ATF3, c-Jun, CGRP and galanin), although non-
neuronal  cell  recruitment  and  neuronal  survival  was  normal.  ATMIN  deletion  caused 
increased  peripheral  and  central  misrouting  that  did  not  interfere  with  gross  motor 
performance when rearing, but impeded precise motor coordination and paw-placement, 
resulting in increased number of forepaw footslips in grid-walking tasks. 
Taken together, these results highlight the dual and cell-specific role of c-Jun in neuronal 
regeneration  and  repair.  Schwann  cell  c-Jun  signalling  during  the  de-differentiaton 
response to axotomy is essential for Schwann cell support of the injured neuron resulting 
in neuronal survival; conversely, Jun in the neuron is necessary for neuronal cell death 
and cellular response to axotomy-induced stress. Upregulation of it and ATF3 via ATMIN 
deletion leads to increased, albeit aberrant axonal sprouting. Novel understanding of this 
versatile  and  complex  transcriptional  regulator,  gleaned  through  this  study,  will  prove 
integral in the further translation of c-Jun-related treatment strategies for neuronal injury 
and will positively shape the future of regenerative medicine. 
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CHAPTER 12:  APPENDIX 
  Concentr
ation 
Host 
Species 
Optimized 
By 
Obtained From  Secondary 
ATF3  1:300  Rabbit (Rb)  Titration  Gift  from  Prof.  PN 
Anderson 
Goat  Anti-
Rabbit 
CD3  1:1600  Rat (Rt)  Titration  Chemicon  Goat Anti-Rat 
CD44  1:1000  Rat  Titration  Chemicon  Goat Anti-Rat 
CGRP  1:800  Rabbit  Titration  Penninsula Lab ICH  Goat  Anti-
Rabbit 
c-Jun  1:200  Rabbit  Titration  Santa Cruz  Goat  Anti-
Rabbit 
GALANIN  1:400  Rabbit  Titration  Penninsula Lab ICH  Goat  Anti-
Rabbit 
GFAP  1:6000  Rabbit  Stable  Zymed  Goat  Anti-
Rabbit 
αM  1:5000  Rat  Stable  Serotec  Goat Anti-Rat 
αX  1:200  Hamster 
(Hm) 
Titration  Novus Molecular Inc  Goat  Anti-
Hamster 
β1 Integrin  1:300  Rat  Titration  Chemicon  Goat Anti-Rat 
  4 Days  14 Days 
  Contralateral  Ipsilateral  Contralateral  Ipsilateral 
CGRP  c-Jun
 F/F  Average  46.3  62.2  41.3  54.6 
    SEM  2.9  2.1  4.8  2.4 
    N  5.0  5.0  9.0  9.0 
  c-Jun
S  Average  46.9  50.4  47.9  45.6 
    SEM  3.3  3.4  2.4  1.7 
      N  4.0  4.0  6.0  5.0 
GALANIN  c-Jun
 F/F  Average  6.6  13.4  6.7  13.0 
    SEM  1.2  3.3  0.9  1.4 
    N  5.0  5.0  10.0  10.0 
  c-Jun
S  Average  4.9  5.6  9.8  8.1 
    SEM  0.6  0.8  1.6  1.2 
    N  5.0  5.0  6.0  6.0 
CD44  c-Jun
 F/F  Average  9.3  51.7  7.5  45.2 
    SEM  1.2  4.8  1.5  9.1 
    N  5.0  5.0  10.0  10.0 
  c-Jun
S  Average  12.8  15.9  8.2  13.3 
    SEM  1.8  1.8  2.5  4.2 
    N  5.0  5.0  6.0  6.0 
BETA 1  c-Jun
 F/F  Average  5.8  9.3  7.6  17.0 
    SEM  0.4  0.7  1.1  1.8 
    N  5.0  5.0  10.0  10.0 
  c-Jun
S  Average  6.7  6.0  5.3  6.5 
    SEM  1.5  0.9  0.4  0.6 
    N  5.0  5.0  6.0  6.0 
ATF3   c-Jun
 F/F  Average  30.5  41.7  29.1  40.8 
    SEM  3.0  1.2  1.9  2.7 
    N  5.0  5.0  9.0  9.0 
  c-Jun
S  Average  26.8  27.8  28.3  30.9 
    SEM  3.6  1.7  3.4  3.0 
    N  5.0  5.0  6.0  6.0 
Data Measured in OLV 
 
Table 3: Immunohistochemical Antibody Data for Cellular Response Trials. 
Table 4: Impaired Cellular Response in c-Jun
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Alpha 
M 
Day 4            Day 
14 
       
  Contra    Ipsi        Contra    Ipsi     
  Mean  SEM  Mean   SEM  N    Mean  SEM  Mean   SEM  N 
WT1  18.2  1.6  45.6  3.4  5    14.5  2.4  49.3  9.0  5 
JNK1  19.8  1.6  45.5  2.9  3    15.2  2.3  49.2  7.5  5 
WT2  15.4  1.8  59.4  6.9  3    11.2  1.3  50.9  10.6  3 
JNK2  19.0  2.5  42.5  3.4  4    12.7  1.4  84.9  5.4  6 
WT3  11.1  4.5  52.9  14.5  3    11.7  2.0  56.3  5.2  4 
JNK3  14.7  1.5  41.5  8.5  3    10.7  1.8  58.9  6.0  3 
WTAA  10.3  1.2  35.6  1.4  5    10.4  0.6  50.0  5.6  7 
JunAA  11.4  0.7  35.3  2.2  5    7.7  0.7  61.5  3.4  7 
 
GFAP  Day 4                 Day 14             
   Contra    Ipsi        Contra    Ipsi       
   Mean  SEM  Mean   SEM  N     Mean  SEM  Mean   SEM  N 
WT1  17.2  2.6  65.9  8.9  5     14.7  2.5  69.9  8.8  3 
JNK1  11.6  1.6  61.8  6.3  4     9.1  0.6  40.1  13.7  2 
WT2  10.7  1.0  36.0  1.2  3     11.2  1.3  50.9  10.6  3 
JNK2  13.5  3.8  47.4  6.1  4     11.7  2.0  56.3  5.2  4 
WT3  9.3  1.5  44.3  9.3  4     12.4  1.3  12.4  1.3  6 
JNK3  15.3  1.4  70.9  10.1  4     10.7  1.8  58.9  6.0  3 
WTAA  9.0  2.3  40.3  2.0  5     21.5  1.1  49.6  2.9  7 
JunAA  11.0  1.9  42.3  2.9  5     22.1  1.5  60.2  3.4  7 
 
CD3  Day 14             
   Contralateral     Ipsilateral       
   Mean  SEM  Mean   SEM  N 
WT1  3.7  1.2  42.0  13.3  5 
JNK1  6.0  2.1  54.1  12.3  5 
WT2  4.5  1.0  34.8  4.6  3 
JNK2  2.6  0.9  28.7  6.2  5 
WT3  6.0  0.5  34.9  3.9  6 
JNK3  2.0  0.8  8.4  0.4  4 
WTAA  0.1  0.1  9.0  3.5  7 
JunAA  0.4  0.2  15.1  4.2  7 
 
B7.2  Day 14             
   Contralateral     Ipsilateral       
WT1  Mean  SEM  Mean   SEM  N 
JNK1  3.0  0.8  28.0  5.1  6 
WT2  2.8  0.8  39.5  8.4  8 
JNK2  4.6  1.2  18.9  1.7  4 
WT3  4.7  2.2  37.6  7.1  4 
JNK3  3.5  0.7  26.1  7.3  4 
WTAA  5.3  2.3  16.9  4.9  5 
 
   
Table 5: Alpha M (MAC-1) Expression Day 4 and 14 After Facial Nerve Axotomy in JNK mutants 
Table 6: GFAP Expression Day 4 and 14 After Facial Nerve Axotomy in JNK mutants 
Table 7: CD3 Expression Day 14 After Facial Nerve Axotomy in JNK mutants 
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CD44  Day 4                 Day 14             
   Contra    Ipsi        Contra    Ipsi       
   Mean  SEM  Mean   SEM  N     Mean  SEM  Mean   SEM  N 
WT1  7.3  0.6  43.2  6.4  5     5.3  0.9  39.5  4.2  4 
JNK1  7.8  1.6  43.7  1.9  5     7.0  3.4  30.6  3.3  5 
WT2  6.3  0.8  22.1  5.4  3     5.3  1.2  35.2  6.3  4 
JNK2  5.6  0.9  29.5  3.6  4     5.0  0.4  32.2  4.1  6 
WT3  6.7  0.9  39.0  4.4  4     8.0  0.6  59.9  2.3  4 
JNK3  7.0  1.8  38.9  5.3  3     5.1  0.5  37.6  6.8  3 
WTAA  3.4  0.7  28.7  1.8  5     4.8  0.9  31.9  1.7  7 
JunAA  3.9  0.7  22.0  0.1  5     6.2  0.6  31.9  1.8  7 
CGRP  Day 4                 Day 14             
   Contra    Ipsi        Contra    Ipsi       
   Mean  SEM  Mean   SEM  N     Mean  SEM  Mean   SEM  N 
WT1  6.5  0.5  8.1  1.5  4     6.5  0.5  8.1  1.5  4 
JNK1  7.1  1.5  9.9  1.8  5     7.1  1.5  9.9  1.8  5 
WT2  8.4  0.8  11.1  1.6  3     7.8  0.3  12.1  1.2  2 
JNK2  8.2  0.6  16.3  4.0  3     6.6  1.0  9.5  1.8  4 
WT3  5.7  0.9  9.0  1.1  5     7.7  0.7  12.0  1.9  6 
JNK3  5.9  0.3  9.9  0.6  4     6.2  0.7  8.6  1.9  4 
WTAA  16.2  1.9  27.4  1.8  5     33.0  2.4  30.8  1.2  7 
JunAA  20.0  2.1  27.6  4.1  5     26.9  1.8  27.2  1.2  7 
ATF3  Day 4                 Day 14             
   Contra    Ipsi        Contra    Ipsi       
   Mean  SEM  Mean   SEM  N     Mean  SEM  Mean   SEM  N 
WT1  10.8  2.2  24.4  2.9  4     9.2  1.1  14.0  2.2  3 
JNK1  9.8  0.4  22.8  1.5  4     7.5  1.2  10.5  2.1  5 
WT2  12.0  3.6  29.4  6.7  3     7.6  0.9  12.1  1.2  3 
JNK2  7.5  0.7  23.5  3.7  4     8.1  1.3  12.5  1.1  5 
WT3  7.3  0.7  13.9  1.9  5     11.0  1.2  19.9  1.2  6 
JNK3  9.3  0.9  17.7  1.1  4     12.8  1.0  23.3  5.2  4 
 
   
Table 9: CD44 Expression Day 4 and 14 After Facial Nerve Axotomy in JNK Animals 
 
Table 10: CGRP Expression Day 4 and 14 After Facial Nerve Axotomy in JNK Animals 
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Contralateral White  ATMIN +/+  ATMIN -/- 
D
i
s
t
a
n
c
e
 
F
r
o
m
 
L
e
s
i
o
n
 
  Mean  SEM  N  Mean   SEM  N 
-1.5  0.0  0.0  4  0.0  0.0  5 
-1  0.3  0.3  4  0.6  0.6  5 
-0.5  0.0  0.0  4  0.6  0.6  5 
0  1.8  1.8  4  0.0  0.0  5 
+05  0.0  0.0  4  6.0  6.0  5 
+1  0.0  0.0  4  2.0  2.0  5 
+1.5  0.0  0.0  4  6.0  6.0  5 
Contralateral Grey  ATMIN +/+  ATMIN -/- 
D
i
s
t
a
n
c
e
 
F
r
o
m
 
L
e
s
i
o
n
 
  Mean  SEM  N  Mean   SEM  N 
-1.5  0.3  0.3  4  17.0  12.4  5 
-1  0.0  0.0  4  24.4  19.0  5 
-0.5  0.8  0.5  4  17.0  12.2  5 
0  1.0  0.7  4  1.0  1.0  5 
+05  5.0  5.0  4  6.0  6.0  5 
+1  0.0  0.0  4  4.0  4.0  5 
+1.5  5.0  5.0  4  0.0  0.0  5 
Contralateral CST  ATMIN +/+  ATMIN -/- 
D
i
s
t
a
n
c
e
 
F
r
o
m
 
L
e
s
i
o
n
 
  Mean  SEM  N  Mean   SEM  N 
-1.5  0.3  0.3  4  5.8  3.0  5 
-1  0.0  0.0  4  6.4  3.2  5 
-0.5  0.5  0.5  4  7.6  3.4  5 
0  0.3  0.3  4  0.0  0.0  5 
+05  0.0  0.0  4  2.0  2.0  5 
+1  0.0  0.0  4  0.0  0.0  5 
+1.5  0.0  0.0  4  0.0  0.0  5 
Ipsilateral CST  ATMIN +/+  ATMIN -/- 
D
i
s
t
a
n
c
e
 
F
r
o
m
 
L
e
s
i
o
n
 
  Mean  SEM  N  Mean   SEM  N 
-1.5  68.5  16.6  4  100.4  22.2  5 
-1  49.8  13.7  4  84.4  25.5  5 
-0.5  50.5  13.4  4  89.0  27.9  5 
0  3.5  1.3  4  13.6  10.7  5 
+05  0.0  0.0  4  2.0  2.0  5 
+1  2.5  2.5  4  0.0  0.0  5 
+1.5  0.0  0.0  4  0.0  0.0  5 
Ipsilateral Grey  ATMIN +/+  ATMIN -/- 
D
i
s
t
a
n
c
e
 
F
r
o
m
 
L
e
s
i
o
n
 
  Mean  SEM  N  Mean   SEM  N 
-1.5  29.8  10.8  4  120.6  52.6  5 
-1  32.5  12.4  4  131.0  89.1  5 
-0.5  24.3  13.6  4  151.8  72.7  5 
0  3.5  3.5  4  7.6  4.8  5 
+05  0.0  0.0  4  30.0  21.4  5 
+1  0.0  0.0  4  4.0  4.0  5 
+1.5  0.0  0.0  4  10.0  10.0  5 
Ipsilateral White  ATMIN +/+  ATMIN -/- 
D
i
s
t
a
n
c
e
 
F
r
o
m
 
L
e
s
i
o
n
 
  Mean  SEM  N  Mean   SEM  N 
-1.5  4.3  2.8  4  35.4  21.3  5 
-1  4.5  2.4  4  30.6  24.9  5 
-0.5  8.5  6.0  4  25.0  14.2  5 
0  0.3  0.3  4  0.2  0.2  5 
+05  0.0  0.0  4  38.0  25.8  5 
+1  5.0  5.0  4  16.0  13.6  5 
+1.5  10.0  10.0  4  14.0  9.8  5 
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Left Forepaw  ATMIN +/+  ATMIN -/- 
D
a
y
s
 
A
f
t
e
r
 
I
n
j
u
r
y
    Average 
WT 
SEM  N  Average 
MU 
SEM  N 
-1  4.8  1.3  8  3.4  1.3  7 
2  13.0  3.0  8  11.7  3.8  7 
7  12.8  2.0  8  16.6  3.0  7 
14  13.3  2.3  6  20.0  4.6  5 
21  15.8  2.6  8  17.7  3.3  7 
28  11.5  2.6  8  18.3  1.7  7 
Right Forepaw  ATMIN +/+  ATMIN -/- 
D
a
y
s
 
A
f
t
e
r
 
I
n
j
u
r
y
    Average 
WT 
SEM  N  Average 
MU 
SEM  N 
-1  3.8  1.1  8  4.6  1.7  7 
2  6.5  1.5  8  6.0  1.9  7 
7  7.5  1.7  8  4.6  1.9  7 
14  3.7  1.7  8  13.6  3.7  7 
21  10.3  2.2  8  12.6  3.8  7 
28  5.8  2.0  8  8.3  2.0  7 
Left Hindpaw  ATMIN +/+  ATMIN -/- 
D
a
y
s
 
A
f
t
e
r
 
I
n
j
u
r
y
    Average 
WT 
SEM  N  Average 
MU 
SEM  N 
-1  0.8  0.4  8  0.9  0.4  7 
2  10.3  3.7  8  9.4  1.6  7 
7  7.5  3.5  8  6.3  2.5  7 
14  4.0  1.0  6  2.0  1.1  5 
21  11.0  2.9  8  10.0  2.5  7 
28  3.5  0.9  8  7.4  3.9  7 
Right Hindpaw  ATMIN +/+  ATMIN -/- 
D
a
y
s
 
A
f
t
e
r
 
I
n
j
u
r
y
    Average 
WT 
SEM  N  Average 
MU 
SEM  N 
-1  0.5  0.3  8  0.9  0.4  7 
2  5.0  2.5  8  3.4  2.0  7 
7  1.8  0.8  8  1.1  0.6  7 
14  1.3  0.8  6  2.0  1.5  5 
21  3.3  1.4  8  1.4  0.6  7 
28  3.0  2.0  8  0.6  0.4  7 
 
Rearing Left/Right  ATMIN +/+  ATMIN -/- 
D
a
y
s
 
A
f
t
e
r
 
I
n
j
u
r
y
    Average 
WT 
SEM  N  Average 
MU 
SEM  N 
-1  104.00  5.00  8  102.00  7.00  7 
2  0.00  0.00  8  0.00  0.00  7 
7  26.00  17.00  8  21.00  10.00  7 
14  31.00  11.00  8  17.00  13.00  7 
21  31.00  17.00  8  43.00  14.00  7 
28  23.00  9.00  8  32.00  14.00  7 
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A large number of cytokines and growth factors support the
development and subsequent maintenance of postnatal motor
neurons. RegIII, also known as Reg2 in rat and HIP/PAP1 in
humans, is a member of a family of growth factors found in many
areas of the body and previously shown to play an important role
in both the development and regeneration of subsets of motor
neurons. It has been suggested that RegIII expressed by motor
neurons is both an obligatory intermediate in the downstream
signaling of the leukemia inhibitory factor/ciliary neurotrophic
factor (CNTF) family of cytokines, maintaining the integrity of
motor neurons during development, as well as a powerful inﬂu-
ence on Schwann cell growth during regeneration of the periph-
eral nerve. Here we report that in mice with a deletion of the
RegIII gene, motor neuron survival was unaffected up to 28
weeksafterbirth.However,therewasnoCNTF-mediatedrescueof
neonatal facial motor neurons after axotomy in KO animals when
compared with wild-type. In mice, RegIII positive motor neurons
are concentrated in cranial motor nuclei that are involved in the
patterning of swallowing and suckling. We found that suckling
was impaired in RegIII KO mice and correlated this with a
signiﬁcant delay in myelination of the hypoglossal nerve. In sum-
mary, we propose that RegIII has an important role to play in the
developmentalﬁne-tuningofneonatalmotorbehaviorsmediating
the response to peripherally derived cytokines and growth factors
and regulating the myelination of motor axons.
Schwann cells  suckling  hypoglossal nerve  LIF
A
large number of neurotrophic factors and cytokines have
been shown to sustain developing motor neurons and to
encourage the survival of postnatal motor neurons after damage
(1–6). Rat Reg2 [also known as RegIII in mouse and HIP/
PAP1inhumans(7)]hasbeenreportedtoplayanimportantrole
in both the support of motor neurons during development and
in the process of axon regeneration through axon–Schwann cell
signaling in the adult peripheral nervous system (8, 9). Reg2 is a
member of a large family of over 17 related genes divided into
four subtypes (types I, II, III, and IV) based on the primary
structures of the encoded proteins of the genes (10–13). Reg2 is
the equivalent of mouse RegIII gene, which share 90% homol-
ogy at both the nucleotide and protein level. First identified as
a transcript up-regulated in pancreatitis, Reg2, a secreted pro-
tein (relative Mr 16,000) found in many sites throughout the
body, was shown to have an anti-apoptotic action on pancreatic
cell lines (14). Reg2 also promotes the growth of epithelial
intestinal cells, whereas loss of Reg2/RegIII delayed liver
regeneration (10, 15–18).
Two roles have been proposed for Reg2 in the nervous system.
First, in vivo studies have suggested that Reg2 is released from
damaged motor and sensory neurons and has a proregenerative
function (9, 19, 20). Secondly, in vitro data have cast Reg2 as a
neurotrophic factor for motor neurons acting as an obligatory
intermediate for the ciliary neurotrophic factor (CNTF)/
leukemia inhibitory factor (LIF) family of cytokines (8). In the
adult rat, Reg2 is massively up-regulated in motor neurons and
some sensory neurons after nerve crush (19) and is rapidly
transported to the lesion site, where it is thought to be secreted
and act on Schwann cells. In vitro, Reg2 has a mitogenic effect
on Schwann cells and inhibition of Reg2 with a neutralizing
antibody retards the progress of regeneration. Taken together,
it seemed likely that the Schwann cell response at the point of
axotomy was potentiated by release of Reg2 from damaged
axons (9).
Here, we describe the effects of targeted ablation of the
RegIII gene in mice and show a developmental role of RegIII
in axon–Schwann cell signaling. We also report that RegIII is
required to promote the response of subsets of motor neurons to
CNTF but not for motor neuron survival.
Results
Generation of RegIII-Deficient Mice. KO mice were homozygous
for a targeted disruption of the RegIII gene locus created in ES
cells, in which a region from exons 2 to 5 was deleted and
replaced by an IRES-Tau-LacZ-loxP/MC1neopA/loxP reporter/
selection cassette, thus resulting in a null allele. Mice homozy-
gous for the RegIII-null allele were phenotypically indistin-
guishable from wild-type or heterozygous littermates. No
embryonic lethality or significant developmental defects were
observed in RegIII/ animals. Adult RegIII/ mice of both
sexes were fertile, and litter size was normal. We compared the
expression of RegIII between wild-type and KO animals by
using quantitative RT-PCR (RT-qPCR) and found that, as
expected,theexpressionofRegIII mRNAdroppedfrom100
25.2% (wild type) to 0.08  0.02% (KO) (n  6 per group).
Immunohistochemistry also showed a complete lack of RegIII
protein-like immunoreactivity in postnatal KO mice (Fig. 1). To
check for potential compensatory up-regulation, we also mea-
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differenceinRegIIIexpression(10067%inwildtypevs.62
43% in KO), but we found a substantial elevation of RegIII in
the brainstem of KO mice (100  26% in wild type vs. 667 
181% in KO).
RegIII Labeling of Neuronal Populations Is Restricted and Develop-
mentally Regulated. In wild-type embryos, RegIII proteins are
first detected in subsets of motor neurons at embryonic day
(E)13–E14 in cervical spinal cord, as previously described in rat
(8), with expression peaking at E18.5 (2). Within the brainstem
at postnatal day (P)1–P5, subsets of neurons along the medial
half of the motor nucleus of the trigeminal and in the dorsal and
medial regions of the facial nucleus were immunoreactive for
RegIII (Fig. 2). The heaviest concentrations of RegIII posi-
tiveneurons(upto50%atP1)werefoundthroughoutthecaudal
half of the hypoglossal nucleus (XII) and nucleus ambiguus
notably at day 1, but staining intensity reached maximal levels by
P4. By P11, RegIII staining had been lost from all areas of the
brain and spinal cord.
Motor Neurons Are Not Lost After RegIII Deletion. Two lines of
evidence imply that motor neuron survival is not compromised
by loss of RegIII. First, in KO mice, -galactosidase staining is
still visible in motor neurons similar in position to those that
show RegIII expression in wild-type mice (Fig. 3). The tau–
lac-Z strategy designed to transport -galactosidase into axons
met with limited success because the reaction product was only
obviously visualized in motor neuron cell bodies and dendrites.
These motor neurons included the spinal motor neurons and
trigeminal, facial, hypoglossal, and nucleus ambiguus motor
neurons up to P10. Postnatally, sacral motor neurons stained
positively for -galactosidase (Fig. 3B), but brainstem expression
was restricted to small foci within the cytoplasm of motor
neurons (Fig. 3C) or the occasional heavily stained motor
neuron (Fig. 3A). In the spinal cord, -galactosidase reaction
product was found in only the medial column of neurons
comparable in position to RegIII immunoreactive neurons
seen in wild-type mice (Fig. 3B). -Galactosidase expression was
not present beyond P10. Second, the total number of motor
neurones in the facial motor nucleus of P5.5–P10.5 mice or mice
24 weeks old were not significantly different between wild-type
and KO mice implying that no motor neuron cell death had
resulted from the loss of RegIII [see supporting information
(SI) Fig. S1].
Lack of Effect of CNTF on Facial Motor Neuron Survival in RegIII KO
Mice. CNTF applied to the cut end of the facial nerve delays the
axotomy provoked death of neonatal rat facial motor neurons
(21). To examine the effects of CNTF in RegIII KO mice, we
cut the facial motor nerve unilaterally at P3.5 and then imme-
diately applied CNTF or saline to the cut end of the nerve. Mice
were then allowed to survive for 3 days. The loss of facial motor
neuronsafterfacialnervelesion(FNL)wascomparablebetween
wild-type and KO mice (45% and 49% loss when compared with
contralateral side in wild-type and KO, respectively) (Fig. 4).
There was a significant effect of CNTF on wild-type mice when
P5.5 +/+ Mouse
Facial nucleus
P5.5 -/- Mouse
Facial nucleus
A
B
Fig. 1. RegIII immunoreactivity is found in subsets of facial motor neurons
in P5 wild-type mice but was not found in the postnatal KO mouse central
nervous system. (A) Facial motor nucleus (P5) of a wild-type mouse. (B)
Absence of staining in KO facial nucleus. (Scale bar, 120 m.)
AB
C
D
Fig. 2. RegIII immunoreactivity is found in subsets of cranial and spinal
motor nuclei up to P12. (A) Facial motor nucleus with labeled axons (arrow)
streaming into the facial nerve. (B–D) RegIII-positive neurons within the
nucleusambiguus(B),thehypoglossalnuclei(C),andthemotornucleusofthe
trigeminal(D).AllspecimenswerefromP5mice.[Scalebars:100m(A,B,and
D); 150 m( C).]
AB
C
Fig. 3. -Galactosidase activity is present postnatally in subsets of motor
neuronsintheRegIIIKOmouse.(A)Motorneuroninthefacialmotornucleus
at P3. (B) Sacral motor neurons at P1. (C) Punctate -galactosidase staining in
the facial motor nucleus at P5. [Scale bars: 20 m( A); 60 m( B); 40 m( C).]
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type mice (24% and 32% savings respectively, P  0.001 for
both) (Fig. 4). When mice were allowed to survive for four days
after FNL, cell loss was considerable but CNTF produced
significant savings in the numbers of dying neurons in wild-type
mice when compared with KO mice (Fig. S2).
We have previously shown (9) that section of the sciatic nerve
results in down-regulation of Reg2/RegIII in motor neurons in
rat pups and up-regulation in adult rats. However, in mouse pups
with facial nerve axotomy at P3.5 and perfused 2 days later, we
did not detect any change in numbers of RegIII-positive
neurons in the facial motor nucleus. However, application of
CNTF after facial nerve section at P3.5 in mouse pups signifi-
cantly increased the number of RegIII-positive neurons seen 2
days later to 148% compared with the contralateral side (P 
0.0001) (Fig. 5 and Fig. S3). Finally, whereas in adult rats, Reg2
is expressed by all facial motor neurons within 24h of axotomy,
in adult mice, RegIII is not reexpressed in facial motor neurons
1–7 days after axotomy (Fig. S4).
Loss of RegIII Impairs Suckling Behavior. In newborn mouse pups,
we noted that neurons immunoreactive for RegIII were found
to be concentrated in cranial motor neurons that have been
associated with suckling and swallowing, such as the hypoglossal
nucleus and nucleus ambiguus. We therefore examined the
ability of RegIII KO mice to ingest milk during a 1-h period of
suckling after a 2-h period of isolation from the mother. Com-
pared with wild-type pups, we found a significant reduction in
milk/colostrum ingestion: percentage weight increase in wild-
type mice, 3.1  0.2%; and in KO mice, 0.45  0.2 (P  0.01).
LossofRegIIIDelaysMyelinationoftheHypoglossalNerve.Because
of the influence of Reg2 on Schwann cells (9) and the reduced
efficiency of suckling described above, we used electron micros-
copy to analyze myelination in the hypoglossal nerve at P5 in
wild-type and KO mice. Oculomotor neurons never express
RegIII, and we, therefore, used the P5 oculomotor nerve as a
control. We found a significant increase in the numbers of
unmyelinated nerve fibres in both the medial and lateral hypo-
glossal nerves in KO mice at P5 (Fig. 6 A–C). One-way ANOVA
revealed a significant effect of genotype on axon type in both the
medial (F1,14  24.8; P  0.01) and lateral hypoglossal nerves
(F1,1321.5;P0.01)Therewerenodifferencesinthenumbers
of unmyelinated axons in the oculomotor nerves in P5 wild-type
and KO mice. In the lateral hypoglossal nerve, the total numbers
of axons in the RegIII KO mice exceeded that in the wild-type
animals (Fig. 6C). We therefore counted the total number of
myelinated axons in the lateral and medial hypoglossal nerves at
P21. We found that there were no differences between the two
groups (wild type: lateral, 352.3  25.8; medial, 980.3  9.5; KO:
lateral, 360.0  16.5; medial, 950.3  41.9 KO; n  3 in each
group). We concluded that excess collateralization of hypoglos-
sal axons occurs because of delayed myelination during the early
postnatal period in KO mice and is lost later by selective pruning
of excess axonal branches (22, 23).
The impaired suckling phenotype, thus, may result from a
disruption of myelination in mutant mice. We also examined the
hypoglossal innervation of tongue musculature in wild-type and
KO mice by using protein gene product (PGP) as a marker for
nerve fibers and -bungarotoxin for muscle end plates. We
found no evidence of changes in innervation density or size of
muscle end plates (data not shown).
Discussion
Previous research has suggested that in vitro rat Reg2 is a motor
neuron survival factor essential for the actions of CNTF-like
cytokines and a powerful Schwann cell mitogen that potentiates
axonal repair and regeneration in vivo (8, 9). However, we show
herethatinmicewithageneticdeletionoftheRegIIIgene(the
equivalent gene to Reg2 in rats), there is no increased motor
neuron cell death during development. Nevertheless, we report
that the efficacy of CNTF in reducing neuronal cell death was
diminished in RegIII KO mice indicating that RegIII is
important for the survival functions of CNTF. Finally, we found
that myelination was delayed in subsets of hypoglossal motor
neurones in KO animals and the efficiency of milk ingestion
reduced.
RegIII Is an Intermediate in the CNTF Survival Pathway. The sug-
gestion that Reg2/RegIII was a motor neuron neurotrophic
factor and a signaling intermediary in the CNTF survival path-
way stems from elegant in vitro studies demonstrating that
purified Reg2 can act as a paracrine/autocrine neurotrophic
factor for a subset of motor neurons (8). Furthermore, it has
been shown that CNTF, as well as the related factors LIF,
cardiotrophin 1, and oncostatin-M, rapidly induces Reg2 mRNA
in some motor neurons and that released Reg2 acts in a
paracrine/autocrinefashiontosupportmotorneurons(8,9).The
CNTF/LIFfamilyofcytokinessignalthroughareceptorcomplex
that includes the LIF receptor (LIFR) subunit, and it has been
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of facial motor neurons in wild-type but not KO mice counted 3 days after
nerve section. The data show means  SEM (n  4-5 in each group). **,
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Fig. 5. CNTF increases the number of RegIII positive neurons. (A) Applica-
tion of CNTF to the cut facial nerve results in increased numbers of RegIII-
positivefacialmotorneuronsinwild-typemice2daysafternervesection.The
data show means  SEM (n  7 in each group). ***, P  0.0001. (B and C)
RegIII-positive neurons in wild-type mice after facial nerve cut and CNTF (B)
orsaline(C)application.ThearrowindicatestheincreasednumberofRegIII-
positive neurons induced by CNTF. [Scale bar, 150 m( B and C).]
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of Reg2/RegIII during development (9). Thus, Reg2/RegIII
expression in some developing motor (and sensory) neurons
dependsoncytokinesoftheLIFfamilyactingthroughareceptor
complex containing LIFR.
TheabsenceofmotorneuroncelldeathinKOmice,therefore,
is puzzling, especially given that RegIII is essential for the in
vitro neuronal survival effects of CNTF to be manifest. The
evidence for a lack of effect on motor neuron survival comes
from the presence of -galactosidase reaction product in post-
natal neurons up to P10 and the normal numbers of facial motor
neurons in KO mice. However, in CNTF KO mice, there is
similarly no increased loss of motor neurons during the first
weeks of life (24, 25). This, perhaps, is not surprising, given that
levels of CNTF are low during development and, although
Schwann cells are the richest source of CNTF in the adult
peripheral nervous system, levels only rise during the first
postnatal week (26–28). Knockout of the CNTF gene did result
in motor neuron loss 28 weeks after birth (24); however, RegIII
mice did not show motor neuron loss in later adult stages.
Previous studies suggest that CNTF itself is not the key ligand
acting at the CNTF/LIF receptor complex. Nishimune et al. (8)
found that RegIII expression was unimpaired or delayed in a
range of KOs including cntf, ct1, and cntf/lif double mutants,
leading them to suggest that a factor as yet unknown was key to
driving the expression of RegIII in motor neurons.
That CNTF-like factors are as important in vivo as in vitro and
require ReIII expression is implied by the observation that
RegIII expression increases in axotomized neurons only when
CNTF is applied to the nerve stump and that CNTF has no
survival effect on motor neurons in RegIII KO mice. We also
show that the number of RegIII neurons increased in wild-type
mice when CNTF was applied to the cut nerve. This implies that
many motor neurons have the capacity to express RegIII, but
this number is restricted by availability of CNTF-like factors
during development. Nevertheless, RegIII may not be the only
intermediary involved in CNTF-like factor signaling as only
15–20% of facial motor neurons express RegIII, and CNTF
has previously been shown to rescue 75% of rat facial motor
neurons from cell death when axotomized soon after birth (24).
However,thesubstantiallylargerconcentrationofCNTFusedin
these experiments (5 g vs. 250 ng used in the present study) may
well have driven the expression of RegIII in many more
axotomized facial motor neurons than seen here and resulted in
greater levels of survival (24). Also the dynamics of Reg2
expression in rat are different from that of RegIII in mice.
RegIII never reappeared in the adult mouse after section of the
facial nerve (Fig. S4) or sciatic nerve (data not shown) and did
notnoticeablydecrease24hafteraxotomy,aswasobservedafter
sciatictransectioninneonatalrats.Presumablyotherfactorsmay
play a similar role to RegIII in adult mouse motor neurons,
although it is unlikely to be RegIII, which although up-regulated
in the KO mouse, did not potentiate CNTF-mediated survival.
Growth Factors and Myelination. We show here that myelination of
asubsetofhypoglossalmotorneuronaxonsisdelayedinRegIII
KO mice at P5.5 but normal by P21. This seems likely to be
attributable to the loss of RegIII because myelination of
oculomotoraxonsinKOmicewasnormalandoculomotormotor
neurons did not express RegIII at any stages of development.
This delayed myelination would be expected to disrupt the
transmission of signals along the axon and may account for the
reducedefficiencyofsucklingbehavior.Delayedmyelinationdid
not, however, result in any reduction in the size or number of
motor neuron end plates in target muscles of the hypoglossal
such as the glossohyoid (unpublished data). However, how then
does RegIII promote myelination in discrete populations of
motor neuron axons, and why is there such a restricted pattern
of RegIII expression?
Axons regulate Schwann cells during development of the
peripheral nervous system (29–33). The axon signals for regu-
lating Schwann cell differentiation are known to include both
proteins encoded by the neuregulin gene (NRG) signaling
through the erbB family of receptors, adhesion molecules such
as L1 and N-cadherin and neurotrophic factors such as brain-
derived neurotrophic factor (BDNF) (34–37). It has been sug-
gested that cell adhesion molecules on the axon surface as well
as signals from the extracellular matrix and neurotrophins are
also required for myelination to proceed efficiently and accu-
rately. For example, BDNF supports postnatal facial motor
neurones after axotomy and acts through p75 NTR to inhibit
Schwann cell migration and promote myelination (35, 36, 38). It
seems likely that RegIII released from subsets of motor neuron
axons is playing much the same role as BDNF in driving the
processofmyelination.AswithNRG1typeIII,ithasbeenshown
that RegIII signals through the PI3-kinase pathway (8, 17), and
this may represent a common pathway for axonally released
RegIII to influence Schwann cells. Why RegIII expression is
restricted to motor neurons concerned with the suckling and
swallowing is unclear, but we suggest that the patterning of this
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by release of factors from target musculature concerned with
suckling in an activity-dependent fashion (8).
Materials and Methods
All procedures complied with the United Kingdom Animals (Scientiﬁc Proce-
dures) Act 1986.
Generation of the RegIII-Deficient Mice by Gene Targeting. The generation of
these mice has been described elsewhere (18). Complete knockout of the gene
was conﬁrmed in nervous tissue with immunocytochemistry by using antibodies
generatedagainstratReg2protein,andabsenceofRegIIImRNAwasconﬁrmed
by using real-time PCR in brain, pancreas, and regenerating liver (16, 18).
Real-Time RT-qPCR Assay. Tissue preparation and RNA extraction were as
described previously (39). RNA samples were treated with DNase I (Qiagen).
Equalamounts(3g)oftotalRNAwerereversedtranscribedbyusingrandom
nonamers (Sigma) and SuperScript TM III RT (Invitrogen) for1ha t50°C in a
total reaction volume of 20 l. cDNAs were immediately quantiﬁed by real-
time PCR or kept at 20°C until further experiments. Real-time PCRs were
performed with a DNA Engine (Bio-Rad) by using SYBR Green Jump Start
RT-PCR master mix (Sigma) with each gene-speciﬁc primer (RegIII forward,
5-AAGAATATACCCTCCGCACGC-3; RegIII reverse, 5-CAGACAT-
AGGGCAACTTCACC-3; RegIII forward, 5-GAAGTGCCCTCTCCACGTACC-3;
RegIII reverse, 5-ACAAATGGTAATGTCCCATCG-3; RegIII forward, 5-
GCTCCTATTGCTATGCCTTGTTTAG-3; RegIII reverse 5-CATGGAGGACAG-
GAAGGAAGC-3; -actin forward, 5-CAACGAGCGGTTCCGATG-3; -actin re-
verse, 5-GCCACAGGATTCCATACCCA-3). One microliter of cDNA was ampli-
ﬁedinathree-stepcyclingprograminaﬁnalreactionvolumeof25l.Control
cDNA samples (obtained without transcriptase) were always included, as well
as samples without any cDNA template. Reactions were performed in tripli-
cate for ﬁve to six biological replicates, and threshold cycle values were
normalized to -actin gene expression. The speciﬁcity of the products was
determined by melting curve analysis. The ratio of the relative expression of
target genes to -actin was calculated by using the 2CT formula.
Facial Nerve Section. Pups were cooled on wet ice (4°C), and the extent of
anesthesia was determined by assessing reﬂex responses to tail pinch. Adult
micewereanesthetizedwithFluothane.Therightfacialnervewastransected
at the stylomastoid foramen. One to 10 days later, mice were deeply anes-
thetized with Euthatal i.p. and transcardially perfused with 4% paraformal-
dehyde (PFA) in 0.1 M sodium phosphate buffer (PB) (pH 7.4) preceded by a
briefwashwithheparinizedsaline.Aftera2hpostﬁxinPFA,tissuewasmoved
to sucrose (30%) PB solution in preparation for freeze sectioning. In some
pups,5lofCNTF(250ng)appliedtoapieceofGelfoamin5lsaline,orsaline
alone, was applied to the cut end of the facial nerve at the time of section.
Animals received only one treatment: either CNTF or saline.
Detection of -Galactosidase Staining by X-Gal Staining. PFA-ﬁxed tissue was
washed in PBT (PBS/0.1% Tween-20) several times. After a rinse in X-Gal
staining solution [5 mM K3Fe(CN)6,5m MK 4Fe(CN)6, 1 mM MgCl2, 0.01%
sodium deoxycholate, 0.02% Triton plus X-Gal (4-chloro,5-bromo,3-indolyl-
-galactosidase)at1mg/ml,suspendedinPBS(pH7.2)],tissuewastransferred
to fresh staining solution. Tissue was incubated at 37°C in the dark overnight.
Sections were washed several times with PBT.
Cell Counting. Sections (40 m) were cut through the facial nucleus and all
sections (the facial nucleus is 700 m in length in the anterior–posterior
direction) were mounted and stained with neutral red. All neuronal proﬁles
in every section were counted and total counts corrected by using the Aber-
crombie correction (40).
Immunohistochemistry. Mice were deeply anesthetized with pentobarbitone
(60 mg/kg, i.p.) and transcardially perfused with 4% PFA in 0.1 M sodium
phosphate buffer (PB) (pH 7.4) preceded by a brief wash with heparinized
saline. Tissue was dissected and postﬁxed for2ha t4 ° Ca n dthen transferred
to 30% (wt/vol) sucrose in 0.1 M PB containing 0.02% (wt/vol) sodium azide.
40mfree-ﬂoatingtissuesectionswereprocessedaspreviouslydescribedbut
for detection of RegIII (9, 39). Hypoglossal innervation of tongue muscula-
tureinwild-typeandKOmicewasassessedwithPGP,amarkerfornerveﬁbres,
and -bungarotoxin, a marker for muscle end plates.
ElectronMicroscopy.Mousepupsoradultmice(P21)weredeeplyanesthetized
with Nembutal and perfused with 10 ml heparinized saline followed by 20 ml
4% PFA plus 0.5% gluteraldehyde. Tissue was ﬁxed overnight before dissec-
tion of the caudal tongue and attached hypoglossal nerves and the oculomo-
tor nerve still attached to the optic nerve and eyecup. After being osmicated
(30 min in 1% OsO4 in 0.1 M PB), the sections were stained for 15 min in 0.1%
uranyl acetate in sodium acetate buffer at 4°C, dehydrated in ethanols,
clearedinpropyleneoxide,andembeddedinAraldite.Semithinsectionswere
cut with glass knives and stained with toluidine blue adjacent to thin sections
cut with a diamond knife on an Ultracut ultramicrotome (Reichert). The
sections were collected on mesh grids coated with a thin Formavar ﬁlm,
counterstained with lead citrate, and viewed in a JEOL 1010 electron micro-
scope. Counts were made from four photographs of the lateral and medial
nerves for each animal taken at 4,000 magniﬁcation. Total counts of my-
elinated ﬁbers at P21 were made from photomicrographs of the lateral and
medial hypoglossal nerves at 1,000 magniﬁcation.
Measurement of Milk/Colostrum Intake. The procedure described by Fujita and
colleagues (41, 42) was followed. Brieﬂy, pups were separated from the dam
for 2 h and kept in a warm, dark chamber. The pups were then weighed and
placed back with the mothers for 1 h before reweighing. Thirty to 40 pups of
each genotype were used for the measurement of milk intake.
Statistical Analysis. The data are expressed as means  SEM. The data were
analyzed by general linear model univariate or multivariate test, as appropri-
ate, followed by Bonferroni post hoc tests or Student’s t test, as appropriate.
For all statistical analysis, statistical signiﬁcance was set at P  0.05.
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ABSTRACT
Generation of new axonal sprouts plays an important role
in neural repair. In the current study, we examined the
appearance, composition and effects of gene deletions on
intrabrainstem sprouts following peripheral facial nerve
axotomy. Axotomy was followed by the appearance of ga-
lanin
 and calcitonin gene-related peptide (CGRP)

sproutspeakingatday14,matchingbothlarge,neuropep-
tide
 subpopulations of axotomized facial motoneurons,
but with CGRP
 sprouts considerably rarer. Strong im-
munoreactivity for vesicular acetylcholine transporter
(VAChT) and retrogradely transported MiniRuby following
its application on freshly cut proximal facial nerve stump
conﬁrmed their axotomized motoneuron origin; the
sprouts expressed CD44 and alpha7beta1 integrin adhe-
sion molecules and grew apparently unhindered along
neighboring central white matter tracts. Quantiﬁcation of
the galanin
 sprouts revealed a stronger response follow-
ing cut compared with crush (day 7–14) as well as en-
hanced sprouting after recut (day 8  6 vs. 14; 14  8 vs.
22), arguing against delayed appearance of sprouting be-
ing the result of the initial phase of reinnervation. Sprout-
ing was strongly diminished in brain Jun-deﬁcient mice but
enhanced in alpha7 null animals that showed apparently
compensatory up-regulation in beta1, suggesting impor-
tant regulatory roles for transcription factors and the
sprout-associated adhesion molecules. Analysis of inﬂam-
matory stimuli revealed a 50% reduction 12–48 hours fol-
lowing systemic endotoxin associated with neural inﬂam-
mation and a tendency toward more sprouts in TNFR1/2
null mutants (P  10%) with a reduced inﬂammatory re-
sponse, indicating detrimental effects of excessive inﬂam-
mation.Moreover,thestudypointstotheusefulnessofthe
facialaxotomymodelinexploringphysiologicalandmolec-
ular stimuli regulating central sprouting. J. Comp. Neurol.
518:699–721, 2010.
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axonal elongation play a vital role in the neural repair pro-
gram following injury to the nervous system. In the classi-
cal case of axonal regeneration in the injured peripheral
nerve, the tip of the proximal axon still connected to the
neuronal cell body is gradually transformed into a motile
and sprouting growth cone that moves across the gap be-
tween the proximal and nerve stump, enters neural tubes
in the distal part, and uses them as a scaffold on its way to
the peripheral target (Witzel et al., 2005). Supernumerary
axonal sprouts can also develop more proximally, at the
nodes of Ranvier (Ramon y Cajal, 1928; Friede and
Bischausen, 1980; McQuarrie, 1985; Ide and Kato, 1990),
from distal dendrites (Fenrich et al., 2007), and occasion-
ally even at the level of the injured neuronal cell body
(Linda et al., 1985).
In addition to outright regeneration, nerve injury can
also elicit sprouting from uninjured axons. This includes
collateral sprouting from functionally appropriate or inap-
propriate adjacent intact axons into the deafferented part
of the central nervous system (Cotman et al., 1990) or
peripheral tissues, including skin (Diamond et al., 1987),
muscle (Mehta et al., 1993; Nguyen et al., 2002), and
nerve (Ide and Kato, 1990; Tanigawa et al., 2005). Periph-
eral axotomy can also induce the sprouting of central sen-
sory processes of the affected dorsal root ganglia (DRG)
neurons in the spinal cord (Woolf et al., 1992) as well as
the appearance of perineuronal neurite baskets in the
DRGs themselves (McLachlan et al., 1993; McLachlan and
Hu, 1998; Li and Zhou, 2001; Liu et al., 2005). Both pro-
cesses have been indcated to contribute to posttraumatic
neuropathic pain (Woolf et al., 1992; Liu et al., 2005).
Despite the variability in origin, regulation, and dynamics,
in most cases these different forms of posttraumatic neu-
riteoutgrowthappeartostartwithintheﬁrstfewdaysafter
injury or to represent a very late response that may be
associated with frustrated regeneration.
Transectionoftheadultfacialnerveisawell-established
model system for studying the axonal response and neu-
ronal regeneration (Moran and Graeber, 2004). Moreover,
experimental work in gene-deﬁcient and-overexpressing
mice has begun to provide insight into molecular signals—
transcription factors, cell adhesion molecules, cytokines,
and neurotrophins—that determine axonal regeneration as
well as posttraumatic neuronal survival and cell death and
different aspects of the neural inﬂammatory response
(Werner et al., 2000; Kalla et al., 2001; Heumann et al.,
2001;Raivichetal.,2004;forreviewseeRaivichandMak-
wana, 2007). However, these studies also suggested a de
novo appearance of neuropeptide-immunoreactive
sprouts in and around the axotomized facial motor nu-
cleus, during the midphase of axonal regeneration after
facial nerve cut (Kloss et al., 1999; Werner et al., 2000;
Galiano et al., 2001).
The aim of the current study was to determine the pre-
cise neuronal origin of these sprouting neurites and deﬁne
their time course, neuroanatomical distribution, and mo-
lecular characteristics. We show that these axons origi-
natefrominjuredandregeneratingneurons,arecapableof
growing for more than 0.5 mm into different white matter
tracts surrounding the lesioned facial motor nucleus, and
express high levels of cell adhesion molecules such as
CD44 and alpha7beta1 integrin. Surprisingly, deletion of
the alpha7 integrin subunit led to a further increase in the
number and extent of neuropeptide-immunoreactive neu-
rite growth cones, suggesting an inhibitory role of alpha7
in this form of posttraumatic central axonal sprouting.
MATERIALS AND METHODS
Animals, surgical procedures, and tissue
treatment
Normal, wild-type, C57Bl/6 mice were generated at our
animal facilities at Max-Planck Institute of Neurobiology,
Martinsried, and then at the Biological Services Unit, UCL.
Transgenic, TNFR1/2–/–mice and wild-type controls
(/) were obtained from BRL (Basel, Switzerland) and
were on a mixed B6  129 background. In the TNFR1
transgenic strain, TNFR1 gene exons II and III, ﬂanked by
theNheIandBglIIrestrictionsiteswerereplacedbyortho-
oriented pgk-neomycin resistance cassette, abolishing
speciﬁc tumor necrosis factor- (TNF) binding in
TNFR1–/–thymocytes (Rothe et al., 1993). In the TNFR2
strain, the pgk-neomycin resistance cassette was inserted
into the BstB II site of the second TNFR2 exon, just down-
stream of the sequence encoding the signal peptide, re-
sultinginacompletelackofTNFR2protein(Ericksonetal.,
1994). Both strains were crossed together, to obtain dou-
ble heterozygotes (TFR1/–TNFR2/–), then crossed
again for the TNFR1&2–/–and controls.
Brain c-Jun-deﬁcient animals were generated by cross-
ing mice carrying a ﬂoxed jun allele encoding c-Jun, jun
f,
with the loxP sequences at the XbaI restriction sites sur-
rounding the exon carrying the entire c-Jun open reading
frame (Behrens et al., 2002), with those expressing cre
recombinase under the control of nestin promoter
nes::cre. In the nes::cre transgene, the cre gene is placed
immediately downstream of the 5-kb large 5-promoter,
followed by the human growth hormone polyadenylation
signal and the second nestin intron, which contains a
neuroepithelium-speciﬁc enhancer (Tronche et al., 1999).
The resulting jun
f/wt  nestin::cre animals were then
crossed again with jun
f/f, to generate the jun
f/f 
nestin::cre mutant mice, in which both jun alleles are inac-
tivated in cells derived from embryonic neuroepithelium
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n). Compound jun
n mice were on a mixed 129Ola/
C57BL6/FVBN genetic background. Sibling animals lack-
ing the cre transgene, with functional, unrecombined ho-
mozygousjun
f(jun
f/f),servedascontrols.Thehomozygous
alpha7–/–and littermate controls on the 129/Sv back-
ground used in this study were obtained from heterozy-
gous crossing of alpha7/–mice generated by Mayer et
al. (1997). In that transgenic strain, a 1-kb stretch of the
alpha7 genomic sequence ﬂanked by the NcoI restriction
sites including part of exon 1 and the following intron and
encoding the entire signal sequence plus 107 bases cod-
ing for the start part of the mature protein is replaced by a
reverse-oriented neomycin resistance cassette (Mayer et
al., 1997).
To study the effects of enhanced neural inﬂammation,
Escherichia coli lipopolysaccharide (O55:B5 serotype, 1
mg; Sigma, Deisenhofen, Germany) was dissolved in
phosphate-buffered saline (PBS: 10 mM Na2HPO4, 0.85%
NaCl, pH 7.4), and injected intraperitoneally into C57
black 6 mice (8 weeks old, 25–30 g weight; n  3 per
group)12–96hourspriortothe14-daytimepoint.Control
groups of animals were left alone or were injected with
saline and allowed to survive for 24 hours.
Allsurgicaltechniqueswereperformedwithanimalsun-
der anesthesia with 2,2,2-tribromethanol (Avertin; Sigma,
Deisenhofen, Germany), 0.4 mg/g body weight, on 3–6-
month-old mice. All animals belonging to the same exper-
imentalgroup(day1group,day2group,day4group,etc.)
were also operated upon on the same day, inside a narrow
time window of 1–3 hours. Animal experiments and care
protocolswereapprovedbytheRegierungvonOberbayern
(AZ 211-2531-10/93 and AZ 211-2531-37/97) in Ger-
many and the Home Ofﬁce (Scientiﬁc Procedures Act) in
the United Kingdom.
The right facial nerve (including the retroauricular
branch) was cut or crushed at its exit from the stylomas-
toid foramen. For the reaxotomy experiments, the cut was
made 1 mm distal to the original injury, and the retroau-
ricular branch was not recut. Animals were euthanized af-
ter survival times of 1–42 days and perfusion ﬁxed with
200 ml PBS (10 mM Na2HPO4, 0.85% NaCl, pH 7.4), fol-
lowed by 200 ml of 4% paraformaldehyde in PBS (PFA/
PBS), then by a 2-hour immersion of the brainstem in 1%
PFA/PBS at 4°C on a rotator (8 rpm), with an overnight
rotating immersion in a phosphate-buffered sucrose solu-
tion (PB: 10 mM Na2HPO4, pH 7.4, 4°C; 30% sucrose), and
frozen on dry ice.
Immunoﬂuorescence, double labeling, and
confocal scanning microscopy
Frozen brainstems were cut at the level of the facial
nucleus, and 20-m sections were collected on warm,
0.5% gelatin-coated slides (Merck, Darmstadt, Germany),
refrozen on dry ice, and stored at –80°C until further use.
Axonal growth cones in and around the facial motor nuclei
were quantiﬁed by using immunoﬂuorescence against
CGRP or galanin, the neuropeptides expressed in axoto-
mized facial motoneurons. For standard immunoﬂuores-
cence, the sections were thawed, rehydrated and spread
in distilled water, ﬁxed in 4% formaldehyde in 0.1 M PB,
defatted in acetone, and pretreated with 5% goat serum
(Vector, Wiesbaden, Germany) in phosphate buffer/PB as
describedbyMo ¨lleretal.(1996).Brieﬂy,thesectionswere
incubated overnight at 4°C with 1:100 diluted, primary
rabbit antibodies against CGRP or galanin (Table 1),
washed in PB, and incubated with a biotinylated goat anti-
rabbit antibody (1:100; Vector) and Texas red streptavidin
(Jackson Laboratories). The sections were then covered
withVectaShield(Vector)andstoredinthedarkat4°Cfor
confocal scanning and quantiﬁcation.
For immunoﬂuorescence, ﬁxed sections were preincu-
bated as in brightﬁeld immunohistochemistry. Both pri-
mary antibodies were applied overnight at 4°C, washed,
incubated with two appropriate secondary antibodies
(biotin-conjugated donkey anti-rabbit Ig and FITC-
conjugatedgoatanti-ratIg;1:100;Dianova,Hamburg,Ger-
many), washed again, and then incubated with a tertiary
FITC-conjugateddonkeyanti-goatantibody(1:100;Sigma)
and Cy3-avidin (1:1,000; Dianova). In the case of colocal-
izationwiththegoatanti-VAChT,onlythedonkeyanti-goat
antibody was used. Omission of the primary antibody or
replacement with nonspeciﬁc immunoglobulin from the
same species (rat, rabbit, or hamster) at the same dilution
led to the disappearance of speciﬁc labeling.
Digital micrographs of FITC and Cy3 or Texas red fuo-
rescence were taken with a Leica TCS confocal laser mi-
croscope with a 10 objective for quantiﬁcation and a
100 objective for illustrations in eight-bit gray-scale,
1,024  1,024 pixel format as described in previous stud-
ies (Raivich et al., 1998; Kloss et al., 1999). Twelve con-
secutiveequidistantlevelswith30-mspacingwitha10
objectiveor20levelswith0.5-mspacingat100objec-
tivewererecordedandcondensedontoasinglebitmapby
using the MaxIntense algorithm.
Antibody characterization
A summary of primary, secondary, and tertiary antibod-
ies used to characterize the facial sprouts by double label-
ing with antibodies for galanin, CGRP, or vesicular acetyl-
choline transporter (VAChT) 14 days after facial nerve cut
are listed in Table 1. The speciﬁcity of alpha7, alphaM,
CD44, CGRP, and galanin was conﬁrmed by using the ap-
propriate knockouts, compared with the wild-type con-
trols. Homozygous deletion of the alpha7 gene caused the
disappearance of neuronal and terminal alpha7 immuno-
reactivity in facial motoneurons as well as throughout the
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(Werner et al., 2000). Homozygous alphaM null mice and
littermate controls (Hu et al., 2000), obtained through col-
laboration with Dr Tanya Mayadas Norton (Boston, MA),
showed the disappearance of all microglial alphaM immu-
noreactivity throughout the brain of the alphaM null mice
as well as in the axotomized facial motor nucleus. Similar
absence of neuronal immunoreactivity for galanin was ob-
served in galanin gene-deﬁcient mice, obtained through
collaboration with Dr David Wynick (Holmes et al., 2000);
for CGRP in facial motoneurons of the alpha CGRP-
deﬁcient mice, through collaboration with Dr Jean-Pierre
Changeux(Salmonetal.,2001);andforCD44inCD44null
mice, provided through collaboration with Dr Rudolf
Schmits (Schmits et al., 1997). In all cases, the wild-type
littermate controls showed normal, speciﬁc immunoreac-
tivity. The null mutants showed very little, diffuse staining
throughout the brain.
In addition, antibody speciﬁcity for cell adhesion, neu-
ropeptide, and cholinergic markers was further conﬁrmed
by Western blotting with unfractionated tissue homoge-
nates from trigeminal ganglia, brainstem, spleen, and
TABLE 1.
Summary of Antibodies
1
Detected
antigen Immunization with
Primary antibody
(code, type) Dilution Application Source
Alpha4 integrin
(CD49d)
Mouse spontaneous T-lymphoma
line TK1 (AKR Cum strain)
R1-2, 01271D, RtM,
IgG2b, 
1:1,000 DIF Pharmingen, United Kingdom catalog
No. 553154 lot No. 38618
Alpha5 integrin
(CD49e)
Mouse mast cell line MC/9 5H10-27 (MFR5) RtM,
IgG2a, 
1:200 DIF Pharmingen, United Kingdom catalog
No. 553319 lot No. C510514
Alpha6 integrin
(CD49f)
Mouse mammary tumour (balb/
C)
GoH3, RtM, IgG2a 1:3,000 DIF Serotec, United Kingdom catalog No.
MCA699GA
Alpha7 integrin
(CD49g)
Synthetic peptide (aa 1117-
1136) coupled to maleimide-
activated key limphole
hemocyanin (KLH), Pierce,
Rockford, IL
Anti-alpha7, RbP 1:5,000 IHC, DIF Ulrike Meyer, U East Anglia Norwich,
United Kingdom
AlphaM
integrin
(CD11b)
T-cell-enriched B10 mouse
spleen cells
5C6, RtM 1:6,000 DIF Serotec, United Kingdom catalog No.
MCA 711
Beta1 integrin
(CD29)
Raised against the beta1 integrin
(von Ballestrem et al., 1996)
MB1.2, RtM, IgG2a,  1:3,000 IHC, DIF Chemicon, United Kingdom catalog
No. MAB1997 lot No.
0507004326
CD44 Puriﬁed human blood
lymphocyte CD44 lacking v1–
v10 exons
MAB2137, RtM, IgG2b 1:5,000 DIF Chemicon, United Kingdom catalog
No. MAB2137
CGRP Calcitonin gene-related peptide
(Bachem)
2
anti-CGRP, RbP 1:400 IHC, DIF Bachem, United Kingdom T-
4032.0050
Galanin Galanin peptide (Bachem)
3 Antigalanin, RbP 1:400 IHC, DIF Bachem, United Kingdom T-
4334.0050
MAP2 Puriﬁed rat brain microtubule-
associated protein (MAP2)
Anti-MAP2, RbP,
AB5622
1:3,000 DIF Chemicon, United Kingdom P11137
AB5622
NF-H Rat NFH fusion protein
containing 37 KSP repeats
anti-NFH, RbP AB1991 1:200 DIF Chemicon, United Kingdom catalog
No. AB1991 lot No. 23080338
VaChT Synthetic peptide (aa 511-530)
from the cloned rat VAChT
G4481, GtP AB1588 1:6,000 DIF Chemicon, United Kingdom AB1588
Secondary and
tertiary
Goat Ig Goat immunoglobulin FITC-cj -Gt Ig, DkP 1:100 DIF Dianova, United Kingdom
Hamster Ig Hamster immunoglobulin FITC-cj -Hm Ig, GtP 1:100 DIF Dianova, United Kingdom
Rat Ig Rat immunoglobulin Biot. -Rt Ig, GtP 1:100 IHC Vector, United Kingdom
Rat Ig Rat immunoglobulin FITC-cj -Rt Ig, GtP 1:100 DIF Dianova, United Kingdom
Rabbit Ig Rabbit immunoglobulin Biot -Rb Ig, GtP 1:100 IHC Vector, United Kingdom
Rabbit Ig Rabbit immunoglobulin Biot -Rb Ig, DkP 1:100 DIF Dianova, United Kingdom
1Antigens: CD44, cluster of differentiation 44; CGRP, calcitonin gene-related peptide; MAP2, microtubule-associated protein 2; NFHm, neuroﬁlament
heavy isoform; VaChT, vesicular acetylcholine transporter. Antibodies: RtM, rat monoclonal; HmM, hamster monoclonal; RbP, rabbit polyclonal; GtP, goat
polyclonal; DkP, donkey polyclonal; FITC-cj ﬂuorescein isothiocyanate conjugated. Applications: DIF, double immunoﬂuorescence; IHC, immunohisto-
chemistry (light microscopy).
2CGRP peptide sequence: H-Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-
Ser-Glu-Ala-Phe-NH2, Cys1-Cys2 disulﬁde bond.
3Galanin peptide sequence: H-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr-NH2.
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alpha4 integrin subunit detected a prominent band that
migrates at 	80 kDa and a faint band that migrates at
	65 kDa. Although the predicted molecular weight of al-
pha4 is 115 kDa (UniProt, Q00651), experimentally it has
been demonstrated that the molecule is cleaved into frag-
ments of 80 and 66 kDa upon T-cell activation (Blue et al.,
1992). The monoclonal 5H10-27 (MFR5) antibody against
the alpha5 integrin subunit detected a band at 90 kDa
corresponding to the heavy chain. The full predicted mo-
lecularweightis115kDa;however,itiscleavedintoheavy
(	90 kDa) and light (	16 kDa) chains, (UniProt, P11688).
Cleavage had also been reported experimentally (Teixido
et al., 1992) with the products migrating at 80 and 70 kDa
undernonreducingconditions.Underreducingconditions,
migration of bands might be altered. The monoclonal
GoH3 antibody to alpha6 detected a band at 87 kDa cor-
responding to the heavy chain predicted at 88 kDa (Uni-
Prot,Q61739)andasmallerbandthatmigratesat60kDa.
Cleavage has been previously reported for this molecule
withtheproductmigratingat	70kDaundernonreducing
conditions (King et al., 2008). The polyclonal antibody
against alpha7 detected a unique band at 129 kDa corre-
sponding to the full-sized molecule (UniProt, Q61738;
Echtermeyer et al., 1996); the monoclonal 5C6 antibody
against alphaM detected a single band at 127 kDa corre-
sponding to the full-size molecule (UniProt, P05555). The
monoclonal MB1.2 antibody against beta1 detected a
band at 88 kDa consistent with the predicted weight (Uni-
Prot, P09055) and two smaller bands at 70 and 53 kDa
consistent with previously reported cleavage products
(Menon et al., 2006). As a general trend, the literature
associates proteolytic cleavage of integrins with more ac-
tive cells. Antibody to CD44 detected a unique band at 63
kDa consistent with the common hematopoetic isoform 6
(UniProt, P15379-5). The polyclonal VAChT antibody de-
tected a single band at 57 kDa as previously reported
(UniProt, O35304, http://www.millipore.com/catalogue/
item/ab1588). The antibody reveals strong staining on cho-
linergic terminals surrounding the brainstem and spinal mo-
tor neurons as well as comparatively week labeling of the
cholinergic neuronal cell body itself (Gilmor et al., 1996).
Both features were also conﬁrmed in the current study
(seeFig.5AI–AIK).Galaninantibodydetectedasingleband
at 13 kDa consistent with its predicted size (UniProt,
P47212). CGRP antibody detected a band at 14 kDa con-
sistent with the signalling peptide (Uniprot, Q99JA0). The
Western blots for alpha4, alpha6, alpha7, and beta1 inte-
grinsubunitsandCD44intrigeminalganglionareshownin
Supporting Information Figure 3.
The antibodies against microtubule-associated protein
2 (MAP2) and heavy neuroﬁlament isoform (NF-H) were
used as previously well-established cellular/subcellular
markers. For the anti-MAP2 polyclonal antibody (http://
www.millipore.com/catalogue/item/ab5622#), Western
blotting with adult rat brain soluble extract detected a
strong and speciﬁc band for the 280–300-kDa dimer, in
our current study, appropriately diluted antibody also re-
sulted in strong dendritic staining, in line with many previ-
ous publications (see, e.g., Sigurjonsson et al., 2005;
Nateri et al., 2007). For the antineuroﬁlament H (heavy,
200 kDa NFH) polyclonal antibody (http://www.millipore.
com/catalogue/item/ab1991#), raised against the rat
NFH fusion protein containing 37 lysine-serine-proline
(KSP) domain repeats, the manufacturer’s data sheet de-
scribes strong reactivity to this major neuroﬁlament pro-
tein. Insofar as the middle neuroﬁlament protein (160 kDa
NFM) also contains a few lysine-serine-proline sequences,
there is generally some NFM cross-reactivity, but not with
the light 70-kD neuroﬁlament, NFL (Harris et al., 1991).
The NFL staining is generally restricted to neuroﬁlaments
in the white matter axons (see, e.g., Fig. 5J–L) as well as
dendriticandperikaryalneuroﬁlamentsinthegraymatter.
In the case of rat monoclonal antibodies raised against
alpha4 (CD49d), alpha5 (CD49e), alpha6 (CD49f), and
beta1 (CD29) integrins, previous studies have also de-
tailed a massive up-regulation of encoding mRNA species
following axotomy in the mouse facial motor nucleus, cor-
responding to a strong increase in the appropriate immu-
noreactivity (Kloss et al., 1999; Werner et al., 2000). All
four monoclonal antibodies are well deﬁned, with long-
established functional characterization for alpha4 (Holz-
mann and Weissman, 1989), alpha5 (Uhlenkott et al.,
1996), alpha6 (Hemler et al., 1988), and beta1 (von
Ballestrem et al., 1996) integrin subunits. In the mouse,
immunoreactivities for all four subunits were colocalized
on blood vessel endothelia as well as on activated micro-
glial cells (Hristova et al., 2009), but only the beta1 was
alsopresentinaxotomizedandregeneratingmotoneurons
(Klossetal.,1999;Raivichetal.,2004).Thispatternofjust
vascular and microglial, and not neuronal (or sprout), im-
munoreactivity for alpha4, alpha5, and alpha6 immunore-
activity was also reproduced in the current study. The cra-
nial motoneuron expression of the alpha7 and beta1
integrin subunits was also conﬁrmed by Pinkstaff et al.
(1999) for trigeminal, facial, and hypoglossal motoneu-
rons.
Quantiﬁcation of central axonal sprouting
Quantiﬁcation of growth cones was performed on four
sections per facial nucleus, with an interval of 200 m
between each section. Brieﬂy, the sections were scanned
in a TCS 4D confocal laser microscope (Leica, Nussloch,
Germany) with a 10 objective using Cy5 settings (ex
wavelength647nm,LP665,pinhole30).Fourteenconsec-
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with the MaxIntense projection.
Small, strongly ﬂuorescent growth cones were differenti-
ated from the large neuronal cell bodies with the Sobel ﬁlter
and a three-step Growth Cone Detection (GCD) algorithm in
Optimas 6.2 software (Media Cybernetics, United Kingdom).
In the ﬁrst step, the mean value of the overall luminosity
(MEANcor) and the standard deviation (SDcor) of the cor-
rected images (normal image) was recorded. This procedure
was repeated following Sobel ﬁlter treatment (MEANsob,
SDsob, sobel image), which calculates the direction-
independent local intensity gradient in a 3  3 pixel kernel.
The threshold for neuropeptide-immunoﬂuorescent growth
cones in the Sobel image was set with the formula: Thresh-
oldMEANsob11SDcor.Areasatandabovethreshold
were ﬁltered with the Object Classes function using two ad-
ditionalcriteriainthenormalimage:Areasize
10pixeland
MEANarea –SDarea 
 1.4  MEANcor, with MEANarea be-
ing the mean intensity and SDarea the standard deviation for
each individual area proﬁle. The remaining areas matched
with the proﬁles of the neuropeptide-immunoﬂuorescent
neuronalgrowthconesandservedasameasurefortheirtotal
area in the tissue section.
In addition, the number of sprouts in and around facial
motor nucleus was visually counted by a blinded observer,
with the identifying marking on the glass slide covered by
an opaque adhesive sticker carrying a code. In this case,
two sections per facial nucleus, 320 m apart, were used
to assess the number of sprouts per animal.
Immunohistochemistry for light and electron
microscopy
Immunohistochemistry for light microscopy was per-
formed by using the same procedure as for immunoﬂuo-
rescence up to the secondary antibody, followed by incu-
bation with the ABC reagent (Vector), visualization with
diaminobenzidine/H2O2 (DAB; Sigma, Deisenhofen, Ger-
many),dehydrationinalcoholandxylene,andthenmount-
ingwithDepex(BDH,Poole,UnitedKingdom).Forelectron
microscopy, 80-m-thick vibratome sections cut at the
facial nucleus level were stained for alpha7 integrin sub-
unit, galanin, or VAChT with a slightly modiﬁed protocol
(Werneretal.,2000).Thevibratomesectionswereﬂoated;
treatment with acetone was omitted; preincubation with
goat serum (or donkey serum in case of VAChT) was ex-
tended to 4 hours at RT; the rabbit anti-mouse alpha7
antibody was applied at a concentration of 1:500, galanin
antibody at 1:400, or VAChT antibody at 1.1,000, over-
night; the biotinylated goat anti-rabbı ´t or donkey anti-goat
secondary antibody (Vector, Jackson) was applied for 8
hours (4°C); and the incubation with the ABC reagent was
performed overnight (4°C).
For the DAB staining, vibratome sections were ﬁrst pre-
incubated in DAB (without H2O2) for 20 minutes, followed
by a 15-minute DAB/H2O2 reaction at RT, with Co/Ni en-
hancement(seeabove).Thesectionswerethenﬁxedfor7
days in 2% glutaraldehyde in PBS, osmicated, dehydrated,
and embedded in araldite (Fluka, Basel, Switzerland).
Semithin sections were counterstained with toluidine blue
for light microscopy, and ultrathin 100-nm sections were
counterstained with uranyl acetate and lead citrate and
examined in a Zeiss EM 10 and EM 109 electron micro-
scope.
Quantiﬁcation of light microscopic
immunohistochemistry
A Sony AVT-Horn 3CCD color video camera was used to
obtaineight-bitdigitalimagesbasedona0–255(eight-bit)
scale of optical luminosity values. Images of both control
and axotomized nuclei and for the glass were captured at
10 magniﬁcation on a light microscope with 0.06 Neu-
tralﬁlter. Captured images were run through an algorithm
to obtain mean and SD values for optical luminosity. SD
was subtracted from the mean for each image (mean-SD
algorithm), and the resulting values for axotomized and
control sides were each subtracted from the mean optical
luminosity values of the glass as described previously
(Mo ¨ller et al., 1996).
Statistical analysis
Statistical analysis for growth cone areas in two group
comparisons was performed by using a standard, two-
tailed Student’s t-test or with ANOVA followed by post hoc
Tukey in cases of more than two groups.
RESULTS
Facial axotomy causes delayed central axonal
sprouting: distribution and orientation
In view of previous reports of neuropeptide-immuno-
reactivesprout-likestructuresintheaxotomizedfacialmo-
tor nucleus 2 weeks after facial nerve cut (Galiano et al.,
2001; Werner et al., 2001; Makwana et al., 2007), our ﬁrst
aim was to provide a detailed mapping of their neuroana-
tomicaldistribution.AsshowninFigure1A,facialaxotomy
after nerve transection at the styloid foramen was as-
sociated with the appearance of sprout-like, galanin-
immunoreactive (galanin
) neurites inside the brainstem
in and around the lesioned facial motor nucleus. A high
number of galanin
 sprouts with a 4–10-m large termi-
nal bulb was observed in the white matter surrounding the
lesioned facial motor nucleus, in the ventral corticobasal
tract, in the ascending as well as descending part of the
intracerebral portion of the facial motor nerve (Fig. 1A,F),
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Some neurites were located as far as 0.5–1.0 mm away
fromtheborderofthefacialnucleusinthedorsal(Fig.1A),
and 0.3 mm in the caudal (Fig. 1B,C) direction, with the
stalk attached to a bulb, usually pointing away from the
nucleus (Fig. 1H,I).
Figure 1. Distribution of galanin-immunoreactive sprouts in and around the facial motor nucleus (FMN), 14 days following facial nerve cut.
A: Composite of the facial nucleus and surrounding areas; the nucleus outline is indicated by the dotted line. Note the numerous immunoreactive
sprouts in the white matter surrounding the lesioned facial motor nucleus, particularly in the ventral corticobasal tract (vCBT) but also in the
ascending part of the intracerebral portion of the facial nerve (aFN), and to the medial and lateral of the facial nucleus. B–G: Sprout distribution
in the rostral direction, from the same ventrolateral brainstem position but 300 m (B) and 150 m (C) caudal to the axotomized facial nucleus,
the axotomized nucleus (D), and the descending part of the intracerebral facial nerve (F). Note the paucity of strongly stained neurites in the
contralateral, uninjured facial nucleus (E) and nerve (G). H: The orientation of central sprouts was determined by drawing two lines, one from the
center of the terminal bulb to that of the nucleus (dashed line, 0°) and the second from the bulb center to that of the farthest visible part of
the stalk and extending it farther into the image (dotted line) and then measuring the angle between the two lines as shown in H. The inset in H
shows the terminal bulb, the attached stalk, and the orientation of the two lines at higher magniﬁcation. I: Distribution of the orientation angles
for the galanin-immunoreactive sprouts outside the axotomized facial motor nucleus with respect to the nucleus. Percentage of the total number
of sprouts, with orientation angles of 0–20°(A), 20–40°(B), 40–60°(C), etc., with 0° pointing directly away from and 180° pointing directly
towardthenucleus.MeanSEM,n4mice.Notethatthemostcommonorientationistheonefacingaway(A),withthesecondlargestrunning
approximately parallel to the facial nucleus (E). Scale bar  0.5 mm in A; 0.8 mm for B–G; 0.36 mm for H; 0.1 mm for inset.
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motornucleusitself,buttheywerelessdenseinthehorse-
shoe form of the facial nucleus gray matter, containing the
axotomizedmotoneurons,thaninitswhitematter-likeven-
tral cleavage (Fig. 1H). A similar distribution was also ob-
served for the CGRP
 sprouts, but their density was con-
siderably lower compared with that of the galanin
 ﬁbers.
Although individual galanin
 and CGRP
 neurites were
observed in the contralateral facial nucleus (Figs. 1E, 2H),
these neurites lacked the typical appearance of sprouts
with the engorged terminal bulb. These sprouts were also
absent in the intracerebral part of the contralateral nerve
(Fig. 1G); the ipsi-and contralateral pyramidal tract (Fig.
2H); the dense neurite network in the dorsal part of the
spinal nucleus of the trigeminal nerve (Fig. 2G); or in other
brainstem, cerebellar, or cortical white matterstructures
(not shown). CGRP and galanin immunoreactivities were
also present in adjacent axotomized motoneurons, each
labeling approximately 40–45% of the total facial mo-
toneuron pool (Moore, 1989; Raivich et al., 1995), but the
intensity of the cell body labeling was weaker than that
observed in the sprouts.
To explore the overall orientation of these central
sprouts, we next examined the orientation angle of gala-
nin
 sprouts outside the facial nucleus on brainstem sec-
tions containing the axotomized nucleus. The orientation
was determined as the angle between the line from the
facialnucleuscentertothecenteroftheaxonalbulbanda
secondlinefromthebulbcentertothefarthestvisiblepart
of the attached axonal stalk, as shown in Figure 2H and H,
inset. The angles were determined at 10 magniﬁcation,
using confocal images from brainstems of four control
C57Bl/6 mice, 14 days after facial nerve cut, and for each
animal subgrouped into one of the nine categories A–I,
from0°to20°(pointingoutward,A),to160–180°(point-
ing to the center of the facial nucleus, I). Angles greater
than 180° (second line to the left of the central line, in-
stead of to the right), were entered by subtracting 180°,
i.e.,265°wasenteredas95°.AsshowninFigure1,sprout
angledistributionwasverynonuniform,withthefrequency
in three groups (A, E, and I) rising above that in the directly
adjacent groups. In total, these three groups were respon-
sible for approximately 70% of the sprouts. The A group
with sprouts facing away from the nucleus was the largest
(39%  3%, mean  SEM), followed by groups E, which
contained sprouts oriented approximately parallel to the
nucleus (24%  1%), and I, with the sprouts directly or
almost directly facing toward the nucleus (8.5%  2.2%).
The number of sprouts in the adjacent and intermediate
categorieswasunderrepresented.Althoughthenumberof
sprouts in B was slightly higher (8.7%  0.6%) than in I,
these two groups were not adjacent. In comparisons with
the directly adjacent groups (A vs. B, E vs. D or F, and I vs.
G) the frequency in A, E, and I was each time both signiﬁ-
cantly and very clearly higher (P  5%, one-way ANOVA
followed by post hoc Tukey test). Although the numbers
were considerably lower, the frequencies in the two seg-
ments directly adjacent to each of the three peaks, A, E
and I, again showed similar proportions of approximately
3:2:1 for the outward pointing (B,C, 15.2%), to roughly
perpendicular (D,F, 8.3%), to inward pointing (G,H, 4.5%)
groups.
Motoneuron origin of central axonal sprouts
To determine whether the bulb-carrying neurites origi-
nated from the lesioned motoneurons, axotomized neu-
rons were retrogradely labeled with a 1% solution of the
dual, anterograde and retrograde, tracer Mini-Ruby (Fig.
2A). As shown in the composite of the ventral brainstem in
Figure 2H, application of the tracer on the proximal nerve
stump surface immediately after facial nerve cut led to a
highly selective labeling of neuronal cell bodies and their
proximal branches in the ipsilateral facial motor nucleus.
Double labeling with galanin immunoreactivity demon-
strated clear Mini-Ruby ﬂuorescence inside a fraction of
galanin
 sprouts around the axotomized facial motor nu-
cleus (Fig. 2B,H, insets). Similar double labeling was also
presentinsidetheintracerebralpartoftheipsilateralfacial
nerve (Fig. 2F, insets). Finally, this colocalization was also
observed with the CGRP
 sprouts (Fig. 2C). Compared
with the neuropeptide immunoreactivity, Mini-Ruby ﬂuo-
rescence was more concentrated to the central parts of
the axonal bulb, with weaker and more fragmented label-
ing of the neighboring axonal stalk.
Quantiﬁcation of the double-labeled sprouts directly
outside the facial motor nucleus, shown in Table 2, dem-
onstratedclearMini-Rubyﬂuorescencein19%3%ofthe
galanin
 and 42%  9% of the CGRP
 sprouts and, in
addition, 39%  1% of the VAChT
 sprouts in adjacent,
galanin-, CGRP-, and VAChT antibody-stained brainstem
sections (P  5% ANOVA followed by Tukey post hoc test,
for differences vs. the galanin
 sprouts; n  4 C57Bl/6
mice, three sections per animal). In the reverse experi-
ment,quantiﬁcationoftheneuropeptideimmunoreactivity
showedthat64%3%oftheidentiﬁed,Mini-Rubyﬂuores-
centsproutsalsoexhibitedgalanin,44%10%CGRP,and
44%  2% VAChT immunoreactivity (not signiﬁcant). This
double labeling, Mini-Ruby/CGRP, Mini-Ruby/VAChT, or
Mini-Ruby/galanin, was not observed outside the main ar-
eas of central axonal sprouts. Thus the ipsilateral spinal
nuclei of the trigeminal nerve (Fig. 2G), contralateral facial
nerve (Fig. 2F), or contralateral facial nucleus (Fig. 2H,
right side) were all devoid of axonal Mini-Ruby ﬂuores-
cence.
However, in addition to sprouts, Min-Ruby ﬂuorescence
was also occasionally present in large and ellipsoid
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706 The Journal of Comparative Neurology  Research in Systems NeuroscienceFigure 2. Demonstration of central axonal sprout origin using Mini-Ruby, a dual anterograde/retrograde tracer. A: Schematic summary. A gelfoam sponge
soaked in 1% Mini-Ruby solution was applied onto the fresh, proximal cut end of the facial nerve, followed by retrograde transport to axotomized motoneurons
anda14-daysurvival.B,C:HighmagniﬁcationofMini-Ruby(green)colocalizationwiththeimmunoreactivity(IR)fortheneuropeptidesgalanin(B)andCGRP(C)
(red)inaxonalsproutsjustoutsidetheaxotomizedfacialmotornucleus.Thedouble-labeledsproutinBandthebottomsproutinCareoutwardpointing(op-s);
the top sprout in C is oriented in parallel to the center of the nucleus (“cruising,” c-s). The insets in B show the individual red and green ﬂuorescence channels.
InC,Mini-Rubyisalsoincorporatedbyperivascularmacrophages(pvm).D:Mini-RubyuptakeinastringofalphaMbeta2integrin(aM)-positive(red)perivascular
macrophages(*)liningacerebralbloodvessel.TheneighboringaM-positiveandramiﬁedmicroglia(mg)aredevoidofMini-Ruby.E–G:Doubleﬂuorescencefor
Mini-Ruby and galanin-IR in the descending intracerebral part of the contralateral facial nerve (E); the axotomized, ipsilateral facial nerve (F); and the ipsilateral
spinalnucleusoftrigeminalnerve(G,isntn).TheinsetsinFshowahighermagniﬁcationofthefacialnerve(left,redandgreen;right,redonlyﬂuorescence).Note
thedouble-labeledsproutsintheaxotomizednerve(arrows)andtheirabsenceintheneighboringtrigeminalnervenucleusandcontralateralnerve.Theasterisk
pointstoaMini-Ruby
butgalanin
–sprout.AsinC,Mini-Rubyisfrequentlypresentinthepopulationsofperivascularmacrophagesassociatedwithlargerblood
vessels(D,pvm).ThemicrographsinEandFshowthesamegalaninlabelingmotifasinFigure1E,FbutcombineitwiththeMini-Rubyﬂuorescence.H:Composite
ofMini-Rubyandgalanin-IRﬂuorescenceintheventralbrainstemacrosstheipsilateralsubstantiagelatinosa,theipsilateralandcontralateralfacialmotornuclei
(ifnc,left;cfnc,right,respectively),andtheipsilateralandcontralateralpyramidaltracts(ipyrandcpyr).Mini-Rubyneuronalcellbodylabelingisstrictlylimitedto
the axotomized facial motor nucleus, with a high density of galanin-positive sprouts in the surrounding tissue. Note the absence of both in the pyramidal tracts
and the contralateral facial nucleus. The insets show higher magniﬁcations for galanin/Mini-Ruby double labeling (yellow) of two sprouts just dorsal of the
axotomizedfacialnucleus;theirpositionsinthecompositeareindicatedbytherectanglesinH.Amagenta/greenversionofFigure2isavailableasSupporting
Information Figure 1. Scale bar 10 mi nB ,4 5m in C and D, 270 m in E–G; 350 m in F insets.
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2D, this Mini-Ruby labeling colocalized with the alphaM-
beta2 immunoreactivity in the perivascular macrophages
and was easy to differentiate from the smaller Mini-Ruby-
ﬂuorescent axonal bulbs inside the neural parenchyma.
The alphaMbeta2
 parenchymal microglia were uniformly
Mini-Ruby
–.
Time course after injury and effects of
reinnervation and recut
Comparison of the galanin-and CGRP-immunostained,
axotomized facial motor nuclei 1–42 days after facial
nervecutwithunoperatedcontrols(day0)revealedatran-
sient sprouting pattern, shown in Figure 3A–AF. No
sprouts were observed in the unoperated facial nuclei or
1–4 days after nerve cut. A moderate number of galanin

and CGRP
 sprouting neurites was observed at day 7;
these became much more common at day 14, decreased
in number at day 21, and disappeared by 42 days after
nerve injury and the ensuing regeneration (Fig. 3A–
F,AG,AI).
As shown in Figure 3AH, automatic quantiﬁcation of the
intensely neuropeptide-immunoﬂuorescent end-bulbs in
and around the facial motor nucleus using confocal scan-
ning and the GCD algorithm (see Materials and Methods)
reproduced this time course for galanin, with a peak den-
sity at day 14, with 5,200 parts per million (ppm) or 0.52%
ofthetotalareaofthe1mm1mmregionwiththefacial
nucleusatitscentercoveredwithgalanin
end-bulbstruc-
tures. However, the GCD algortihm was associated with a
low-level “noise” of 200–600 ppm on the contralateral
side throughout the time course, or approximately 4–12%
of the peak signal levels at day 14.
Direct visual counting of the CGRP
 growth cones (Fig.
3AI)showedatimecoursewithashapesimilartothatwith
galanin (Fig. 3AG). Maximal levels were observed at day
14, with 24  5 CGRP
 sprouts per 20-m section, ap-
proximately 3–4-fold less than with galanin in the directly
adjacent sections (89  8). Unlike the case with galanin,
quantiﬁcation of the CGRP
 end-bulbs with the GCD algo-
rithm revealed a comparatively broader and statistically
signiﬁcant elevation of detected structures on days 4–21
compared with the contralateral side (Fig. 3AJI). However,
the overall levels (200–260 ppm) were much lower, and
the more granular (Nissl-shoal) appearance of the CGRP
immunoreactivity in neuronal cell bodies could have made
automatic growth cone detection more complicated. For
this reason, both quantitation methods, visual counting
andGCDalgorithm,wereusedsidebysideinthefollowing
experiments.
Becausethetimecourseofsprouting,withapeakatday
14, occurred at roughly the same time as the morphologi-
cal reinnervation and functional recovery in the facial axo-
tomymodel(Giladetal.,1996;Werneretal.,2000;Raivich
et al., 2004), we next sought to determine whether the
appearance of sprouts is due to target reinnervation. Re-
innervation is known to occur earlier, more promptly, and
with less error after crush than after cut (Nguyen et al.,
2002; Witzel et al., 2005), so we ﬁrst examined the differ-
ential effects of the facial nerve crush vs. cut on galanin

growth cone proﬁles at days 7, 10, and 14. Here, facial
nerve crush induced the appearance of galanin
 spouts
that peaked at day 10, with 800 ppm of the total area (Fig.
4A). Compared with crush, nerve transection produced a
more robust sprouting response, with a slight but not sig-
niﬁcant increase at days 7 and 10 and an almost 10-fold
increase at day 14 (P  5%, Student’s t-test). As shown in
Figure 4A,C, automatic quantiﬁcation with the GCD algo-
rithm (Fig. 4A) and visual counting (Fig. 4C) revealed very
similar changes in the timing of sprouting changes and
Figure 3. A–AJ: Time course of the appearance (A–AF) and quantiﬁ-
cation (AG–AJ) of galanin- and CGRP-immunoreactive sprouts in the
facialmotornucleus,1–42daysafterfacialnerveaxotomy;day0are
uninjured controls. A–AF show the immunoﬂuorescence in injured
facialnucleusatlowmagniﬁcation(A,E,I,M,Q,U,Y,ACforgalanin,and
C,G,K,O,S,W,AA,AE for CGRP) and at 4o r8 higher magniﬁcation
forgalanin(B,F,J,N,R,V,Z,AD)andCGRP(D,H,L,P,T,X,AB,AF).Notethe
massive increase in the neuropeptide-labeled sprouts (arrows) at
days7–21;arrowheadspointtoneighboringmotoneuroncellbodies.
AG–AJ: The graphs at right show the total number of galanin-and
CGRP-immunoreactive sprouts per section (AG and AI, respectively)
and the quantiﬁcation of the area taken by the galanin-and CGRP-
immunoreactive sprouts (AH, AJ) in parts per million (ppm). Mean 
SEM,n3animalspergroupinAGandAI,n4inAHandAJ).*P
0.05, Student’s t-test compared with the unoperated, contralateral
side. In the case of galanin, both parameters, number (AG) and area
(AH), show a sharp peak at day 14. The same also holds true for the
CGRP
 sprout number (AI), but the CGRP
 area recognized by the
Optimas GCD algorithm (AJ) shows a broader, elevated plateau be-
tween day 4 and day 21. Scale bar  250 m in ﬁrst and third
columns; 0.063 m in the second column; 0.032 m in fourth
column.
TABLE 2.
Colocalization of Mini-Ruby (MR) With Galanin and CGRP-
Positive Growth Cones (n  4 Animals, Three Facial Nucleus
Sections per Animal; Mean  SEM)
Growth cone
neurochemical marker
(NCM)
MR
NCM
/
NCM
 (%)
MR
NCM
/
MR
 (%)
Galanin 19  36 4  3
CGRP 42  9
1 44  10
VAChT 39  1
1 44  2
1P5%,one-wayANOVA,followedbyTukeyposthoctestfordifferences
in the frequency to MR
/galanin
 growth cones. The percentages are
derived from, on average, approximately 50-60 double-labelled growth
cones per animal and axotomized facial motor nucleus.
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ﬁrming the cross-validity of both techniques for the gala-
nin
 sprouts.
To determine further whether the appearance of growth
cones was due to the onset in reinnervation of peripheral
targets occurring 8–14 days after injury, we next exam-
ined the effects of single facial nerve cut vs. a second
transection. The facial nerve was recut 1 mm below the
initial lesion (n  5 animals per group) on day 8 with sur-
vival to day 14 or was recut on day 14 with survival to day
22 and compared with normal animals 8, 14, and 22 days
after facial nerve cut, which served as controls (Fig. 4B,D).
Surprisingly,thegrowthconeswerenotabrogated;infact,
theareaundergrowthconeproﬁleswas1.5–2-foldgreater
than in control day 14 or day 22 postcut brainstems (P 
2%, ANOVA). As in Figure 4A,C, very similar quantitative
effects were observed with the GCD algorithm (Fig. 4B)
and visual counting (Fig. 4D).
Preliminary studies with shorter recut times (1, 2, and 4
days) and total transection time of 14 days revealed that
the growth cone proﬁles were more numerous than after a
simple day 14 cut, but the effects were less pronounced
than in 8  6 vs. 14, or 14  8 vs. 22 (data not shown).
Finally, retrograde tracing experiments with application of
MiniRuby to the ipsilateral whiskerpad, the principal pe-
ripheral target of the facial nerve maxillary and zygomatic
branches on day 12, showed some motoneuron cell body
labelingbutfailedtobeincorporatedintothefacialgrowth
cones at day 14 (data not shown), unlike the Mini-Ruby
labeling applied on the freshly cut facial nerve stump,
shown in Figure 2B,C,E and the inset in Figure 2H.
Molecular markers and ultrastructure
To deﬁne the molecular markers of axotomy-induced
sprouts, we next examined the presence of VAChT,
microtubule-associated protein 2 (MAP2), synaptophysin,
and NFH as cholinergic, dendrite, presynaptic, and pan-
neuritemarkers,respectively(Fig.5,threeleftcolumns)as
well as the CD44 hyaluronic acid receptor and the alpha4,
alpha5, alpha6, alpha 7, and beta1 subunits of the beta1
integrin family (Fig. 5, three right columns), using double
immunoﬂuorescence with galanin, CGRP, or VAChT (Fig.
5G–I,S–Y). Markers labeled with rabbit polyclonal antibod-
ies (MAP2, NFH, alpha7) were double stained with guinea
pig antibodies against VAChT, and those labeled with rat
monoclonal antibodies (alpha4–6, beta1, CD44) were
double stained with galanin or CGRP.
TheCGRP
(Fig.5A–C)andgalanin
(Fig.5D–F)sprouts
colocalizedwithVAChTimmunoreactivity,conﬁrmingtheir
cholinergic phenotype. They were also positive for CD44
(Fig. 5V–Y) and beta1 (Fig. 5S–U) but not for alpha4, al-
pha5 or alpha6 (not shown). Most VAChT sprouts were
alsopositiveforsynaptophysin(Fig.5P–R),andmanywere
alpha7
, even though some large and distended alpha7

sprout end-bulbs were VAChT
– (Fig. 5G–I). VAChT

sprouts did not colocalize with NFH (Fig. 5G–I) or MAP2
(Fig. 5M–O) immunoreactivity, suggesting that most
sprouts are derived from cholinergic neurons, that they
do not colocalize with typical components of dendritic
(McDermid et al., 2004) or axonal shaft cytoskeleton, and
that they express regeneration-associated CD44 and
alpha7beta1 integrin cell adhesion molecules (Werner et
al., 2000; Raivich et al., 2004). Similarly pronounced,
regeneration-associated immunoreactivity was also ob-
served on the Mini-Ruby-labeled axonal sprouts, shown in
Figure5Z–ABforthealpha7,inFigure5AC–AEforbeta1,in
Figure 5AF–AH for CD44, and in Figure 5AI–AK for VAChT,
reconﬁrming the facial motoneuron origin of these neuro-
chemically tagged structures.
Many alpha7
, galanin
, and VAChT
 sprout end-bulbs
were particularly pronounced in the basal white matter
located ventrally of the axotomized facial motor nuclei, so
wenextexploredtheirutrastructuralmorphologybytrans-
mission electron microscopy (EM), 14 days after facial
nervecut(Fig.6A,B).Startingwithalpha7,immunolabeling
against the intracellular part of the alpha7 integrin subunit
revealed strong cytoplasmic staining surrounding numer-
Figure 4. A–D: Central axonal sprouting depends on the mode of
injury. A,C: After facial nerve crush, the sprout area in ppm (A) and
the number of sprouts per section (C) reach a moderate peak at day
10 and after cut a much higher peak at day 14. *P  0.05, Student’s
t-test for crush vs. cut (n  3 animals per group, mean  SEM). B,D:
Additional injury exacerbates central axonal sprouting following fa-
cial nerve cut—both in total area (B) and in the number of sprouts
(D)—compared with the same total cut period (8  6 vs. 14 days,
148vs.22days).*P0.05,one-wayANOVAandpost-hocTukey,
n  4–5 animals per group.
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acetylcholine transporter (VAChT), double labeling with CGRP (A–C), galanin (D–F), alpha7 integrin subunit (G–I), neuroﬁlament heavy (NFH)
isoform (J–L), microtubule-associated protein-2/MAP2 (M–O), and synaptophysin/SynPh (P–R) immunoreactivities. VAChT
 sprouts were very
frequently positive for galanin, frequently also for alpha 7 and synaptophysin, and more rarely for CGRP immunoreactivity (white arrows in A–C,
bluearrowsmarksingle-labeledVAChT
sprouts).NotetheabsenceofdoublelabelingforNFHandMAP2.A–CandP–Rareinsidethefacialmotor
nucleus, D–L in the adjacent ventral white matter, and M–O at the gray/white matter interface. A–C and P–R are composite micrographs, to
illustratethecolocalizationofsomebutnotallVAChT
sproutswithCGRPandsynaptophysin.S–Y:Colocalizationofgalanin-positivesproutswith
the beta1 integrin subunit (S–U) and with CD44 (V–Y). Z–AK: Colocalization of Mini-Ruby-labeled growth cones with the alpha7 (Z–AB) and beta
1 (AC–AE) integrin subunits, CD44 (AF–AH), and VAChT (AI–AK). White arrows point to double-labeled sprouts in AC,AD, in AF,AG, and in AI,AJ).
Asterisks in AC and AD label a Mini-Ruby
, perivascular macrophage. Micrographs in AI–AK are from the border region between facial nucleus
(left) and medial white matter and also show two adjacent, Mini-Ruby-labeled motoneurons (n) at left, surrounded by large, VAChT
 synapses.
Z–AH are inside the dorsal white matter, next to the facial nucleus. A magenta/green version of Figure 5 is available as Supporting Information
Figure 2. Scale bar  50 m for A–C,J–L; 27 m for Z–AB,AI–AK; 12.5 m for P–R; 40 m in all other micrographs.
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large structures characteristic of growth cone morphology
and the associated 0.3–0.5-m thin axonal stalks that
were frequently directly in contact with neighboring
alpha7-negative oligodendroglial surfaces (Fig. 6A). There
was no alpha7 immunoreactivity on the associated myelin
or myelinated axons (Fig. 6A), blood vessel endothelia, or
largeperivascularcells(Fig.6B).However,somesubmem-
braneous alpha7 immunoreactivity was also present on
the small pericytes and the astrocytic processes contact-
ing the perivascular basal membranes (Fig. 6B).
Similar sprout ultrastructure was also observed using
immunoreactivity for galanin (Fig. 6C, E) and VAChT (Fig.
6D, F). To determine the approximate frequency of differ-
ent contacts, we analyzed 39 galanin
 and 57 VAChT

sprouts at 10,000 magniﬁcation (Table 3). Assessment
with these latter, common and unambiguously neuron-
speciﬁc markers revealed frequent growth cone contacts
Figure 6. Ultrastructure of axonal growth cones and their cellular contacts using alpha7 (A,B), galanin (C,E), and VAChT (D,F) immunoreactivity
in the white matter surrounding the facial motor nucleus, 14 days following facial nerve cut in WT animals. A: Intensely cytoplasmically stained
axonal growth cones (alpha7), containing numerous (unstained) mitochondria and synaptic vesicles and contacting adjacent oligodendrocytes
(OL). B: Strong alpha7 immunoreactivity in submembranous astrocyte cytoplasm (arrowhead) next to the ﬁnger-like protrusions of the basal
membrane (BM). Some alpha7 immunoreactivity was also present in blood vessel pericytes (P). L, blood vessel lumen; EC, endothelial cell; PC,
perivascularcell;AF,astrocyteﬁbrils.C,E:Galanin(GALN)-immunoreactivegrowthcones,herecontactingastrocytelamella(AL;C),unmyelinated
axons(AX;C),andnumerousmyelinatedaxons(E).D,F:VAChT-immunoreactiveaxonalsproutsgrowingalongsideaVAChT-negative(GC*)growth
cone (D) and an astrocyte ﬁbril (AF)-containing process (F). Scale bar  1 m for A,B,F; 0.35 m for C; 1.2 m for D; 0.6 mi nE .
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lae (Fig. 6C), other growth cones (Fig. 6D), myelin sheaths
(Fig. 6E), and large astrocyte processes containing astro-
cyte ﬁbrils (Fig. 6F). As shown in Table 3, quantiﬁcation of
identiﬁed growth cones and their contacts in the electron
microscopic sections of perifacial ventral white matter re-
vealed that they were particularly frequent with neighbor-
ingunmyelinatedaxons(97–100%),astrocytelamella(91–
95%), and outer myelin sheaths (54–56%), and with lower
frequency with other growth cones, ﬁbrillar astrocyte pro-
cesses (21–23%), and oligodendroglial cell bodies (0–3%).
This frequency of cellular contacts was very similar for the
galanin
 and VAChT
 sprouts. The only exception were
contacts with other growth cones, which were approxi-
mately 2.5-fold more common in the VAChT
 sprouts
(39%) than in galanin
sprouts, with 15% (P  2%, 
2 test).
Effects of lipopolysaccharide-induced
inﬂammation and alpha7, brain c-Jun, and
TNFR1/2 deletions
Previous studies with the facial axotomy model examin-
ing neuronal cell death (Mo ¨ller et al., 1996; Raivich et al.,
2002),leukocyteinﬂux(Raivichetal.,1998;Bohatscheket
al., 2001), bystander-activation inﬂammatory changes in
neighboring microglia, and induction of late neuronal
regeneration-associated molecules such as galanin and
beta1 integrin subunit (Kloss et al., 1999) showed that
these events also peak at day 14, coinciding with the cur-
rently detected maximum in intracerebral facial axonal
sprouting. To determine their effects on the delayed facial
sprouting, we next examined the changes resulting from
speciﬁc gene deletion mutants for alpha7, brain c-Jun, and
TNFreceptortypes1and2(TNFR1/2)genedeletions,and
LPS-induced inﬂammation, which were previously shown
to affect cell death, regeneration, bystander activation,
and neural leukocyte recruitment.
Inthecaseofc-Jun,preliminarydatasuggestedareduc-
tion of sprouting in the absence of brain c-Jun (Raivich et
al., 2004; Supp. Info. Fig. 2). In the current study, direct
quantiﬁcation of growth cone area using GCD algorithm
and visual counting conﬁrmed this effect (Fig. 7A–C), re-
vealing a 97% decrease in area and a 96% decrease in the
number of galanin
 sprouts in mice lacking brain c-Jun
(P  1%, Student’s t-test). Deletion of the alpha7 integrin
subunit (Fig. 7G–I) caused a 45% increase in area and 50%
increaseinthenumberofgalanin
sproutsinthe–/–mice
(P  5%); that of TNFR1/2 (Fig. 7J–L) was associated with
a 39% increase in area but minimal change (–3%) in the
number of sprouts, with neither change reaching the level
of statistical signiﬁcance (P  10.5% and 92%, respec-
tively).Systemicapplicationof1mgE.colilipopolysaccha-
ride(LPS)in0.9%saline(Fig.7M–R)witha0.5-,1-,or2-day
interval preceding day 14 caused an approximately 50%
reductionintheareaofgalanin
sprouts(P2%,one-way
ANOVA followed by post hoc Tukey); the effect disap-
peared at the 4-day interval. Injection of saline alone with
a 1-day interval did not affect sprouting (Fig. 7O). Direct
visual counting revealed similar, approximately 40% de-
crease in the number of sprouts 0.5–2 days following ex-
posure to LPS (P  5%, one-way ANOVA, post hoc Tukey).
Becauseabsenceofbrainc-Junalsostronglydiminished
the postaxotomy increase in neuronal galanin immunore-
activity in a previous study (Raivich et al., 2004), it is pos-
sible that the currently detected effect of c-Jun was due to
galanin-presumptivesproutscarryingverylittlegalaninim-
munoreactivity and thus escaping detection. This problem
appears to be speciﬁc for galanin and c-Jun; deletion of
alpha7 did not appear affect the overall galanin immuno-
reactivity (Werner et al., 2000). In the current study, we
reconﬁrmed this lack of effect on the overall galanin im-
munoﬂuorescence (IF) in the axotomized facial motor nu-
cleus in the alpha7 mutants [10.0  0.4 vs. 9.6  0.7 in
optical luminosity values (OLV) for the IF in alpha7/
and –/–mice, respectively; P  61%] and noted similar
lackofeffectinTNFR1/2mutants(8.40.8vs8.60.5,
P  86%), or the application of LPS (8.76  0.61 for con-
trol, 9.51  0.80 for 0.5 days, 9.88  1.11 for 1 day,
9.55  0.61 for 2 days, and 9.53  0.89 for 4 days,
respectively; P  90% in one-way ANOVA). In general,
brightly ﬂuorescent axonal growth cones showed an ap-
proximately 3–3.5-fold higher staining compared with the
whole facial motor nucleus (0.50–0.55 in log10 relative
intensity of staining and contrast/RISC units). However,
unlike the results in the interleukin-6 deletion study
(Galiano et al., 2001), we did not observe a statistically
signiﬁcant change in the RISC values of the mutants (jun,
alpha7, TNFR1/2) compared with their wild-type litter-
mates (t-test) or in LPS-injected animals compared with
controls (one-way ANOVA).
TABLE 3.
Utrastructural Growth Cone Contacts
Detected growth cone
immunoreactivity
Galanin
positive (%)
VAChT positive
(%)
Contact with myelin 56 (22/39) 54 (31/57)
Oligodendroglial cell body 3 (1/39) 0 (0/57)
Astrocyte lamella 95 (37/39) 91 (52/57)
Filamentous astrocyte process 23 (9/39) 21 (12/57)
Neighboring axon 97 (38/39) 100 (57/57)
Another growth cone 15 (6/39) 39 (22/57)
1
1P  2%, 
2 test comparing this contact type for galanin
 vs. VAChT

growth cones. Galanin
 and VAChT
 can contact several different struc-
tures at the same time, so the total number of different contacts can be
higher(approximatelythreetimeshigher)thanthenumberofthelabelled
growth cones in either column.
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1995), quantitative experiments on total CGRP immunore-
activitydidrevealconstitutivelystrongstainingonthecon-
trolsideand,at14daysafteraxotomy,amoderatethough
signiﬁcant increase on the injured side in the control jun
f/f
(Fig. 7F, inset, two left bars) as well as in the brain Jun-
deﬁcient mice (Fig. 7F, inset, two right bars; P  1%, Stu-
dent’s t-test). Moreover, neither the control nor the axoto-
mized side nor the increase in CGRP staining on the
axotomized side was affected by deletion of brain c-Jun.
To validate the effect of brain c-Jun on facial axonal
sprouting, we therefore examined the effects on the
CGRP
 sprouts. As shown in Figure 7D,E, deletion of brain
c-Junbroughtonavisiblereductioninsproutslabeledwith
CGRP immunoreactivity, while not affecting the intensity
of neuronal cell proﬁles. In the same vein, quantitative
comparison of the area covered by CGRP
 sprouts (Fig.
7F) showed a 60% decrease in brain Jun-deﬁcient animals
compared with their jun
f/f controls (P  2%, Student’s
t-test). Direct visual counting revealed a similar, approxi-
mately 67% decrease in the number of sprouts (P  5%).
Changes in beta1 integrin levels
The beta1 integrin subunit is the obligate partner of
alpha7 and shows a neuronal expression peak 14 days
following facial nerve cut (Kloss et al., 1999), so we next
exploredtherelationshipbetweensproutingresponseand
levels of this regeneration associated molecule. As shown
in Figure 8A, absence of the alpha7 integrin caused signif-
icantly elevated beta1 integrin levels at day 14 compared
with littermate controls (34%, P  5%, Student’s t-test).
Similarly, deletion of brain c-jun also showed a 68% de-
crease in beta1 integrin immunoreactivity following facial
axotomy at day 14 (Fig. 8B; P  5%), in line with the ab-
sence in central sprouting observed in these mutants.
AdministrationofLPSdidnotaffectbeta1integrinlevels
signiﬁcantly at any of the time points (0.5–4 days) tested
(Fig.8D).Therewasalsonosigniﬁcantdifferencebetween
cutandcrushinjuryatday7orday14,buttherewasa25%
increase at day 10 (Fig. 8C). Reinjury paradigms (8  6,
14  8) caused a signiﬁcant, 26% and 27% decrease (P 
5%), respectively, compared with their controls at days 14
and 22 (Fig. 8E).
DISCUSSION
Regenerativeaxonalsproutingiscriticalforrepairofthe
adult nervous system, but the speciﬁc signals involved are
only beginning to be understood. The facial nerve axotomy
modelisawell-characterizedparadigmforstudyingmolec-
ular mechanisms involved in successful peripheral regen-
erationandfunctionalrecovery,andpreviousstudieshave
reported the appearance of central galanin
 sprouts in-
side the facial motor nucleus 14 days after nerve cut
(Galiano et al., 2001; Makwana et al., 2007). The aim of
the current set of experiments was to establish the
neuroanatomical origin and distribution of these growth
cone-carrying axons, determine the time course of their
sprouting response, and identify physiological causes re-
sponsible for its transient appearance and regulation fol-
lowing injury.
As shown in the current study, transection of axons in
the peripheral part of the facial motor nerve caused the
delayed appearance of sprouting, galanin
, and to a lesser
extent CGRP
, neurites inside the central nervous system, in
and around the affected facial motor nucleus. These sprouts
appeared to originate from axotomized facial motoneurons
basedontheirselectiveappearanceontheinjuredside;pres-
ence of vesicular acetylcholine transporter as a marker of
cholinergic phenotype; presence of both galanin
 and
CGRP
 subpopulations of facial motoneurons; and colocal-
ization with the bidirectional, retrograde and anterograde,
tracerMini-Rubyﬁrstappliedtotheproximalstumpofthecut
facial nerve. As demonstrated in Figure 2H, cell body ﬂuores-
cence for Mini-Ruby was completely limited to the axoto-
mized facial motor nucleus. Together with the absence of
axonal Mini-Ruby staining in sensory projection areas (brain-
stem, substantia gelatinosa, spinal nucleus of the trigeminal
nerve), this argues against a major sensory contribution to
the perifacial sprouting. This point is reinforced by the pres-
ence of VAChT as a marker of cholinergic phenotype on a
large number, although not in all, of sprouts detected here
and the fact that VAChT
 innervation of motoneurons is not
affected by removal of sensory input (Oliveira et al., 2003).
Finally, sprouts located outside the nucleus and visualized
with their stalk and bulb had their leading structure, the
growthconebulb,inthemajorityofcasespointingawayfrom
thenucleus,suggestinggrowthaway,notgrowthtoward,the
nucleus.
Figure 7. Effects of neural c-Jun (jun
N; A–F), TNFR1/2 (G–I), and
alpha7 (J–L) gene deletions and LPS-induced inﬂammation (M–R)o n
galanin (A–C,G–R)-and CGRP (D–F)-immunoreactive central axonal
sprouting in the facial motor nucleus 14 days after cut. Left row,
littermate controls; center, mutants; right, quantiﬁcation of the ef-
fects on the area (left Y-axis, parts per million) and number (#, right
Y-axis) of galanin-or CGRP-positive sprouts (mean  SEM, n  3–6
animals per group). Solid bars, littermate controls; open bars, mu-
tants. In the case of endotoxin (O), single intraperitoneal injection of
1mgE.coliLPS/kgcausedatransientdecreaseofsprouting12–48
hours after injection (solid bars). Uninjected animals (0) and mice 24
hours after saline (sal) injection served as controls (open bars). *P 
5%, Student’s t-test (C,I) or ANOVA followed by post hoc Tukey test
(O). The inset in F shows the overall CGRP immunoreactivity (in OLV
values) in the axotomized (ax, solid bars) and contralateral (co, open
bars) for the jun
f/f controls (left) and jun
N mutants (right). Scale
bar  200 m in R (applies to A,C,G–R); 80 m for D,E.
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the proﬁle of growing axon terminals. They contained
highlevelsofanterogradelytransportedneuropeptidesga-
lanin and CGRP, synaptophysin, and VAChT; expressed
regeneration-associated CD44 and alpha7beta1 integrin
celladhesionmolecules(Werneretal.,2000;Raivichetal.,
2004); and lacked MAP2, a typical component of dendritic
cytoskeleton(McDermidetal.,2004).Theabsenceofneu-
roﬁlament H staining is also in line with the fact that neu-
roﬁlaments do not extend into the terminal growth cone
structures (Jacobs and Thomas, 1982; Tetzlaff and Bisby,
1989). Detailed morphological studies in similar models in
axotomized cat spinal motoneurons and commissural in-
terneurons showed that these sprouts had a long, axon-
like process can project directly from the soma, proximal
principal dendrite, or even very distal part of the dendrite,
depending on the type of axotomized neuron (MacDermid
et al., 2004; Fenrich et al., 2007). Although the current
data focus more on the molecular characterization and
regulatorydynamicsofthesproutingresponse,itwillbeof
considerable interest to identify in a future study the main
subcellular origin of the proliﬁc sprouting response that is
observed following mouse facial axotomy.
Sprouting orientation
Theoretically, growth cones associated with the injured
facialmotornucleuscouldbeorientedinanydirectionwith
respect to the nucleus. In fact, they did show a clearly
trimodal distribution (Fig. 1I), with three of the nine seg-
ments responsible for 70% of the orientations taken.
Sprouts in the largest of these three groups (A, 38%) were
oriented away from (0°–20°) and those in the smallest (I,
8%) were oriented directly toward the nucleus (160°–
180°). Sprouts in the relatively large intermediate group
(E, 24%) oriented themselves roughly perpendicular to the
vector from the center of the nucleus and parallel (80–
100°) to the outline of the nucleus proper. The overall
predominanceofoutward-pointingsproutsappearstosug-
gestthepresenceofastrongrepellentcueassociatedwith
the injured facial motor nucleus, which would be consis-
tent with the lower density of sprouts inside than directly
outside the nucleus, as shown in Figure 1H. In the same
vein, the presence of a smaller segment of sprouts point-
ing toward the nucleus (8% in I, 13% in the inward three
segments G–I) could be due to a paradoxical reaction, re-
versing a repellent to an attractant response (Tear, 1998;
Gavazzi, 2001) or the presence of bona ﬁde attractors, to
which only a smaller subpopulation is sensitive. Finally,
instead of a gradual increase from the directly inward-to
outward-pointing segments, there is a relatively large, in-
termediate fraction of “cruising” sprouts that run perpen-
dicular to the vector from the nucleus center. Although at
ﬁrst puzzling, this could suggest that some sprouts lay a
decidedlyequidistantcoursebetweentwosimilarlyattrac-
tive directions.
At present the identity of signals regulating this orienta-
tiondistributionareunknown.Injuredfacialmotorneurons
are known to change the expression for a series of che-
morepellant molecules and their subcellular signalling,
with increased semaphorin IIIC and plexin A2 synthesis
(Pasterkamp et al., 1998; Spinelli et al., 2007; Oschipok et
al., 2008). However, some repellent signals may also orig-
inate from neighboring microglia (Schifman and Selzer,
2007), which exhibit maximal activation at day 14 (Bo-
hatschek et al., 2004), together with the peak sprouting
response. Here, cell-type-selective deletion of expressed
chemorepellent cues will improve insight into the cellular
source and speciﬁc effects of signals guiding sprouting
inside the adult central nervous system.
Effects of regeneration, reinnervation, and
recut
The onset and peak of sprouting at day 7 and day 14
after cut occur at roughly the same time as the beginning
of facial motoneuron reinnervation of their peripheral tar-
get described in previous studies (Werner et al., 2000;
Raivich et al., 2004). Moreover, denervated muscle ﬁbers
Figure8. Effectsofalpha7(A)andneuraljun(B)deletions,crushvs.
cut(C),applicationofLPS(D),andadditionalnerveinjury(E)onbeta1
integrin subunit levels in the axotomized and contralateral facial mo-
tor nuclei. *P  5%, Student t-test (A–C) or ANOVA and post hoc
Tukey test (E). Beta1 immunoreactivity was quantiﬁed by using the
Mean-SDalgorithmandisshowninOLVvalues,n3–6animalsper
group, as in Figure 7. A,B,D show the results from facial motor nuclei
14 days after nerve cut; C compares crush with cut 7–14 days after
axotomy;Eshowstheeffectsofsecond(cut)injury.co(C),contralat-
eral side to the lesion.
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(Covault and Sanes, 1985; Koliatsos et al., 1993; Funako-
shietal.,1993;Ishiietal.,1994;Springeretal.,1995)that
could provide a transient surge in trophic signals available
to axotomized motoneurons during the initial process of
reconnection. However, our data do not suggest that rein-
nervation is responsible for the sudden burst in central
axonalsprouting.Althoughreinnervationisknowntooccur
earlier,morepromptly,andwithlesserroraftercrushthan
after cut (Nguyen et al., 2002; Witzel et al., 2005), peak
levels of sprouting after cut were more than 5-fold higher
than after crush. Similarly, the reinterruption of axonal
connections with a recut (8  6, 14  8) led to a signiﬁ-
cantly stronger sprouting response compared with that
observed following a single cut at day 14 and day 22,
respectively. This enhanced sprouting could be due to a
conditioning effect (Woolf et al., 1992; Gilad et al., 1996).
However, the 14  8 sprouting was less than at day 14,
suggesting that overall duration and presence of recut,
rather than the conditioning effect, are the primary vari-
ables that deﬁne the extent of central sprouting.
Surprisingly, these facial axonal sprouts were particu-
larly numerous in the white matter tissue that appears to
inhibit the outgrowth of corticospinal, rubrospinal, or pe-
ripheral sensory axons via rapid growth cone collapse
(Thallmair et al., 1998; McKerracher, 2001; Cafferty et al.,
2008). At the ultrastructural level (Table 1), the facial
sprouts showed frequent and close contact with neighbor-
ing myelinated sheaths (Fig. 6E, Table 1) and occasionally
with the oligodendroglial cell bodies (Fig. 6A), while main-
taining an active growth state. Interestingly, and unlike
mostofthecasesmentionedabovefrompreviousstudies,
dissociated sensory neurons microtransplanted into the
spinal cord showed almost no inhibition, growing robustly
through normal or even through predegenerated white
matter (Davies et al., 1999). In fact, they were stopped
only by glial scars surrounding CNS lesions. Although
these effects appeared to be speciﬁc for peripheral sen-
sory neurons—similarly dissociated cortical neurons did
not regenerate into white matter (Tom et al., 2004)—the
facialsproutingresponseshowninthecurrentstudycould
suggest that similar resilience to white matter inhibitory
signals is inducible in central neurons. Understanding the
molecular signals associated with the formation of facial
axonal sprouts could thus provide clues to improving re-
generative response in the white matter of the central ner-
vous system.
Neuronal cell death and inﬂammation
The peak in central axonal sprouting in the mouse facial
axotomy model also coincides with the maximum in sub-
stantial neuronal cell death and also with inﬂammatory
changesinmicrogliaandastrocytesandleukocyterecruit-
ment observed in this CNS injury and repair model. Previ-
ous evidence also shows that those subtypes of neurons
that are most likely to be programmed to launch a regen-
erative response after injury, for example, retinal ganglion
cells, also exhibit a high rate of cell death (Berkelaar et al.,
1994),whichisinlinewithobservationsinwhichparticular
transcription factors such as c-Jun that contribute to cell
death are also required for regeneration (Raivich et al.,
2004).
In the same vein, brain c-Jun-deﬁcient animals with an
absence of neuronal cell death following facial nerve cut
(Raivich et al., 2004) do show a reduced sprouting re-
sponse in the mutant animals. However, this correlation is
not maintained in other mutants with effects on cell death
in the same model. TNFR1/2 null mice show a 4-fold re-
duction in cell death (Raivich et al., 2002) and a slight,
though not signiﬁcant, tendency toward higher central
sprouting. Transforming growth factor-1 null mice also
show greatly increased cell death, together with a signiﬁ-
cantly reduced sprouting response (Makwana et al.,
2007). A similar lack of linear correlation is also observed
forperipheralregeneration,withenhancedsproutinginIL6
null (Galiano et al., 2001) and alpha7 null (Fig 6G–I) ani-
mals and reduced sprouting in the brain c-jun-deﬁcient
animals(Fig6A–F);allthreegroupsofmutantmiceshowa
signiﬁcant reduction in the speed of peripheral nerve out-
growth (Zhong et al., 1999; Werner et al., 2000; Galiano et
al., 2001; Raivich et al., 2004).
Current data do show a relatively straightforward corre-
lation between neural inﬂammation and reduced central
axonal sprouting in the facial axotomy model. Systemic
applicationof1mgE.coliendotoxincausingsevereneural
inﬂammation and granulocyte recruitment (Bohatschek et
al., 2001), resulted in a 50% reduction in sprouting re-
sponse 12–48 hours following the intraperitoneal injec-
tion (Fig. 6M–R). Enhanced neural inﬂammation in TGF-
beta1 null mice is associated with reduced sprouting
(Makwana et al., 2007). This also appears to be true in
reverse, with attenuated inﬂammation and 50% enhanced
sprouting in IL6 null mice (Galiano et al., 2001). Finally,
reduced inﬂammatory response in the TNFR1/2 null mice
(Hristova et al., 2005; Bohatschek et al., 2005; Liu et al.,
2006) coincides with the tendency toward improved
sprout outgrowth in these mutant mice shown in the cur-
rent study and agrees with the appearance of MAP2-
negative dendraxon sprouts in permanently axotomized
cat motoneurons (McDermid et al., 2004).
Induced inﬂammation around the cell body has been
shown to improve sensory axon outgrowth into the CNS
(Lu and Richardson, 1991). However, these results were
obtained when inﬂammatory stimulus was used instead of
peripheral nerve injury, unlike the current model in which
peripheral injury is followed by a robust inﬂammatory re-
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Graeber, 2004). Central injury frequently produces a mild
retrograde reaction, in which additional inﬂammation will
elicit a stimulatory effect (Hossain-Ibrahim et al., 2006),
raising the question with regard to those components of
neuronal response that speciﬁcally enhance neurite out-
growth inside the injured CNS.
Endogenous signals in central axonal
sprouting
Up-regulation of neuronal transcription factors such as
c-Jun, ATF3, or STAT3 plays an important role in the neural
responsetoinjuryandthesynthesisofmoleculesrequired
for regeneration and repair (Herdegen and Leah, 1998;
Tsujino et al., 2000; Schweizer et al., 2002). As shown in
this study, neural expression of c-Jun transcription factor
strongly supports the delayed appearance of central
axonal sprouting. Although numerous regeneration-
associated genes and proteins show an early onset and
peak of expression following injury (e.g., ATF3, GAP43,
CD44, CGRP, alpha7 integrin subunit) that may allow the
different stages in the initiation and execution of neurite
outgrowth(Seijffersetal.,2007),thereisasecondorlater
groupofmoleculessuchasgalanin,beta1,andnoxa(Kloss
et al., 1999; Galiano et al., 2001; Kiryu-Seo et al., 2005; Di
Giovanni et al., 2006) with a relatively delayed expression
that coincides with central sprouting and neuronal cell
death.Moreover,manyofthelatebutalsoearlymolecules
are brain c-Jun dependent and as shown in the current
study are actually expressed in the facial axonal sprouts,
for example, CD44, galanin, and alpha7beta1 integrin.
These growth-cone-localized molecules support axonal
elongation and outgrowth in the peripheral nerve (Werner
etal.,2000;Holmesetal.,2000)andmayenhancecentral
sprouting as well as allow nascent central growth cones to
withstand numerous inhibitory cues such as NOGO, MAG,
and OMGP that are present in the white matter (McKer-
racher, 2001). Although hypothetical, the neurite-
outgrowth enhancing properties of galanin could also be
involved in the much stronger sprouting observed in the
galanin
 compared with the CGRP
 populations of axoto-
mized facial motoneurons.
Deletionofthealpha7integrinsubunitincreasescentral
sprouting, which could point to an inhibitory role of the
alpha7beta1 integrin. Previous immunohistochemical
studies revealed prominent localization of both integrin
components, alpha7 and beta1, on the terminal parts of
growing axons and the cell bodies of axotomized motor
andsensoryneurons,withverylittleexpressiononmostof
the axons or in dendritic arborizations (Kloss et al., 1999;
Werner et al., 2000). The current study also shows a very
similar distribution, with much higher levels of both com-
ponents in the terminal part of the sprout than in the adja-
cent axon-like stalk (Fig. 5S–U,Z–AB,AC–AE), pointing to a
speciﬁc growth cone function. Furthermore, the appar-
ently compensatory up-regulation of beta1 could suggest
enhanced activity, for example, via one of the other 11
currently identiﬁed beta1-associating alpha subunits (Sixt
et al., 2006), by interacting with ﬁbronectin, the main ex-
tracellular matrix component associated with the out-
growth of transplanted sensory neurons in central white
matter, for example (Tom et al., 2004). Moreover, the
strong decrease in posttraumatic neuronal expression of
beta1 in brain Jun-deﬁcient mice could also contribute to
thereductionincentralsproutinginthesemutantanimals.
This potential involvement of beta1-family integrins is
qualiﬁed by incomplete overlap of peak beta1 levels (day
10)andsprouting(day14)inthecutvs.crushexperiment.
It is possible that the regulatory control exerted by the
alpha7beta1 integrin is in fact several steps upstream of
the actual sprouting response, particularly inasmuch as
the immunoreactivities for beta1 (Fig. 8C) and for alpha7
(Fig. 1b in Werner et al., 2000) both peak between day 7
and day 10 and are already strongly decreased at day 14.
Moreover, the signiﬁcant reduction of beta1 levels in the
recutexperimentwasassociatedwithenhancedsprouting
(Fig. 7D,E) and could indicate the presence of additional
pathways involved in the regulation of central axonal out-
growthundervaryinggeneticandexperimentalconditions.
Nevertheless, the hypothesis for beta1-integrin-family in-
volvement will have to be tested using central neuronal
deletion of the beta subunit to settle this issue. Further-
more, if these experiments do show positive involvement
of beta1, identifying the cognate alpha subunit(s) involved
in central axonal sprouting could enhance the therapeutic
understanding of the repair processes operating in the
injured brain and spinal cord.
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